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Marie-Louise T. Johnson, M.D., Ph.D., New York University School of Medicine;
and Jean Roberts, M.S., Division of Health Examination Statistics
INTRODUCTION
This report contains estimates of the preva-
lence of the various types of skin pathology
including those derrnatological conditions about
which the individual expresses concern, the ex-
tent of handicap or discomfort from such condi-
tions, and the extent of need for related medical
care among the civilian noninstitutionalized pop-
ulation of the United States 1-74 years of age.
These national estimates are based on findings
from the first Health and Nutrition Examination
Survey of 1971-1974. The prevalence data are
analyzed by age and sex.
An Advance Data report “Prevalence of Der-
matological Disease Among Persons 1-74 Years
of Age: United States” summarizing some of
these findings has been published. 1
The Health Examination Survey in which
these data were obtained is one of the major
programs of the National Center for Health Sta-
tistics authorized under the National Heahh Sur-
vey Act of 1956 by the 84th Congress as a con-
tinuing Public Health Service activity to deter-
mine the hezdth status of the population.
The intent of the National Health Survey2 is
carried out through the programs of the Health
Examination Survey; the Health Interview Sur-
vey which collects health information from sam-
ples of persons by household interviews focused
primarily on the impact of illness and disability
within various population groups; the Health
Manpower and Facilities surveys which obtain
data on hospitals, nursing homes and other resi-
dent institutions, and the entire range of person-
neI in the health occupations; and the Health
Resources Utilization surveys.
Only in the Health Examination Survey pro-
grams are health data collected by direct physi-
cal examinations, tests, and measurements per-
formed on samples of the population. Hence, it
provides the best of the survey methods for
obtaining diagnostic data on the prevalence of
medicaI1y defined illness. It is the only one of
the survey programs of the National Center for
Health Statistics that secures information on
previously unrecognized or undiagnosed condi-
tions as well as on a variety of physical, physio-
logical, and psychological measures within the
population. Medical history, demographic, and
socioeconomic data with which the examination
findings may be interrelated are also collected
on the sample population under study in these
examination surveys.
Since it was organized, the Health Examina-
tion Survey has been conducted as a series of
separate programs, called “cycles, ” each of
which is Iimited to some specific segment of the
U.S. population and to specific aspects of
health. During the first cycle in 1960-1962, the
prewdence of certain chronic diseases, including
heart disease and =thritis, and the distributions
of various physical and physiological measures
were determined among a defined adult popula-
tion.3 ~4For that program, a national probability
sample of 7,710 adults, of whom 6,672 (86.5
percent) were examined, was selected to repre-
sent the 111 million civilian noninstitutionalized
adults age 18-79 years in the U.S. population at
that time.
For the second and third cycles in
1963-1965 and 1966-1970, the target popula-
tions were the Nation’s noninstitutionalized chil-
dren age 6-11 years and youths age 12-17 years,
respectively.5 Y6 In both programs, the examina-
tion focused primarily on health factors related
to growth and development. For the second pro-
gram, a national probability sample of 7,417, of
which 7,119 (96 percent) were examined, was
selected to represent the nearly 24 million U.S.
children age 6-11 years in the noninstitutional-
ized population. For the third program, a na-
tional probability sample of 7,514, of whom
6,768 (90 percent) were examined, was selected
to represent the 22.7 million of that age in the
civilian noninstitutionalized population.
The first Health and Nutrition Examination
Survey (HANES I), from which the findings in
this report were obtained, was designed to meas-
ure the nutritional status of the U.S. population
age 1-74 years and to obtain some limited infor-
mation on the general health status of the entire
age group as well as more detailed information
on the health status and medical care needs of
adults age 25-74 years in the civiIian noninstitu-
tionalized population. A comprehensive descrip-
tion of the specific content and plan of opera-
tion of the HANES I program, including sample
design, has been published.7 Data collection
operations were slowed during the survey be-
cause of budgetary limitations, making it neces-
sary to extend HANES I through mid-1974 so
that the entire probability sample selected in the
original design for this program could be ex-
amined.
As in previous Health Examination Survey
programs, the U.S. Bureau of the Census cooper-
ated in the sample design and in the initial visits
and interviewing at selected eligible households
in the 65 primary sampling units (PSU’S)
throughout the United States. Additional house-
hold visiting, interviewing, history taking, and
explaining of the examination portion of the
program were done by members of the field
teams of the mobile examination center. The
selected sample persons for whom an appoint-
ment could be made were brought into the
specially constructed mobile examination cen-
ters which were moved into a central location in
each of the PSU’S. The teams that traveled to
the various survey locations throughout the
country included medical and dental examiners
as well as technicians, interviewers, and other
staff.
The probability sample design used ifi the
study provided for a sampling ratio of poor per-
sons, preschool children, women of childbearing
ages, and the elderly that was higher than the
ratio among others in the civilian noninstitu-
tionalized population.
Field data collection operations for HANES
I were started in April 1971 and completed in
June 1974. Of the 28,043 persons 1-74 years
selected in the national probability sample to
represent the 194 million of those ages at mid-
survey time in the civilian noninstitutionalized
population, 20,749 (74.0 percent) were ex-
amined. The response rate decreases with age
from 83.7 percent among those 1-5 years to
64.3 percent among those 65-74 years. When
adjustments are made for the differential, samp-
ling ratios used in the age-sex-income-defined
population subgroups, this represents an effec-
tive response rate of 75.2 percent.
The findings in this report are shown as
national estimates based on weighted observa-
tion; that is, the data obtained for each ex-
amined person are inflated to the size of the
total population of which the sample was repre-
sent ative.
The estimates have been calculated as
though the examined persons in each of the age
(at interview), sex, and income classes are a ran-
dom subsarnple of the sample persons in the
same class. Although there is evidence from
earlier examination surveys and medical history
data from HANES I that this is not an unr~~ason-
able approximation, it is clear that some esti-
mates are subject to considerable risk of bias
when more than one-quarter of the sample per-
sons in a particular age-sex-income class were
not examined. All age-specific data in this report
are shown as age at the time of examination.
The dermatology component of HANES I
was planned at the request of and in cooperation
with the Committee on Planning for the Na-
tional Program for Dermatology of the National
Academy of Dermatology. Dr. Marie-Louise T.
Johnson, Chairman of the Data Collection Unit
for the National Program, was primarily respon-
sible for planning the content of the den~atol-
ogy examination, recruiting the dermatologists,
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and training them in the examination methodol-
ogy so as to minimize interobserver variation.
Statistical notes on the sampIe design, relia-
bility of the data, and sampling and measure-
ment error are included in appendix I. The der-
matology examination form is reproduced in
appendix II, and a glossary of the most prevalent
dermatological diseases or conditions may be
found in appendix 111.
DERMATOLOGY EXAMINATION
The dermatological part of the HANES I
examination included a complete clinical examin-
ation of the skin and subcutaneous tissue that
considered normal variations in texture and
color, certain manifestations of aging, and all
pathological changes. Whenever possible, signifi-
cant diagnoses such as malignancy were docu-
mented by tissue biopsy and suspected infec-
tions by Tzanck smear or by culture to identify
fungi or bacteria. Estimates were made of actinic
exposure experienced, as well as actinic damage
sustained, and of occupational risk from irritant
and allergic contractants. For an examinee with
a significant hand, foot, or generalized problem,
a judgment was made about the burden to the
examinee in terms of discomfort or disability,
about care sought, and about the effect that
could be expected from the current best care
availabIe in the present state of the art.
The Dermatology Examination form which
provided for the recording of the examiner’s
findings was divided into five parts. The first
gave a summary of the major dermatological
findings and procedures as well as significant
historical and environmental data. The second
provided for information about the skin in gen-
eral such as color, texture, the ectodernd
appendages, vascular lesions, pigmented nevi,
and those pathological changes that occur in a
generalized fashion such as purpura, seborrheic
keratoses, or warts. The third part was for re-
gional findings pecuIiar to amanatomical area as
the head or neck, such conditions as xanthe-
lasma, cheilosis, or scrotal tongue. The fourth
part focused on disease-oriented information
giving more detail on such common problems as
acne, psoriasis, atopy, and others. The last part
represented an effort to evaluate the impact of
the dermatoIogical condition observed-how it
had modified the individual’s life through physi-
cal or psychic incapacitation, and how it may
have precluded a preferred activity. An estima-
tion was made by the examiner of the degree of
disfigurement the condition had produced as
well as the symptoms the exzuninee had suf-
fered. Information was obtained from the
examinee about care sought for the skin prob-
lem or, if no care was sought, why not. Had it
been a matter of not knowing about available
therapy on the part of the examinee or his
physician? Had it been a problem of finances or
inconvenience in travel, or the unavadability of
care at any price or distance? If the person was
receiving treatment, a judgment was made by
the examiner concerning the adequacy of
therapy, and if inadequate, whether the current
best care in the present state of the art in medi-
cine would improve the condition.
Mycological Studies
AH lesions that the examiner considered to
be fungous or to include fungous in the differ-
ential were scraped, as were all scaling lesions of
the hands and feet and all circumscribed scaling
lesions anywhere on the body that might be con-
sidered “ringworm” not only by the nonderma-
tological physician but by the layman or the
pharmacist.
The Iesions were scraped with a scalpel or
slide, and the scrapings, sealed between two glass
slides, were sent the same day to Dr. WilIiam
Epstein, Department of Dermatology, University
of California Medical Center, for examination
and culture to identify any fungus present.
Biopsies
Biopsies were taken only from adults who
could provide consent. With lesions on the head
or neck, ordy those were biopsied that were clin-
ically suggestive of malignancy or of a diagnosis
of grave importance such as lupus erythema-
tosus, the grarndomatous diseases; tuberculosis;
leprosy; sarcoid; and simikw conditions. On the
covered areas of the body, any significant Iesion
or any lesion of obscure or uncertain identifica-
tion was biopsied as needed by the examiner,
but ordy if the examinee understood the reasons




Lesions biopsied were photographed when-
ever possible (but always with the examinee’s
permission) and especially if they occurred in a
cosmetically significant area, or if, after ex-
cision, the defect would require suturing, or if
there were some question about the dia~osis.
These photographs were used in later review to




Both the significant skin pathology and the
skin conditions of concern to the examinee were
identified and classified by the dermatologist
examiner using the Code of Skin Diseases of the
Department of Dermatology, New York Univer-
sity School of Medicines For a glossary defining
the more prevalent of these conditions see
appendix 111.
Quality Control
From the National Academy of DermatoI-
o~, Dr. Marie-Louise Johnson, Chairman of the
Data Collection Unit for the Committee on Plan-
ning for their National Program was primarily
responsible for recruiting the 101 survey derma-
tologists and for training them in the standard
dermatology examination procedures used at the
65 examination locations of the Health and
Nutrition Examination Survey in 1971-1974.
After concluding the examinations, findings
from the mycological studies and biopsies were
used to complete and modify the diagnostic
impressions of the dermatology examination.
A full review was then made with Dr. Johnson
to ensure that all examiners followed the exami-
nation protocol for identifying the various
types of skin pathology and for diagnosing
significant conditions.
As might be expected, despite the standard
protocol, frequent review, and constant surveil-
lance, there is considerable variation among
examiners in the observations recorded. Closer
inspection would indicate that these reflect to a
greater extent geographic and environmentally
related differences in the distribution among
those examined rather than a true examiner vari-
ability. However, the conscientiousness of some
examiners in recording all freckles, for example,
was apparent in cont;ast to others who tended
to underreport banal lesions and normal varia-
tions. However, there was also a considerable
difference among examiners in numbers of
patients considered to have significant skin
pathology. The given guide of significance, a
condition that should be seen at least once by a
physician for assessment or care, permittt!d a
range of interpretation according to the ex-
aminer’s training and personal experience. When
the effect of any difference in the distribution
among those examined by the 101 dermatolo-
gists was removed by direct adjustment (apply-
ing the age-sex-specific rates for each exardiner
against the total number of examinees in $ach
age-sex group ), there were substantial differ-
ences among examiners in the findings of si~nifi-
cant skin pathology and in conditions about
which the examinee expressed concern. Age-
adjusted prevalence rates of significant skin
pathology range from O to 90.4 percent,, the
average being 31.2 percent. Half of the, ex-
aminers found between 14 and 46 percent of
their examinees to have such pathology. The
range in the proportion expressing compl$nts
about skin conditions to the ex~miner was from
O to 70.8 percent per examiner, the avdrage
being 11.4 percent with half of the examiners
showing rates between 2.7 and 19.8 percent.




Skzk pathology. –Nearly one-third (312.4
per 1,000 population), or an estimated 60.6
million of the U.S. population age 1-74 years
have some skin pathoIogy–one or more signifi-
cant skin conditions (table 1) that should be
evaluated by a physician at least once. These
national estimates are based on findings from
the standardized examination given by a derma-
tolo~st among a natiomd probability sample of
the civilian noninstitutionalized population in
the Health and Nutrition Examination Survey of
1971-1974.
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The prevalence of significant skin pathology
increases rapidly with age from a rate of 142.3
per 1,000 chddren age 1-5 years to 362.0 per
1,000 youths age 12-17 years and to 365.1 per
1,000 young adults age 18-24 years, due primar-
ily to the increase in acne .vulgaris associated
with endocrine changes occurring around the
time of pubertyg’1 z (table 2 and figure 1). After
a slight decline at age 25-34 years, the preva-
lence of skin pathology again increases with age
but at a slower rate than among children and
adolescents, reflecting the rapid increases with
age in the prevalence of such diagnoses as psoria-
sis and vitiIigo and such problems as malignant
and benign tumors, actinic and seborrheic kera-
toses.
Skin pathology is consistently more preva-
lent among males than among females from 6
through 74 years (tables 3, 4, and figure 2),
although the differences in the rates across the
age range are too small to be consistently sta-
tistically significant (at the 5-percent probability
Ievel) among children and young to middle-age
adults; among youths age 12-17 years and adults
age 35-44 years the differences are negligible
(less than 3 per 1,000 difference). About one-
fifth of the population (21.7 percent or 42.0
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Figure 1. Prevalence rates for significant skin pathology and
significant skin conditions among persons 1-74 years, by
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Figure 2. Prevalence rate$ for significant skin pathology among
persons 1-74 years, by age and sex: United States, 1971-
1974
million persons) have only one such skin condi-
tion, 6.4 percent or 12.4 milhon have two, and
3.2 percent or 6.1 miUion persons have three
significant types of conditions (table 5). Because
the dermatologist examiner was limited to iden-
tifying no more than the three most serious con-
ditions, the true prewdence rates of some of the
specific conditions in the population may be
slightly underestimated.
Types of conditions. –The increase with age
in the prevalence of significant skin conditions is
more rapid than that shown for skin pathology
in the individual. This is true among youths age
12-17 years, young adults age 18-24 years, and
adults age 35-74 years, indicating that over the
age of 12 years the individuals with essentially
normal skin are somewhat less likely to develop
skin pathology than those with some skin pa-
thology are to deveIop a new problem. Further-
more, males age 12-74 years are abo more Iikely
than are females of comparable age to have more
than one type of significant skin condition
(figure 3).
The most frequently occurring groups of
significant skin conditions are those affecting
the sebaceous glands (84.8 per 1,000 persons);
dermatophytoses or fungal diseases (81.1 per
1,000); malignant or benign tumors (56.5 per
1,000); seborrheic dermatitis (28.5 per 1,000);
atopic dermatitis and eczema (18.4 per 1,000);
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Figure 3. Prevalence rates for significant skin pathology and
significant skin conditions among persons 1-74 vears, bv. . .
age and sex: United States, 1971-1974
males, the most prevalent skin conditions are the
dermatophytoses, diseases of the sebaceous
glands, turn ors, and seborrheic dermatitis;
among females, the diseases of the sebaceous
glands are the most prevalent followed by
tumors (malignant and benign), dermatophyto-
ses, and seborrheic dermatitis (figure 4).
Among the individual types of significant
skin pathology diagnosed, the most prevalent are
acne vulgaris (68,1 per 1,000 population); fungal
conditions on the feet, tinea pedis (38,7 per
1,000); benign tumors (38.2 per 1,000); sebor-
rheic dermatitis, type not identified (28,2 per
1,000); fungal conditions around the nails, tines
unguium (21.8 per 1,000); precancerous and
unspecified tumors (12,4 per 1,000); vmruca
vulgaris (8.5 per 1,000); folliculitis (8.0 per
1,000) and atopic dermatitis (6.9 per 1,000,).
The trend with age in the prevalence ~f the
principal types of skin conditions shows the
rapid increase in diseases of the sebaceous glands
(primarily acne vulgaris) to age 12-17 years,
when it is most prevalent, followed by a steady
decrease from age 18-45 years with essentially
no change from age 55-74 years. The rates for
the dermatophytoses increase with age from
6-54 years then decline slightly, while ~umor
prevalence generally increases from age 6 years
on with the most rapid increase observed among
older adults ages 55-64 and 65-74 years (table A~
figures 5 and 6).
Among males and females, the trends with
age in the prevalence rates for the mo~t fre-
quently occurring skin conditions show a gem
erally similar pattern of peak preval~nce for
diseases of the sebaceous glands (primarily re-
flecting the pattern for acne vulgaris) itt age
12-17 years for both males and females (figure
7), The prevalence rates for the derm@o:phyto~
ses increase substantially more rapidly with age
from 12-54 years among males and remain
higher among nm.les than among females across
the age range 6-74 years. Among men, thd prev-
alence of tumors increases consistently with age
frmn 35-74 years, the rate of increase with age
being more rapid than that for worncn at age
35-54 years, but similar for both sexes frqm age
55-74 years.
Occupational exposure. –Nearly one-fourth
(23.9 percent) of adults 18-74 years of age with
significant skin pathoIogy indicate an exposure
in their work environment to various types of
chemicals, fumes, vapors, oils, or insecticides, or
to prolonged immersion of the hands or feet tit
work. Except for contactants and allerg~s, no
data were generated to infer causal relationships.
The proportion with skin conditions hssoci.
ated with occupational exposure is more than
twice as high among men (32.4 percent) as
women (14.4 percent ). There is a general in-
crease with age in this rate among women but
not men age 18-64 years, Among both sexes the
rates drop off at age 65-74 years (figure 8).
Suppressed conditions, -In addition to the
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Figure 4. Prevalence rates for the 7 most frequently occurring types of skin pathology among persons 1-74 years, by sex: United States,
1971-1974
Table A. Rank order and rates (qreater than 10.0 per 1,000 population) of the most prevalent types of skin pathology, within each ane
1-5 years
Actopic dermatitis, eczema (24.9)
Tumors, malignant and benign (21 .7)
Contact dermatitis (13.9)
18-24 years
Diseases of sebaceous glands (191.1)
Dermatophytoses (61 .7)
Tumors, malignant and benign (43.0)
Seborrheic dermatitis (38.7)
Folliculitis (18.9)
Atopic dermatitis, eczema (1 5.4)
Contact dermatitis (14.2)
Verruca vulgaris (1 2.4)
45-54 years
Dermatophytoses (155.7)
Tumors, malignant and benign (84.9)
Seborrheic dermatitis (31.9)
Diseases of sebaceous glands (21.5)
Contact dermatitis (16.7)
Atopic dermatitis, eczema (13.9)
Psoriasis (11 .4)
group: United States, 1971-1974
6-11 years
Diseases of sebaceous glands (21.4)
Atopic dermatitis, eczema (20.0)
Tumors, malignant and benign (18.9)
Ichthyosis, keratosis (15.5)
Verruca vulgaris (13.1 )
25-34 years
Diseases of sebaceous glands (99.6)
Dermatophytoses (87.7)
Seborrheic dermatitis (41 .9)
Tumors, malignant and benign (39.6)
Atopic dermatitis, eczema (28.0)
‘olliculitis (15.4)
Ichthyosis, keratosis (1 1.5)
55-64 years
Dermatophytoses (1 50.8)
rumors, malignant and benign (100.2)




ltopic dermatitis, eczema (12.8)
Vitiligo (12.6)
12-17 years
Diseases of sebaceous glands (249.9)
Dermatophytoses (33.2)
Tumors, malignant and benign (31 .3)
Seborrheic dermatitis (18.8)





Tumors, malignant and benign (46.8)
Diseases of sebaceous glands (44.1)
Seborrheic dermatosis (41 .6)
Contact dermatitis (17.0)
Atopic dermatitis, eczema (14.7)
Folliculitis (12.8)
65-74 years
Tumors, malignant and benign (184.1 )
Dermatophytoses (126.8)
Seborrheic dermatitis (36.4)
Diseases of sebaceous glands (25.5)
Seborrheic keratosis (24.4)
Contact dermatitis (20.4)
Atopic dermatitis, eczema (18.3)
Vitiiigo (13.6)
7
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the examination and diagnosed by the dermatol-
ogist examiner, those previously diagnosed
significant skin conditions that were suppressed
or in remission at the time of the examination
were also recorded for each examinee. Record-
ing was limited to the two most serious of such
conditions.
One in eight, persons (124.9 per 1,000) has
at least one such clinically inactive condition,
the rate increasing with age from 69.6 per 1,000
at age 1-5 years and 69.1 per 1,000 at age 6-11
years to 162.6 per 1,000 at age 35-44 years then
declining slowly to 123.4 per 1,000 at age 65-74
years (table 5). The proportion of persons with
such conditions is slightly higher among females
than among males, but the pattern across the age
range is not consistent. Less than 15 percent of
Figure 5. Prevalence rates for the 4 most frequently occurring
types of skin pathology among persons 1-74 years, bv aqe: the;e persons have two significant co;dltions in
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Figure 6. Prevalence rates for the principal types of skin pathology within each age group among persons 1-74 years: Unitecl States,
1971-7974
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Figure 7. Prevalence rates for the 4 most frequently occurring
types of skin pathology among persons 1-74 years, by age





Figure 8. Prevalence rates for significant skin pathology with
occupational exposure among persons 18-74 years, by age
and sex: United States, 1971-1974
Approximately one in six persons with.
active- ~ignificant “skin pathology diagnosed also
has a significant skin condition suppressed or in
remission at the time of the examination; among
those with si~ificant skin conditions in remis-
sion, about one-third also have active pathology.
The prevalence rate of significant active and sup-
pressed pathology is 47.4 per 1,000 persons, the
rate generally increasing with age from 12.4 at
age 1-5 years to 68.4 per 1,000 at age 55-64
years.
The coexistence of active and suppressed
skin pathology is greater among males than
among females from age 6-64 years (table 5).
The most prevalent of the specific types of
skin condition s-u~pressed or in remission are the
contact dermatltldes (31.9 per 1,000 persons),
diseases of the sweat and sebaceous gkmds (19.3
per 1,000), atopic dermatitis and eczema (16.0
per 1,000), dermatophytoses (1 1.0 per 1,000),
benign and malignant tumors (10.5 per 1,000),
and infections of the skin including evidence of
a history of verruca vulgaris (10.4 per 1,000) as
shown in table 6.
Aronsignificant pathology. –The dermatolog-
ists recorded all skin pathologies identified in
various stages of the examination, whether the
condition was considered significant or not. Mild
seborrheic dermatitis, for example, would not be
considered sufficiently serious to warrant a visit
to a physician. Nevertheless, it wouId be recog-
nized as an other-than-normal scalp condition
and its presence recorded. By gathering such
data it is possible to determine the total preva-
lence of the various types of skin conditions in
the U.S. population as identified in this survey
examination and the extent to which each was
considered a si~ificant health problem (tabIe
6).
The most prevalent of the skin conditions, as
shown in tabIe B, is the group of disorders that
includes traumatic and surgicaI scars, ephelides,
and other derrnatitides that affect more than
half the population age 1-74 years; ichthyosis
and keratosis, 43 percent; malignant and benign
tumors, 36 percent; diseases of the sweat and
sebaceous glands, 21 percent; diseases of the cir-
culatory system, other than the veins, including
Osler-Weber’s disease, telangiectasis, and simiIar
9
Table B. Prevalence ratas for selectad significant and nonsignificant types of skin conditions and Drooortion of each tvoe rated as
significant among persons 1-74 years: United States, 1971-1974
Condition and NYU codel
Other skin disorders (vitiligo, traumatic scars, ephelides, etc.) ... ... .. ..... . ... .... .. .. .... .... . ..... .. ....716
Ichthyosis, keratosis . . ..... ... .. ..... . ... .... .. .. .... ... .. .... .. ... ... ... .. .... ... .. ..... . .. .... ... .. ..... . ... .... .. .. ..... ... ..71 O
Tumors, malignant and benign, and Ieukemias .. .. .... .. .. .. .... 19x,2(jx,22x,23x,23y, e)(~l”ding
22X,44X
Malignant tumors ... .... .. .. .... .. .... .. .. .. .. ... . .. .. .... .. .. ... . .... .. .. .. . .... ..... ..... . ... ..... .. .. .... . ... ..... 19X
Diseases of swaat and sebaceous glands ..... ... .. .... .. .. .... ... .. .... .. .. . ..... . ... .... .. .. .... ... .. ..... .. .. ... ... ...7l4
Other diseases of circulatory system (Osler’s disease, telangiectasis, etc.) ... .... ... .. .... .....467-468
Corns, callosities .. .... .. .... .... .. .. .. .. ... . ..... .. ... ..... . .. .... .... . ..... .. ... ... .. .... .. .... .. .... .. .. .... ... .. ......c.. .... ..7Og
Lichen planus ........................................................... ..........................................................7o7
Seborrheic karatosis . .. .. .. ..... . .. .. .... . ... .... .. .. ..... .. ... .... .. .. .... .. . .. ..... .. .. ..... . .. .. .. .. .. . ..... .. .. ..... 22X44X
Seborrheic dematitis ... .. .. ..... ... . ..... .. .. .... .. .... ... ... .. .... .. ... ..... .. .. ... .... . ...... . ... .... .. .. .... .... . ..... .. ..$o7OO
Diseases of veins (varicosa veins, phlebitis, etc.) . . ... ... ... . ..... .. .... .... . .. ...... . .. ..... . ... .....o. .. ...46O~66
Darmatophytoses . ... .. ..... .. ... ..... .. .. .... .. .. ..... .. ... .... . ... .... ... .. .... .. ... ..... .. .. ... ... .. ..... ... . ...c..$. ..... ... ..l3l
Diseases of buccal cavity, salivary glands, lips, pancreas, etc. .. ...<........,.. ... ... ... .... . .. . .....530-587
Infections of skin (boils, impetigo, infectious warts, etc.) .. .... .. .. .... ... .. ..... .. .. ... ... .. .. .... ...69O698
Contact dermatitides .. ... .... .. ... ... ... .. ...... . .. .... .. ... .... ... .. ... .. ... ..... .. .... ... .. .. ..... .. .. ..... . .. ..... ... .. .....7o3
Diseases of hair and hair follicles .. .. ..... ... . ..... . .. . ..... .. . ..... ... .. .... .. .... ... ... .. ... ... .. ..... .. .... ... .. .. .....7l3
pruritus .... .. ... .... .. .. .... .... .. .... .. .. .. ... .. .... ... .. .. .... .. .. .. .... .. .. .... ... .. ..... ... . ..... . .. ..... ... . ....$. ....m... .. . .....7O8
psoriasis ... ... .. .... .. .. ..... ... .. .... ... .. ..... . ... .... ... . ..... ... .. ..... . ... .... ... .. ....<. ... .... .. ... .... .. . ...... . ....c... .. .....7O6
Malignant tumors . .. .. .. .... .. .... .... . .... . .... .... .. .. .. .. .. .. . ..... .. ... ..... ... ..... .. .. .... .. .. .. ... .. ... .... ... .. .... .. .. ..lgX
Deep fungal infections .. . .. .... .... . ..... ... . ..... . .... ... .... . .... .. ... ..... . ... ..... . .. ..... .. ... .... .. .. .... ... .. ....l32.l34
Injuries, adverse effacts of chemicals and other external conditions ... . .... .... .. .... .. ... .. ....850-999
Zoonoses ...... . ... .... .. .. .... .... .. ..... . .. .... ... .. .... . .... .... .. .. ..... .. . ...... . ... ..... . ... .... ... . .... .. .... .... .. .. ...l35.l37







































































































conditions, 18 percent; corns and callosities, 16 Extent of Concern for Skin
percent; lichen- pkmus, 14 percent; seborrheic Pathology
keratoses, 12 percent; and seborrheic dermatitis, Nearly one-eighth (11 8.2 per 1,000 persons)
nearly 12 percent. or an estimated 22.9 million of the U.S. popula-
10
tion 1-74 years of age have one or more skin
conditions about which they complain or ex-
press concern (table 7). For most of these per-
sons (96 percent with such conditions or a rate
of 113.6 per 1,000 in the population), a specific
condition affecting their hands, feet, or other
part of the body was identified as the cause of
their concern (table 8). For the remaining 4 per-
cent (rate of 4.6 per 1,000 in the population)
with multiple types of skin complaints, the
pathology was more generalized, not limited to
one or two specific areas of the body.
For some 9 percent of those who com-
plained about an identified type of skin condi-
tion, it is one that affected their hands; for 16
percent, their feet; and for 75 percent, their
face, neck, or other area of the body.
Nearly one-third (31 percent) of persons
with significant skin pathology diagnosed by the
dermatologists express concern about these
specific skin conditions; nearly 18 percent of
those who complain about their skin conditions
are concerned about conditions not considered
serious or significant by the dermatologists
(table 7).
Skin complaints are more prevalent among
youths and adults than among children age 1-11
years, the prevalence rates being 2% to 3%!times
greater than those among children, but showing
no other significant trend with age. Rates for
significant pathology not of concern to the
affected individual increase with age from 1-24
years, drop back at age 25-44 years, then stead-
ily increase with age; the proportion with non-
significant pathology of concern tend to de-
crease slightly with age among adults (table 7
and figure 9).
Skin conditions of concern to the affected
individual are slightly, but not significantly,
more prevalent among males and among females
(rates of 128.2 per 1,000 and 108.8 per 1,000,
respectively), but only from 18-74 years of age
are the rates among males consistently the
higher (figure 10).
Males are slightly more likely to be con-
cerned about a significant type of skin pathol-
ogy at age 35-64 years than are females, and
preschool-age girls are somewhat more likely to
be concerned than a-e boys of like age. “Concern
regarding nonsignificant skin pathology is about
as likely to be expressed by males as by females
except at ages 1-5 years, 12-17 years, and 55-64
1
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Figure 9. Prevalence rates for skin conditions of concern (com-
plaints), significant skin pathology not of concern, and
nonsignificant skin pathology of concern among persons
1-74 years, by age: United States, 1971-1974
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figure 10. Prevalence rates for skin conditions of concern
(complaints) among persons 1-74 years, by age and sex:
United States, 1971-1974
years where these rates are higher among females
and age 45-54 where the rate among males is the
higher.
Types of conditions of concern. –The most
frequently reported skin complaints axe those
affecting the sebaceous glands (28.2 per 1,000
persons 1-74 years of age), dermatophytoses
(fungal conditions–21.6 per 1,000 persons),
atopic dermatitis and eczema (allergies and re-
lated conditions–10.8 per 1,000 persons), malig-
nant and benign tumors (8.1 per 1,000 persons),
11
Table C. Rank order and rates (greater than 3.0 per 1,000 population) of the most prevalent types of skin conditions of concern
(complaints), within each age group: United States, 1971-1974
1-5 years
Atopic dermatitis, eczema (10.9)
Contact dermatitis (3.9)
18-24 years
Diseases of sebaceous glands (71 .4)
Dermatophytoses (1 5.6}
Contact dermatitis (8.7)
Atopic dermatitis, eczema (7.7)
Foilicuiitis (4,6)




Tumors, malignant and benign (14.6)
Seborrheic dermatitis (12.3)
Psoriasis (10.4)









Diseases of sebaceous glands (35.4)
Dermatophytoses (27.7)






Tumors, malignant and benign ( 19.6)
Atopic dermatitis, eczema (8.9)
Contact dermatitis (8.3)
Psoriasis (7.2)
Diseases of sebaceous glands (5.4)
Malignant rumorsl (5.2)
Seborrheic dermatitis (4.4)
lSubgroup of tumors, maIignant and benign.
contact dermatitis (6.4 per 1,000 persons),
seborrheic dermatitis (chronic inflammation—
5.4 per 1,000 persons), and psoriasis (3.8 per
1,000 persons) (table 8). These are the principal
conditions of concern among both males and
females, although the proportion of females con-
cerned about fungal conditions (8.2 per 1,000)
is substantially less than that of males (35.9 per
1,000), consistent with the lower prevalence of
such conditions among females.
Among children 1-11 years, atopic derma-
titis is the most prevalent skin complaint; at ages
12-34 years the major complaint is about
diseases of the sebaceous glands; from 35-64
12-17 years
Diseases of sebaceous glands (86.4)
Dermatophytoses (9.0)
Atopic dermatitis, eczema (8.4)
Contact dermatitis (5.5)





Diseases of sebaceous glands (1 7.6)
Contact dermatitis (10.3)
Atopic dermatitis, eczema (9.2)
Seborrheic dermatitis (5.9)
Folliculitis (5.2)
Tumors, malignant and benign (3.6)
65-74 years
Tumors, malignant and benign (34.6)
Dermatophytoses (21 .8)







years, the dermatophytoses; and in the oldest
group 65-74 years, rn~ignant and benign tumors
(tables 9-11, C, and figure 11). The trend with
age for the more prevalent skin conditions o“f
concern is generzdly similar to that for the si@&if-
icant conditions dia~osed, although the rates
for the former are, as expected, consistently
lower (figures 5 and 12).
Persons with significant skin conditions diag-
nosed in the survey examination are most Ii,kely
to express concern if the condition is psoriasis
(of those diagnosed 69 percent expressed con-
cern), atopic dermatitis (59 percent concerned),
contact dermatitis (47 percent concerned),
12
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Fiaure 11. Prevalence rates for the major types of skin condi-
tions of concern (complaints) within each age group among
persons 1-74 years: United States, 1971-1974
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Figure 12. Prevalence rates forthemajor types ofskincondi-
tions of concern (complaints) among persons 1-74 years,
by age: United States, 1971-1974
malignant tumors (34 percent concerned) and
diseases of the sebaceous glands (33 percent con-
cerned) (tables 1, 8, and D).
Males are the most likely to express concern
about conditions of psoriasis (64 percent con-
cerned), atopic dermatitis and eczema (60 per-
cent concerned), contact dermatitis (50 percent
concerned), malignant tumors (36 percent con-
cerned), and diseases of the sebaceous glands (33
percent concerned). Among females, the most
Table D. Proportion of persons with saiected specific types of significant skin pathology who complained about the condition, within












Atopic dermatitis, eczema (65%)
lsubg~~up of tumom, malignant and beni
6-11 years 12-17 years
Contact dermatitis (76%) Psoriasis (88%)
Atopic dermatitis, eczema (72%) Contact dermatitis (64%)
Verruca vulgaris (52%) Urticaria (56%)
25-34 years 35-44 years
Seborrheic keratosis (1 75%) Atopic dermatitis, eczema (63%)
Contact dermatitis (70%) Contact dermatitis (61 %)
Psoriasis (63%)
Atopic dermatitis, eczema (59%)
Vitiligo (53%)
55-64 years 65-74 years
Folliculitis (71%) Ichth yosis, keratosis (100%)
Atopic dermatitis, eczema (70%) Atopic dermatitis, eczema (57%)




Figure 13. Percent of persons 1-74 years with selected significant skin pathology who are concerned about the condition, by sex:
United States, 1971-1974
frequently cited conditions of concern are pso-
riasis (74 percent ), atopic dermatitis and eczema
(58 percent), contact dermatitis (44 percent),
urticaria (38 percent), malignant tumors (34 per-
cent), diseases of the sebaceous glands (34 per-
cent ), and vitiligo (32 percent) as shown in
tables 1 and 8 and figure 13.
Recurrence and Duration of
Skin Pathology of Concern
An estimated 62.8 per 1,000 in the U.S.
civilian noninstitutionalized population age 1-74
years or 56 percent of those with skin com-
plaints indicate that the condition or conditions
are recurrent. Those conditions affecting the
hands and feet are slightly more likeIy to be
recurrent (66 and 64 percent, respectively) than
those on the face or other parts of the body (54
percent) (tables 7, 12, and E).
Skin conditions affecting the feet are si~ifi-
cantly more likely to be recurrent among males
(70 percent) than among females (45 percent) as
are those affecting the hands (70 percent com-
pared with 60 percent for females); those skin
conditions affecting the face and other parts of
the body are only slightly less likely to be recur-
rent in males (52 percent) than in females (56
percent).
The recurrence of skin conditions of concern
shows no consistent increasing or decreasing
trend with age among youths or adults. For all
types of such conditions the proportion that
recurred is highest at age 25-44 years and lowest
among children age 1-5 years. Conditions affect-
ing the hands are the most likely to be recurrent
among young children age 1-5 years (100 per-
cent ) and adults age 45-54 years (78 percent),
but least likely to be recurrent among the oldest
adult age group in this study (46 percent alt, age
65-74 years) and children age 6-11 years (50 per-
cent). Skin conditions affecting the feet are the
most likely to be recurrent among you~ger
adults age 25-44 years (77 percent at 35-44
years and 70 percent at 25-34 years) and least
likely to be a (recurrent) problem among chil-
dren 1-11 years (O percent at 1-5 years and 35
percent at 6-11 years). The recurrence rate for
conditions affecting the face and other parts of
the body is highest among young adults 18-34
years (66 percent at 25-34 years and 56 percent
at 18-24 years) among whom acne vulgaris and
other diseases of the sebaceous glands (although
just past the peak prevalence for such conditions
at 12-17 years) are still the most prevalent of the
skin conditions of concern in those age groups,
making up about one-half and one-quarter of all
skin conditions of’ COTrem at 18-24 and 25-34
years, respectively.
Nearly half (49 percent) of recurrent skin
conditions have been active in the preceding
7-12 months, 30 percent longer ago than 12
14
Table E. Percent of persons 1-74 years with skin conditions of concern (complaints), by the recurrence and duration of condition, the degree of
resultant handicap or disf igurement, part of body affected, and sex, showing selected standard errors: United States, 1971-1974
Recurrence, duration, and handicap
Condition recurrent ...................................
Recurrent condition active in:
Past 12 months . ..................................
Past 3 monthsl .....................................
Past 6 monthsl .....................................
Condition present:
Less than 2 years ..................................
2-4 years ...............................................
5 years or more .....................................
Condition limits activity:
To any extent .......................................
10 percant or less..................................
More than 25 percent .......... .................










Recurrent in past 12 months ......................
Present-less than 2 years ...........................
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lperc.nt of tho~e ~h~se skin condition is mcu~ent.
months, and 21 percent within the preceding 6 concern that have persisted at Ieast 5 years (70
months (table E): percent) than are f;males (58 percent),- the rates
Duration. –The majority of skin complaints being significantly lower among females only for
have been present for 5 years or longer (62 per- skin conditions affecting the hands (table E).
cent). Those affecting the feet are more likely to
have been present this Iength of time (75 per-
cent ) than those affecting the hands (56 per- Handicap From Skin Condition
cent ) and other parts of tie body (59 p-erce~t). Activity limitation. –Skin complaints are
Males are more likely to have skin conditions of reported to limit activity of 10.5 per 1,000 of
15
the population age 1-74 years or 9 percent of
those persons with such skin conditions (table
E). However, only about one-third of these per-
sons indicated that their activity is more than
minimally limited (more than 10 percent) by
their skin condition(s). Males are slightly less
likely than females are (8 percent compared
with 10 percent) to report any limitation but
among those with some degree of this the pro-
portion with more than minimal limitation is
similar in both sexes (3 percent). No consistent
trend with age is evident in the proportion with
such limitation from a skin condition, although
adults 55-64 years of age and children 6-11 years
of age are slightly more likely than those of
other ages to have such limitation (12 percent
compared with 5-10 percent).
Conditions affecting the hands are more
likely to limit activity (15 percent) than are
those affecting the feet (8 percent) or other
parts of the body. Females are more likely than
males are to have skin conditions affecting their
hands and feet, which limit their activity.
Degree of handicap to employment or
housework. –About 10 percent of those persons
with skin complaints consider the condition(s)
to be a handicap to their employment or house-
work (table E). Only 1 percent indicate they
were severely handicapped, and the remaining 9
percent consider the handicap to be minimal.
Conditions on the hands are more likely than
those on the feet or other parts of the body to
be considered a handicap (26 percent of skin
conditions of concern on the hands compared
with 9 percent of those on the feet and 8 per-
cent of those on other parts of the body) and
such conditions on the hands are somewhat
more likely than those on the feet or elsewhere
to be considered a severe handicap (2 percent on
the hands compared with 1 percent elsewhere).
The proportion with handicapping (for
employment or housework) skin conditions
among all those with skin complaints is, as
expected, lowest among children age 1-11 years
(less than 3 percent) and highest at 25-34 years
(12 percent), 55-64 years (12 percent), and
18-24 years (11 percent) (figure 14). Among
males, only at age 18-24 years does the propor-
tion considered handicapping exceed 1 in 8,
reaching the maximum of 15 percent; among
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Figure 14. Percent of skin conditions of concern (complaints)
considered social or employment-housework handicap by
the individual or to be disfiguring to at least some extent
by the examiner, by age: United States, 1971-1974
34 years (16 percent) and 35-54 years (13 per-
cent ) (tables 7 and 12).
Although there is no consistent age-related
trend in the proportion with handicapping’ (for
employment or housework) skin conditions,
girls of age 12-17 years are more likely to con-
sider skin conditions of the hands and feet t’o be
a handicap than not (58 percent of those ‘skin
conditions affecting the hands are rated as a
handicap compared with 42 percent not so
rated, and 60 percent of conditions affecting the
feet are considered handicapping). Adult women
55-64 years of age are also more likely to con-
sider skin conditions on the hands (but not the
feet ) as being handicapping than not (63 pe~cent
compared with 37 percent not considered h~di-
capping); about one-half of those women 1,8-34
years of age consider skin conditions on their
hands to be handicapping.
The handicap from skin conditions of ‘con-
cern is substantially more likely to be miriimal
than severe, except for those affecting the hands
and feet of girls 12-17 years of age and those
affecting parts of the body other than hands and
feet of men age 45-54 years.
Social handicap. –An extimated 35.1 per
1,000 of the U.S. population 1-74 years of age
or about one-third (33.0 percent) of those per-
sons with skin conditions that concern them
indicate that the condition(s) is (are) a handicap
16
in their social relations (tables
proportion increases with age
12 and E). The
among children
from less than 10 percent among those of pre-
school age to a maximum of 47 percent among
youths age 12-17 years, then decreases with
increasing age among adults to less than 17 per-
cent at age 65-74 years (figure 14). The propor-
tion sociaIly handicapped from their skin condi-
tion is substantially greater among females (34
percent) than among males (25 percent), the
pattern being consistent across the age range in
this study.
Extent of disfigurement. –More than two-
thirds (68. 1 percent) of the skin conditions of
concern to the individual affected are rated as
disfiguring by the dermatologist examiner (table
F). The disfigurement is substantially more
likely to be minimal (48 percent) than moderate
or severe (20 percent). Skin conditions on the
face and parts of the body other than the hands
and feet and skin conditions on the hands are
more likely to be rated as disfiguring (71 percent
and 69 percent, respectively) than skin condi-
tions on the feet (54 percent). The examiners are
slightly more likely to rate skin conditions of
females as disfiguring to any extent and as
moderately or severely disfiguring than those of
males whether the hands, feet, or other parts of
the body were affected. For each sex, skin con-
ditions on the feet are the least likely of the
three sites to be considered (by the examiner) as
disfiguring to any extent, as well as the least
likely to be considered moderately or severely
disfiguring.
Children ages 1-11 and adults 45-54 years
are least likely to have skin conditions rated as
disfiguring to any extent by the examiner (about
50 percent of those with skin conditions of con-
cern to person affected); these rates are highest
among youths age 12-17 years and adults 55-74
years of age. Moderately or severeIy disfiguring
skin conditions are least prevalent among pre-
school-age children 1-5 years old and adults age
45-54 yeas, but most prevalent among those
older adults age 55-64 years (figure 14).
Discomfort From Skin Condition
Pain or burning. –An extimated 22.6 per
1,000 in the U.S. civilian noninstitutionalized
population age 1-74 years or nearly one-fourth
(22.8 percent) of
indicate thev felt a
those with skin complaints
burnirw sensation or ~ain to
some degre~ from the co~dition(s) (ta~les 12
and F). The pain or burning sensation is rated as
moderate or severe for nearly one-third of these
people (6.4 percent of those with skm condi-
tions of concern). Conditions affecting the
hands or feet are less likely than those affecting
other parts of the body to be reported to cause
at least some pain or burning.
School-age children 6-17 years old =e the
,least likely to have these symptoms (16 percent
at 6-11 years and 14 percent at 12-17 years);
preschool age children are the most likely (32
percent). Young adults age 25-34 years are
slightly more likely to have these symptoms (25
percent) than older or younger adults.
Males are less likely than females to report
symptoms of burning or pain from skin condi-
tions on their hands and feet, but are slightly
more likely to do so for conditions affecting the
face or other parts of their bodies.
Itching. –Nearly one-half (45.4 percent) of
persons with one or more skin complaints indi-
cate that the condition(s) itched minimally (25
percent) or to a moderate or severe degree (20
percent ). Preschool-age children 1-5 years of age
are most likely to have such symptoms (58 per-
cent) and, when they do, to have moderate or
severe itching (64 percent) than minimal (36 per-
cent); young adults age 18-24 years are the least
likely to indicate that the skin condition(s)
itched (26 percent), but those 25-34 years of age
are the least likely to have a moderate or severe
itching (30 percent). Males are slightly more
likely to report such symptoms (48 percent
compared with 42 percent of femzdes) but, when
they do, to consider the itching minimal
(table F).
Motion limitation. –Skin condition(s) are
extensive enough or Iocated in areaa so that they
cause limitation of motion for nearly 6 percent
of persons who have skin conditions that con-
cerned them (table F). The rates are highest
among the oldest aduIts, age 65-74 years and the
lowest among adults age 45-64 years. Males are
about as likely as femzdes are to have such limi-
tation from skin conditions that concerned them
(5 percent of males, 6 percent of females) and
both sexes are more likely to have a minimal (4
percent) than moderate or severe limitation (1
17
Table F. Percent distribution of persons 1-74 years with skin conditions of concern (complaints) by extent of discomfort from condition, according to
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~ercent of males and nearlv 2 ~ercent of vears and lower at age 12-17 Years than at other
;emales).
. L
~ges (table F). Only” about one-fourth (28 per-
Overall discomfort. –More than half (58.0 cent ) of those with some overall discomfort
percent) of those persons with skin complaints from the skin condition(s) indicate the discom-
have some overall discomfort from the condi- fort was more than minimal; this proportion
tion, the rates being slightly higher at age 1-5 ranges from a maximum at age 6-11 years (60
18
percent) to a minimum at 12-17 years (46 per-
cent). Females are nearly as likely as males to
have some overall discomfort from a skin condi-
tion (57 for females, 59 for males), but when
they do to indicate moderate or severe discom-
fort (33 percent compared with 24 percent).
Disfigurement–handicap or disability. –
Nearly all (89 percent) of those persons who
consider their skin condition(s) a social handicap
to some degree are also rated as disfigured by
the examiners. This agreement is slightly closer
among adults age 45-64 years and youths age
12-17 years (nearly 95 percent) than other per-
sons among whom the proportion rated as dis-
figured of those considering themselves socially
handicapped by their skin condition ranges from
80 percent at age 35-44 years to 88 percent at
age 65-74 years with no consistent age-related
trend. The agreement is slightly better for
females (92 percent) than for males (86 percent)
(table G and figure 15).
The agreement between the examiner’s rat-
ing of some disfigurement and the individual’s
indication that his or her skin condition is a
handicap to employment or housework is
slightly less than that for social handicap, the
proportion being 80 percent and again being
somewhat higher among females (82 percent)
than among males (77 percent).
More than two-thirds of those persons with
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Figure 15. Percent of males and females 1-74 years with skin
conditions of concern (complaints) rated as disfiguring by
examiner or causing some type of handicap to the affected
person: United States, 1971-1974
tion(s) are also rated as disfigured to some
degree by the examiners. No consistent trend
with age is evident in this agreement, the propor-
tion with some discomfort who are also rated as
disfigured ranges from 57 percent at ages 6-11
years and 45-54 years to 82 percent at age 55-64
Table G. Percent distribution of persons 1-74 years with skin conditions of concern (complaints) reporting some degrea of resultant handicap-employment-
housawork, social, or overall discomfort-by examiner’s rating of extent of disfigurement, age, and sex: United States, 1971-1974
Type of handicap and degree of disfigu rement
Employment.housework handicap with dis-
figu rement rated:
Moderate~evere .. . .. . .. . . . . . . . . . . .. . .. . .. .. . .. . . . . .. . . . . . . . .
Minimat .,, . .. . .. . .. . . . . . . . . . . . . .. . .. . .. .. . . .. .. . . .. .. . . . . . . . . . . .
Ntme .. . .. .. . . .. .. . . . . .. .. . . .. .. . . . . .. . . . . .. .. . . .. .. .. .. .. . . .. .. . .
Social handicep with disfigurement rated:
Moderate.sewre . . . . .. .. . . .. .. . . . . . . . . . . .. .. . . .. .. . . .. . . . .. . .
Minimel .. .. .. . . . . .. .. . . .. .. . . .. .. . .. . .. . . . . . . .. . . .. .. . . .. .. .. . . .
None .. . . .. . . . .. . .. .. . . . . . .. . . . . . . . . . .. .. . . .. .. . . . . . . . . . . .. . . . . . . .
Overall discomfort with disfigurement rated:
Moderate%evere . . .. .. . . .. . . . . . . .. . . . . .. .. . . .. .. . . .. .. . . . . .. .
Minimal .. . . . .. . .. . . . . .. . .. . .. .. . . .. . . . .. . . . . . . . .. . .. . .. .. . . . . .. .
None ... . .. . . . .. . . . . .. . . . . .. . .. .. . .. . . . . . . . . . . . . . . . . .. .. . . .. .. . . . .
Both
sexes 1-5 6-11 12.17 18-24 25-34 3544 45-54 55-84 65-74
1-74 years
1-74 years years years years years years years ~ear.s yaars
years
Male Femele



























































































years and is slightly lower among males (67 per- 1-74 years of age or nearly one-fifth (18.9 per-
cent) than among females (72 percent). cent) of those persons with skin condition(s)
about which they express concern are now
Adequacy of Treatment for
Skin Condition
under the best care pos;ible for the condition(s)
(tables 13 and H). The proportions are slightly
higher among children age 1-11 years and lower
More than 2 percent (21.5 per 1,000) of the ~ong young adults age 18-24 years than among
U.S. civilian noninstitutionalized population adults age 35-74 years. The proportion that the
Table H. Percent of persons 1-74 years with skin conditions of concern (complaints), by tYPa Of cam sought, edBqUeW of prasent treatment, radons for




Pharm~y ....... ........ .............. .... ...... .......
Physician ..............................................
Dermatologist .......................................
Undar bast care now ............................... ...
Expert cara would improve ........................
No advice sought........................................
inadequate edvice given .............................
Did not cooperate with doctor ...................
Other raeaons for not seeking medical
care:








Dermatologist .... ............................ .......
Under best care now ..................... .............
Expart care would improve .....................
No edvica sought........................................
Inadequate edvica given .............................
Did not cooperate with doctor ...................
Other “reastms for not seeking medical
care:




One or more areas of
body affoctad II
Hands I Fact I Other area(s)
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dermatologist examiner consider as now receiv-
ing the best care ranges from 27 percent of pre-
school children age 1-5 years to 13 percent
among young adults age 18-24 yearn (table H
and figure 16). Females are more likely than
males are to be receiving the best care possible
(24 percent compared with 15 percent of those
with skin complaints).
Skin conditions affecting the feet are sub-
stantially less likely than those on the hands or
other parts of the body to be receiving the best
available treatment (10 percent for those on the
feet compared with 21 percent for those on the
hands and 20 percent for those on the face or
other parts of the body). Males are less likely
than females are to have skin condition(s) under
the best care, regardless of the location of the
condition(s), the difference being greatest (and
large enough to be statistically significant) for
those on the feet (6 Percent for males compared.
with 21 percent fo; f;males).
‘a Not under bestcare now
❑ SOmec;iititxo”ld
Is Under besrcare now
n
1.5 6.11 12.17 1S-24 25.34 3544 45.54 55.64 65.74
years Yin-s yem years years years years years years
AGE
Figure 16. Percent distribution of persons with skin conditions
of concern (complaints), by adequacy of treatment for
condition(s) and age: United States, 1971-1974
Among the remaining (81 percent) persons
1-74 years of age with skin conditions that con-
cern them but who are not now receiving the
best care available for the condition, about 94
percent of the persons with complaints have
conditions that could be improved with expert
care. These proportions range from 84 percent
among preschool-age children 1-5 years to 96
percent in the oldest age group 65-74 years
(table J). The proportion that could be im-
proved is similar among males and females and is
nearly as high for conditions affecting the hands
or feet (92 percent) as those on other parts of
the body (94 percent).
About one-half of the U.S. population 1-74
years of age with skin conditions of concern to
them have not sought medical advice for the
problem. The proportion is lowest among chil-
dren 1-11 years of age (37 percent) and adults
55-64 years (38 percent), and highest among
youths 12-17 years (66 percent).
Males are more likely than females are to
have not sought medical care for skin conditions
that concern them (56 percent compared with
44 percent) and across the ages from 12-74 years
the proportion who had not sought such care is
consistently higher among maies.
In addition to those (50 percent) not seeking
medicaI care, nearly 15 percent have been given
medical advice that the dermatologist examiner
considered inadequate. This proportion ranges
from 8 percent at age 12-17 years to 20 percent
at age 55-64 years but shows no consistent trend
with age (table J). Males are about as likely as
females are to have received inadequate medical
advice concerning their skin problem (14 per-
cent compared with 16 percent).
About 6 percent of those with skin condi-
tions that concern them did not cooperate with
the doctors they had consulted, the proportion
being simikr among males and females.
Other obstacles to improvement cited by the
persons with skin conditions of concern are that
they were too far from the doctor (0.9 percent),
that transportation to the doctor was not avail-
able (0.5 percent), that they had insufficient
money for such medlcaI care (3.7 percent), and
a variety of other reasons (7.9 percent) including
“not being aware the condition could be
treated, “ “under care but discouraged because
21
Table J. Percent of persons with skin conditions of concern (complaints), by rea$on no care was sought and adaquacy of treatment sought, according to age and





sexes 1.5 6-11 12-17 18-24 25.34 3644 46.54 55.64 65.74
7-j4 Yeats
1-74 years years yew’s yaerg years yaars years years years
years
Male I Female
Total .. .. . . . . .. .. . . .. .. .. .. .. .. . . .. .. . . . . .. .. . . .. .. . . .
L ‘00’0 w
Percent of persons with skin complaints















No medical advice sought . .. .. . . . . . . . . . . .. .. . .. . 50,1 36.8
Too far to doctor .. . . . . .. .. . . .. .. . . . . .. .. . .. . .. . . . . .. . .. .. . .. . . 0.9 2,8
No transportation .. . . . .. .. . .. . . . . .. .. . .. . . . . .. . .. . .. . . . .. . . . . . 0.5 1.0
Insufficient mOney .. . .. . .. .. .. .. .. . . . . . . .. . . .. . . . . . . .. .. . . .. .. 3.7 3.5
Other reason .. . . .. . . . .. . .. . .. . .. .. . . . . .. . .. .. . .. . . . . . . .. . .. . . . . .. 7.9 11.0
No reason given .. . . . .. .. . . . . . . . .. . .. .. . .. . .. . .. . .. . . . .. . . . . . . . .. 37.1 18,6
Medical advice sought..., . . .. . . . .. . . .. .. . .. . . . . . . . 49,9 63.2
Care inadequate . . . .. .. . . . . .. .. . . . . . . . .. . .. . . . .. . . . . . .. . . .. . .. . . 14.9 14.8
Did not cooperate with doctor.., . . . . . . . . .. .. . . . . . . . . . . . 6.1 4.7
Under best care now .. . . . . .. .. . . .. .. . . . . .. . .. .. . . . . . . . .. . .. .. 18,9 30.4
Care could be improved .. . .. . . . . .. .. . .. . .. .. . . .. .. . .. . . . . . . 10,0 13.3
No madical advice sought..., .. .. . . . . . . . . . . .. .. . 50,1 36.8
Expert care would improve,.,.,...,..,., . . . .. .. . . . .. . . .. . 44.9 25.9
Expert care would not improve . .. . . .. .. . . . . .. .. . . .. .. . . 5.2 10.9
Medical advice sought .. .. . . . . .. . .. .. . . . . . . . .. .. . .. 49.9 63.2
Under best cara now .. . .. .. . . . . . . . .. .. . . . . . . . .. . .. . . . .. . . . . .. 18,9 30,4
Expert cara would improve .. . . . . . . . .. .. . .. . . . . . . . .. . . . .. . 31,0 32.8
Total not utldar best care .. . . .. .. . . . . .. . .. . 81.1 89.6
Could be improved with axpert oare . .. . .. . . . . . . . . . . . 75.9 58.7


































































































































76,5-1-”76.3 83.372.9 77,83.4 15.5 77.54.8 73.45.8 71.19.4 74.64.9 75.73.4 79.6543 71,5540
there was no improvement so stopped, ” “treat-
ment was too painful, “ “medication needed for
other condition was causing the skin eruption, ”
“condition does not bother person that much, ”
“person knows cause,” and “person is treating
himself or herself.” In each category of other
obstacles to improvement the proportions are
slightly higher among females than among males.
Care for skin conditions is most likely to
have been sought from a nondermatologist
physician (24. 1 percent of those with skin con-
ditions that concerned them), a dermatologist
(18.2 percent), or a nonprofessional (16.2 per-
cent), and least likely from a pharmacist (5.1
percent) or from a podiatrist or osteopath (less
than 1 percent) (table H). As expected, physi-
cians are usually consulted for such conditions
of preschool-age children 1-5 years (42, percent
compared with 17 percent for whom care was
sought from a dermatologist, pharmacist, or
nonprofessional). Among school-age children
6-11 years, a nondermatologist physician (3 1
22
percent) or dermatologist (21 percent) is more
fikely to have been consulted than is a norlpro-
fessional (8 percent) or pharmacist (0.4 per-
cent). Among youths, a nonprofessional is the
most likely to have been consulted rather Wan a
nondermatologist physician or dermatolo&st.
Females are more likely than males are to have
consulted either a nonderrnatologist physician
(25 percent for females compared with 21 ,per-
cent for males) or a dermatologist (2 O percent
for females compared with 15 percent for
males); the males are more likely than feniales
are to have sought care from a nonprofessitmal




Published national estimates of the preva-
lence of various types of chronic skin conditions
among the U.S. civilian noninstitutionalized
population of all ages based on findings from the
Health Interview Survey of 196918 are available
for comparison with the findings in this report
from the dermatology examination of the
1971-1974 Health and Nutrition Examination
Survey. In comparing the estimates based on
findings from the national probability samples in
the two surveys, it should be kept in mind that
the Health Interview Survey data were obtained
through household interview of a responsible
adult for all members of the household in
answer to the question “During the past 12
months did anyone in the family have any of
these conditions?” Skin conditions on the list
used by the interviewer included tumor, cyst, or
growth; eczema or psoriasis; trouble with dry or
itching skin; trouble with acne; skin ulcer; any
kind of skin allergy; dermatitis or other skin
trouble. These conditions were later classified
using the Eighth Revision International Classifi-
cation of Diseases, Adapted for Use in the
United States (ICDA). 14 Conditions considered
chronic irrespective of onset and those which
had their onset more than 3 months prior to the
week of the interview and lasted more than 3
months were all considered chronic.
The national prevalence estimates for the 10
groups of skin conditions identified in the
Health Interview Survey (HIS) and the rates for
these groups based on significant pathoIogy,
nonsignificant pathoIogy, and skin complaint
findings from the dermatology component of
the Health and Nutrition Examination Survey
are shown in table K. Estimates for the fungal
conditions—dermatophytoses or dermatomy-
coses—and for chronic infections of the skin
and subcutaneous tissue are substantially
less, and the rates for corns and callosities and
diseases of the nails are substantially higher from
HIS than the HANES estimates based on signifi-
cant pathology or skin complaints. The preva-
lence of corns and callosities and diseases of the
nails, which increase markedly with age, wouId
also be expected to be somewhat higher from
HIS than from HANES since only the former
survey included persons 75 years and older.
The national prevalence estimates for acne
among youths 12-17 years of age from the
1971-1974 Health and Nutrition Examination
Survey and that from the standard physician
examination in the 1966-1970 Health Examina-
tion Survey among a probability sample of
youths are in close agreement-25.O per 100
youths from the present HANES data and 28.3
per 100 youths from the 1966-1970 HES data
when the latter are limited to the moderate to
severe (II-IV) grades of acne. 15
Information on the extent of medical care
received by the civilian noninstitutionalized U.S.
population, characteristics of the persons seek-
ing such care, and the type of care given by
physicians (doctors of medicine and doctors of
Table K. Prevalence of selacted skin conditions from the Health Intewiew Survey (HIS) of 1969 and the dermatology component of the Health and Nutrition
Examination Survey (HANES) of 1971-1974: United States
Condition
Derrrmtophytosasand dBmtatomycoses..............................................
Chronic infections of skin and aubcutanaoustissue..,..........................
Eczema,,dermatitis, and urticaria ........................................................
Psoriqsisand similar tisorders .............................................................
OJher inflammatory conditions of skin and subcutaneoustissue.........
Corns and callositiM............................................................................
Othar hypartrophic and atrophic di$aasesof skin..,,...,, .......................
Diseasesof nail....................................................................................
Diseasasof sebaceousglands...............................................................


















































lNati~nal estimates for the civi]ian noninstitutionaIized population of aI1ages from HIS and for ages 1-74 years from HANES.
2prevaIe”ce of complaints for these 2 groups will slightly exceed these value~.
23
osteopathy) in their offices is obtained through
national probability samples of physician prac-
tice in the NationaJ Ambulatory Medical Care
Survey (NAMCS). From the 1975 findings of
NAMCS,l 6 there were an estimated 28.6 million
visits to physicians offices for conditions in
which the primary diagnosis was a disease of the
skin and subcutaneous tissue (ICDA codes
680-709). Nearly half of these (49 percent) were
return visits to the same physician.
The prevalence of chronic conditions and
related information among the U.S. institution-
alized patients living in nursing homes is ob-
tained through national probability samples of
such homes in the National Nursing Home Sur-
vey (NNHS). From the findings of the NNHS of
August 1973-April 1974,17 an estimated 6,000
of the 1,075,800 residents or 5.6 per 1,000 resi-
dents had a primary dia~osis at their last exami-
nation of a disease of the skin and subcutaneous
tissue (ICDA codes 680-709). At that time, 75
percent of the residents of such homes were 75
years or older.
SUMMARY
Skin condition findings as well as the extent
of resultant handicap and related need for medi-
cal care among persons 1-74 years of age in the
civilian noninstitutionalized population of the
United States as determined through the Health
and Nutrition Examination Survey of
1971-1974 are described and analyzed in this
report. Age and sex differences in these factors
are included.
The dermatology examination component of
this survey was planned and cIoseIy supervised
by the Data Collection Unit of the Committee
on Planning for the National Program of the
National Academy of Dermatology. For the sur-
vey, a national probability sample of 28,043 per-
sons was selected to represent the 194 million of
that age at midsurvey time in the target popula-
tion. Of these sample persons, the 20,749 or 74
percent examined by the survey dermatologists
(when the data are adjusted for the differential
sampling ratios used in the age-sex-income-
defined population sub~oups) represent an
effective response rate of 75 percent.
Nearly one-third (312.4 per 1,000 popula-
tion) or an estimated 60.6 milIion of the U.S.
civilian noninstitutionalized population age 1-74
years have some skin pathology that shoukl be
evaluated by a physician at least once.
The most prevalent of the significant skin
conditions are those affecting the sebaceous
glands (84.8 per 1,000 population) incIuding
acne vulgaris; dermatophytoses or fufigal
diseases (81.1 per 1,000); malignant or behign
tumors (56.5 per 1,000); seborrheic dermatitis
(28.5 per 1,000); atopic dermatitis and eczema
(18.4 per 1,000); and contact dermatitis (13.6
per 1,000).
The prevalence of significant skin pathology
increases rapidly with age from 142.3 per 1,000
preschooI-age children to 365.1 per 1,000 young
adults age 18-24 years due primariIy to the
increase in acne vulgaris; then decreases sIightIy
at 25-34 years before starting the consistent
increase with age from such skin conditions as
psoriasis, vitiIigo, malignant and benign tumors,
and actinic and seborrheic keratoses.
NearIy one-eighth (118.2 per 1,000) or an
estimated 22.9 milIion of the U.S. population
age 1-74 years have one or more skin conditions
about which they complained or expressed con-
cern. Nearly one-third of the persons with skin
conditions that the survey dermatologists d&er-
mined should be evaluated by a ph ysicia,n at
least once express concern about their condi-
tion; an additional one-fifth (18 percent) com-
plain about skin conditions the examiners did
not feel were serious.
The majority of skin complaints have Oeen
present 5 years or longer, with skin conditions
affecting the feet more likely than those affect-
ing the hands or other parts of the body to have
been present this long.
Among persons with skin complaints, 9 per-
cent indicate the condition limited their activity
to some extent, 10 percent consider it a handi-
cap in their employment or housework, and
about one-third feel it was a social handicap to
at least some extent.
The dermatological examiners rated more
than two-thirds of those persons with skin com-
plaints as disfigured to some extent from the
condition; about one-fifth of those were rated
moderately or severely disfigured.
More than half of those persons with skin
24
complaints report some overall discomfort from
the condition, such as itching or burning. For
nearly 6 percent of those with skin complaints,
the condition is extensive enough to cause Imit-
ation of motion.
Nearly one-fifth of those persons with skin
complaints are receiving the best possible care
for the condition, Of the remaining 81 percent
who are not, nearly all (94 percent) could, in the
judgment of the survey dermatologist examiners,
be improved with more expert care; this propor-
tion ranges from 84 percent among preschool-
age children to 96 percent among the oldest age
group in this study (65-74 years).
About one-half of those persons with skin
complaints have not sought medical advice for
the condition; an additional 15 percent who did
are, in the opinion of the dermatologist ex-
aminer, given inadequate medical advice. About
6 percent did not cooperate with the doctors
they had consulted. Other obstacles to improve-
ment are cited by 13 percent of persons with
skin complaints, including insufficient money
(nearly 4 percent), too far from the doctor or
transportation not available (1.4 percent), not
being aware the condition could be treated, dis-
couraged with the treatment, treatment was too
painful, medication needed for other condition
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Table 1. Prevalence of significant skin pathology of all typas and the most frequently occurring types of conditions among persons 1-74
years, by sex, showing rates, number of persons affected, and selected standard errors: United States, 1971-1974
Condition and NYU codel
Persons with one or more significant skin conditions ... .. ..... . ... ... .
Significant skin conditions, all types .. .. .. .... .. .. ...... .. . ..... . .. ..... .. .. ...
Diseases of sebaceous glands . .. . ...... .. .. .... .. . . .... .. .. .... ... . .... .. .. . .... .. ..7l4l.7l49
Acne vulgaris .. ... .. .... . ... ..... .. . ..... . .... .... .. .. ..... .. . .... ... .. .... ... . .... .. ... ...7l4l5O
Cystic acne . ..... .. .. ...... .. .. .... .. .. .... .... ..... . .... .... .. .. .... .. .. .... ... . ..... ... ...714180
Acne scars .. ... .... . ... .... .. .. ..... .. . .. .... .. .. .... .. .. . .... . .... .... .. . ..... .. .. ... .. . ...7l4l9O
Xerosis . ..... .. .. .... .. .... .... .. .. .... ... . .. .... . ... .... ... . .... .. ... ... ... . ...... .. . ..... ...7l493O
Dermatophytoses .. .... .... ..... .. ... ..... . ... .... ... . ..... . ... ..... .. . .... ... .. .... .. .. ..... .. . ...l3l
Tinea pedis . ... .. ... .... .. .. ...... .. . ..... .. .. ...... . .. ... .... .. .... .. ... .. ... .. .... .. ... ..... . .1310
Tinea unguium .. .. .... .. ... .... .. ... .... .. .. ..... . .... .... .. . ..... .. .. ...... . . .... .. ... ..... . 1312
Tinaa versicolor .. .. ..... .. ... .... . ... ...... . .. .... ... .. .... ... .. .... .. .. .... .. .. .... ... . .131910
Tinea cruris ... .... .. .... ... .. ... .... .. .. ...... . ... .... .. .. .... ... .. ..... . . ..... ... . ..... .. ...13131
Tumors2 .. . .... .... .. .. .. .. .. ... ..... .. ... .... .. . .. .... ... . .... .. .. .. .... .. .. ... 19 X,22 X,23 X,23Y
Malignant ..... .. ... .... ... .. .... .. ... .... .. ... .... .. .. .... ... .. ..... . .. .... .... . ..... . ... ... ... ..l9x
Basal%ell epithelioma ... .. .... .. .... .... .. ... ... ... . ..... ... . .... .. . .. .... .. .. .....l9Xl
Benign2 .... .. ..... .. .. ..... . .... ..... . ... ... .. .. .. .... .. .. ..... .. . .... .... . ..... .. .. .... .. .. ..t...22X
Lipoma “22X959, .. .... .. .. .... .. .. . ..... .. .. ...... . .. ... .. .. .. .... .. ... .... . ... .... . .... .... ..
Precancerous and not specified ...... .. .. .... .. .. .... .... . ..... . ... .... .. .. ... 23 X,23Y
Actinic keratosis . ...... .... ..... . .. .... .... ...... .. .. .... .. .. .... .. ... .... .. . .. ...23XO8l
Seborrheic dermatids .... . ... .... .. .. ..... ... .. .... . .. ...... . ... .... . ... ..... .. . ..... ... . .... .. ..7OO
Seborrheic dermatitis, type not indicatad .... . ... .... ... . ..... . ... .... .....700010
Atopic dermatitis, eczema ... . ...... .. .. .... .. .. ..... ...701.708300.7083 lO.7O832O
Atopic dermatitis .... .. ... .. .... .... .. .. .. .. .. .. ..... ... .. .... .. .. ... .. .... ... ... ... ....7 0831 O
Lichen simplex chronicus .. .. .... .. .. ..... .. .. .... .. ... ..... . ... .... .. . ..... .. ... ...7 O832O
Hand eczema.. ............................................................................7olooo
Nummular eczema ... ... . ..... .. .. .... .... .. ... ... .. ... ... .. .... .. ... .... .. .. .... ... ...7'0101 O
Dyshidrotic eczema ... .. ... ..... . ... ..... . .. ..... .. .. .....+... .... ... . .... .. ... .... .. ..7olo3o
Contact dermatitis .... .. .. ..... .. ... .... .. . ...... .. .. ..... .. .. .... .. .. ..... . .... ... .. .. .... ... .. ...7O3
Ichthyosis, keratosis . .... .. .. .... .. .. .. .... .. .. .... .. .. .. .. .. .. .. .... . ... .... ..71 O130.71 Ol5O
Verruca vulgaris .. .... .. .. ..... .. .. ..... .. .. ..... .. .. ..... . .. ..... .. ... .... .. . ..... .. .. ..... ...696O3O
Follicul itis . .. ..... .. . ...... ... . .... ... ... .... .. .. .... .. ... ..... .. .. .... .. .. .... .. ... .... .. . ......l~l39O8
Psoriasis .. .... ... . ..... . ... ..... .. .. .... ... .. .... . .. ... .... . ... ... ... . ...... . ... .... .. . ..... ... .. ...~O6O9O
Seborrheic keratosis .. ..... ... .. .... .. .. .... ... . .. .... .. .. .... .. .. .. .. .. .. ..... . ... ..... . . 22X44X
Vitil igo ... ... .. .... ... . ..... . ... ..... .. .. ..... .. . ..... .. ... .... ... . .... ... .. .... ... ..... ... . ..... ..1~1621 O
Urticaria (hives. etc.) .. ... .. .... .. .. ...... .... .... .. ...... .. .. ...... .. ..... ... .. .... .. .. ...242.243
Herpes simplex .. ... . ... ..... .. .. .... .. .. .... .. .. .. .... .. ... ... ... . .... .. .. .. .... .. . .... ... .. ..t . .. ..O96
All other skin conditions .... . ..... ... .. ..... .. ..... ... .. .... .. .. .... .. .. ..... . ... ..... . .. ..... ... .. .
Persons with one or more significant skin conditions ... ... .. .. .... .. ..




































































































































































































































z~xclude~ seborrhej~ keratosjs (22x44X) which is listed with benign tumors in the NylJ classification.
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Table 2. Prevalence of significant skin pathology of all types and the most frequently occurring types of conditions among persons 1-74 years, by age,
showing rates and standard errors: United States, 1971-1974
Condition and NYU codel
Personswith one or mora significant skin conditions ...........
Significant skin conditions, all types....................................
Diseasesof sebaceousglands...............................................7l4l.7l49
Acne vulgaris......................................................................7l4l5O










Basal+ell epithelioma ....................................................... 19X1
Benign2 ...................................................................................22X
Lipoma ................... .....................................................22X959
Precancerous and not specified ...... .......................... ........ 23 X,23Y
Actinic keratosis ..........................................................23XO8l
Seborrheic dermatitis ................................................................ .....7oo
Seborrheic dermatitis, type not indicated ...........................7WOl O
Atopic dermatitis, eczama ......................701 ,7083 OO,7O831O,7O832O
Atopic dermatitis ............... ................................................7 0831 O
Lichen simplex chronicus ...................................................7 O832O
Hand eczema ............................ ..........................................7olooo
Nummuiar eczema ..............................................................7 0101 O
Dyshidrotic eczema ............................................................701 O3O
Contact dermatitis .........................................................................7O3
Ichthyosis, keratosis ...................................................71 Ol3O.7lOl5O





Urticaria (hives, etc.) ........................................ .... ..................242.243
Herpes simplex ..............................................................................O96
All other skin conditions .....................................................................
1-5 6-11 12-17 18-24 25-34














































































































































































































































































Standard error of rate







































2Exc]udes ~ebOmheic keratosjs (22X44X) which is listed with benign tUmOrSin the NyLJ classification.
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Table 3. Prevalence of significant skin pathology of all types and the mosl; frequently occurring types of conditions among males 1-74 Years, by age:
United States, 1971-1974
Condition and NYU codel
Persons with one or more significant skin conditions ...........
Significant skin conditions, all types ...................................








Tinea versicolor ..................................................................13191 O




8enign2 .............#................. .................... ................................22x
Lipoma ........................................................................22X959
Precancerous and not specified ........................................ 23 X,23Y
Actinic keratosis ...... .... ........................ ........................23XO8l
Seborrheic dermatitis .....................................................................7OO
Seborrheic dermatitis, type not indicated ...........................7 0001 O
Atopic dermatitis, eczema ......................701 ,708300,708310,708320
Atopic dermatitis ...............................................................7O83lO
Lichen simplex chronicus .... ...............................................7O832O
Hand eczema ......................................................................7olooo
Nummuler eczema ..............................................................701 OlO
Dyshidrotic eczema ............................................................701 O3O
Contact dermatitis .........................................................................7O3






Urticaria (hives, etc.) ..............................................................242.243
Herpes simplex ..............................................................................O96






























































































































































































































































































Table 4. Prevalence of significant skin pathology of all types and the most frequently occurring types of conditions among females 1-74 years, by age,
United States, 1971-1974
Condition and NYU codal
Persons with one Or more significant skin conditions ...... .. ...
Significant skin conditions, all types ........................ ..........






Tinaa pedis .. ..........................................................................l3lo
Tinea unguium .......................................................................l3l2
Tinaa varsicolor ...........<......................................................l3l9lo
Tinea cruris ........... ...............................................................l3l3l
Tumorsz ....................................................... ......... 19X,22X,23 X,23Y
Malignant ................................................................................l9X
Basal+ all epithelioma .................... ................................... 19X1
Benignz ................................. .......... ........ ................................22x
Lipoma ........................................................................22X959
Precancerous and not specified ........................................ 23 X,23Y
Actinic keratosis ..........................................................23XO8l
Seborrheic dermatitis ... ..................................................................7oo
Seborrhaic dermatitis, type not indicated ................. ..........7 0001 O
Atopic dermatitis, eczema .... .... ..............701 ,708300,706310,708320
Atopic dermatitis ...............................................................7O83lO
Lichen simplex chmnicus ...................................................7 O832O
Hand aczema ......................................................................701 OOO
Nummular eczema ..............................................................7ololo








Urticaria (hives, etc.) .............................................................242.243
Harpes simplex ..............................................................................O96
All other skin conditions .. . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
~See reference 8.





































































































































































































































































































‘Excludes seborrheic keratosis (22X44X) which is listed with benign tumors in the NYU classification.
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Table 5. Prevalence of significant active skin pathology, significant skin pathology now in remission, and the coexistence of significant
active skin pathology and condition (s) in remission among persons 1-74 years, by age and sex, showing rates, selected standdrd






Rate per 1,000 population






































































51.4Male, 1-74 years .. .. .... ... .. .... .. .... ... .. . ...... .. .. .... .. ... ... ... . ..... .. .. .
l.5years ... .. .. .. .... .. .. .... .. . . ...... .. .. .... .. .... .. .. .. .. .... .. .. .... .. .. .. .... .. . ..... ....
6-11 years ... .. .. .. .. .. .. .. .. .. .. .. .... .. .. ...... .... .... .. .. .. .. .. . . .... .. .. .. .. .. .. .. .... ....
12-17 Vears .. .. .... .... .. .... .. . .. ... .. .. ...... ... .. ..... . . .... .... . ..... .. ... ... .. .. ..... . ...
18-24 Vears .. .. .. .... .. .. .. .. .. .. .. .... .. .. .... .. .... .... . ... .... .. . ...... . .... ... ... ..... . .. .
25-34 years ... .. ..... . ... .... .. .... .... .. .. .... .. .. ..... . .. .... .... .. .... .. ... ... .. .. ..... . ...
35-44 years .. .. .. .. .. .. .. .. .... .. .. .. ..c. .. .... .. .. . ..... .. .. .. .. .. .. .... .. .. .. .. .. .. .. .... .. .
45-54 years . .. . ... .... .. . ..... .. .. ...... . . .. .. ... ... ..... .. . .... .. .. . ..... . ... . ... . .. ..... .. ..
55-64 yaars .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .... .. .. ...... .. .. .. ... . .. ..... ... .. .... .. .. .... .. .






































































43.6Female, 1-74 years ... .... .. . ..... ... . ..... .. ... .... .. . ..... .... . .... .. ... .. ....
1-5 years .. .... .. .. .. .. .. .. .. .... .. .. . ... .. .. ... ... .. .. .... .. ... ..... . . ..... .. ... .... .. .. .... .. .
6-11 years .. ... . .. .. .. .. .. .. .... .... .. .. .. . ... .... .. . ... .. .. ... .... . ... ..... .. .. .... .. .. .... .. .
12-17 years ... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .... .. .. .... .... .. .... .. .. ... ...
18-24 years ... ... .. ... ... . ...... ... . ... .... .. .... .. .. .... . .... .... .. . ..... ... . ... .... .. ... .. ..
25-34 years ... .. .. .. .. .. .. .. .... .. .. .... .. .. .. .... .. .. .... .. .. ..... . .. .... .. ... .... .. . .. .... ..
35-44 Vears .... .. .. .... . .. . .... ... . ...... .. . .... ... .. ..... .. .. .... .. .. .... .... . .... . .... .... ..
45-54 Vears ... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .... .. .. ......cc.... .... .. .... ...c.. .. ..
55-64 Vears .... .. .. ..... . .. ...... .. . ..... .. ... .... ... . .... .. .. ..... . ... ... .... . .... .. ... .... ..
































































Standard error of rate






31.301 ---l ---l ---1 ---
Maler 1-74 years . .... ... .. .... ... .. .... ... .. .... ... . ..... .. . ..... . .. .. .... .. .. .... . ... .... ..
Female, 1-74 years . .... .. .. .. .. .. .... .. .. .. .... .. .. .. .. .. .. .. .. .. .. .... .... ...... . ... .. .. . :Ml :::1 :::I :::1 :::
Nun }er of persons affectad in thousands






42,044 24,236 20,834 3,402 9,193
-
21,021 11,427 9,826 1,601 4,839
21,020 12,809 11,008 1,801 4,354
Male, 1-74 years .. .... .. .. .. .. .. .. .. .... .. .. .... .. .. .. .. .. .. .. .... . . ...... .. .. .... .. .. .... ..
Female, 1-74 years ... .. ..... ... .. ... .. .... ... ... ... .. ... ... .... . ... .... . ... .... .. .. .... .. .
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Table 6. Prevalence of significant active skin pathology, significant skin pathology in remission, and nonsignificant skin pathology among persons 1-74
years, by type of condition, showing rates and number of persons affected: United States, 1971-1974
Condition and NYU codel
Syphilis . .. .. .. . . .. . . .. .. .. . . . .. . .. .. .. . . .. . . .. .. . .. . . . .. .. .. . . . .. . .. .. .. . . . . .. . . .. . . . . .. .. .. . .. . . . .. . . . .. . . .. . . . . ... . ...O2O429
Other venereal diseases .. . .. . . .. . . .. . . . .. . .. .. . . .. . . .. .. .. . .. . . . .. .. .. . . . .. . .. .. . .. . . . .. .. . .. . . . .. . . . .. .. . .. . . . ..O3O039
Bacterial diseases .. .. .. .. .. . . .. .. .. .. .. .. . . .. .. .. . . . .. . .. .. .. . . . .. . .. .. . . .. . . .. .. . .. .. . .. .. .. . .. .. . .. . . . .. . . . .. . . . ..O5O~59
Other spirochetal disemes .. . .. .. .. . . . . .. .. .. . . .. . . .. .. .. .. .. .. .. .. . . .. . . .. .. . .. . . . .. .. . .. .. . . . .. .. . .. . . . .. .. . ..O7O~79
Viral diseases .. . . .. . . .. .. .. .. . . . . .. .. .. .. . .. . ... . .. . . . .. . .. .. . . .. . . .. .. .. .. . . .. .. .. . .. . . . .. .. . . .. . .. . .. .. . . .. . . .. .. . ..O84~96
Rickettsial diseases .. . . .. .. . . . .. . . .. . .. .. .. . .. . .. .. .. . . . . .. .. .. . . .. . . .. . . .. . . . . .. .. .. . . . .. . .. .. .. . .. .. . . . .. . . . .. . ..l OO.lO8
Leishmaniasis and other parasitic diseases .. .. . . .. . . .. .. . . .. . . .. .. .. . . .. . . .. .. .. .. . . .. .. . .. . . . .. .. .. . ..l2O.l3O
Dermatophytoses. .. .. . . .. . . .. .. . .. .. .. . .. .. . .. . . . .. .. .. .. .. .. .. .. .. . . . . .. .. . .. . . .. .. . .. .. . .. . .. . . .. . . . .. . . . . .. .. .. .. . .. ..l3l
Deep fungal infections ... . .. .. . . . .. . .. .. .. . .. . .. .. .. . .. . . . .. .. .. .. . . . . .. .. . ... . .. . . . .. .. . .. .. . . . .. . . . .. . . . . .. . . ..l32.l34
ZOOnOses .. . .. .. .. .. .. . . . . .. .. .. . . .. .. .. .. .. . .. . .. .. . .. .. . . .. . .. .. .. . .. . .. .. .. . . . . .. .. .. . . . . .. .. .. .. . . . . .. .. . .. . . .. . .. ..l35.l37
Sarcoidoses and other parasitic diseases.. .. . .. . . . .. .. .. . . . . .. .. .. . .. . . . .. .. . .. . . . .. .. .. . .. .. . .. . . . .. . . . .. . . . ...l3s
Malignant tumors ... .. .. . . .. . . .. . .. .. . .. .. . .. . . . .. .. .. . .. .. . .. . . .. . . . . ... . .. . .. . . . .. .. . .. . . . .. .. . .. . . .. . .. . .. . . . .. .. .. . .. 19X
Bowen’s disease, Paget’s disease, erythrophasia .. . .. .. .. .. .. .. .. .. .. .. .. .. .. .. . . . . .. .. .. . . .. .. .. .. . 19X0
Basal-cell epithelioma, fibroepithelial tumor . . .. . . . . .. . . .. .. .. . .. . . . .. .. . . .. . . .. .. .. . .. . .. .. . .. .. .. . 19X1
Base-squamous epithelioma or carcinoma and related conditions .. . . .. . .. .. . . . .. . .. .. . .. 19X2
Malignant melanoma, lentigomaligna .. . .. . . . . .. .. .. . .. . .. .. .. .. . . . .. . . . .. . . . .. . .. .. . .. . . .. . .. .. . . . .. . ..l9X6
Squamous+ell carcinoma .. .. .. . . .. . . .. .. . .. . . . .. . . .. . . . . .. .. .. .. . .. . .. .. .. . . . .. . .. .. . .. .. . .. .. .. . . . . .. . . .. . ..l9X8
Adenocercinoma and related conditions .. . .. .. .. . .. . .. .. .. . .. . .. .. . . .. . . . .. . .. . .. .. . . . .. .. .. . . . . .. .. . 19X9
Malignant tumor, skin, NOS ... .. .. .. . . .. .. .. . . .. .. .. .. .. .. . . .. .. .. . . . . .. .. .. .. . . .. .. .. .. . . .. .. .. .. . .. . .. .. . 19XX
Lymphoma, leukemia . .. . .. . . . .. .. .. . .. . .. .. .. .. . . . . .. .. .. . . .. . . .. .. . .. . . . .. .. .. . .. . .. .. .. .. . . . . .. .. .. . . . . .. .. .. . .. . ...2ox
Benign tumor3 .. .. . ... .. . .. . ... .. .. .. . . .. .. .. . .. . . . .. .. . . .. . . .. .. . .. . . . .. .. . .. . .. . . .. .. .. . . . . .. .. .. . .. . .. .. .. . . .. . . .. .. .. . . 22x
Seborrheic keratosis . .. .. . . . . .. .. .. . . .. . . .. .. .. . . . . .. .. .. . . .. . . .. .. . .. . . . .. .. .. . . .. . . .. .. . .. . . . .. .. .. . .. . . . .. .. ..22X44X
Precancels .. .. .. .. .. . . .. .. .. .. . . . . .. .. .. .. .. .. .. .. .. . . . . .. .. .. . . .. . . .. .. . . . .. . .. .. .. . . . .. . .. .. . .. . . . .. .. .. . . .. . . .. .. . . .. .. ...23X
Tumor, malignancy unknown .. .. .. .. . . . . .. .. .. . . . .. . . . .. . . . . .. .. .. . .. . . . .. .. .. . . . . .. .. .. .. .. . . .. .. .. .. . . .. .. .. . . ..23Y
Urticaria< . . .. .. . .. .. .. . .. .. .. . . . ...<. .. .. . . . .. . .. . . . .. .. . .. . . .. . .. .. . . . . .. . . .. . . . . .. .. .. . . . .. .. . .. .. . . . . .. . . .. . . . .. . ....242.243
Allergic eczema or dermatitis due to extarnal sgant .. . .. . . . .. . . .. . .. . .. .. .. . .. .. . .. .. . .. . . . .. . . .. . .. ....2a
Other allergy . . .. . . .. .. .. . . .. . . .. .. .. . .. . .. .. .. .. . . . . .. .. .. .. .. .. .. .. .. . . .. .. .. . .. . . . .. .. . .. . . . .. .. .. . .. . . . .. .. . .. . . . .. .. ....245
Diseases of thyroid glands .. . .. .. .. . .. . . . .. .. .. .. . . .. .. .. .. . . . . .. .. .. . . . . .. . . .. . . . . .. .. . ... . . . . .. .. .. . . . . .. .. ..25O.2W
Diabetes mellitus .. .. .. .. ....!... .. . . .. .. .. .. .. .. . . .. .. .. .. .. .. .. .. .. .. .. .. .. . . .. .. .. .. .. . . . . .. .. .. .. . . .. .. .. .. .. .. .. .. .. . .2643
Other endocrine disorders .. . . . .. . .. .. .. . . . . .. .. .. . .. . .. .. .. . . .. . . .. .. . .. . . . .. .. .. . . . .. . . . .. . .. . . . .. .. .. . . . .. ..27 O.277
Avitaminosis and nutritional deficiencies .. .. .. .. .. .. .. .. . . . .. . .. .. .. .. . . .. .. .. . . . . .. .. .. .. . .. . .. .. .. ..28O.2B6
Lipoidoses and other metabol ic diseases .. . . .. . .. .. . .. .. .. . .. .. . .. .. . . . .. . .. .. . . . .. .. . .. . .. . . . .. . . .. . . . .288-289
Anemias . .. .. .. . . .. .. .. .. . . .. .. .. .. . . .. . . .. .. .. . . .. .. .. .. .. . . .. .. .. .. .. .. .. .. .. . . . . .. . . .. . . .. . . .. .. .. . . . . .. .. .. . . . .. . ...29O.293
Other blood dyscraaias .. . .. .. . .. .. . .. .. .. . .. .. .. . . . . .. . . .. .. . .. . .. . ... . . . . .. .. . .. . . .. . .. .. . .. .. . .. .. .. . . . .. . ...294.299
Psychophysiological and related conditions ... .. .. .. .. .. .. .. .. . . .. .. .. .. .. .. . . .. .. .. .. . . . . .. .. .. . . .. ..32 O.324
Diseases of nerves .. . .. .. .. . . .. .. . . .. .. .. . .. . .. .. . . .. .. .. .. .. .. .. . . .. .. .. .. . . .. .. .. .. .. .. .. .. . .. . . . .. .. .. . . . . .. .. ...36O.369
Diseases of eyes (arcus senil is, etc.) .. .. . .. . . . .. .. .. .. .. .. .. .. .. .. . . .. .. . . .. . . .. .. .. . . . .. . .. . . . .. .. . .. .. . ..37O.3B9
Diseasas of ear .. . .. .. .. . . . .. . . .. . . .. .. . .. . . . .. . . .. . .. .. . . .. . . .. .. .. . . . . .. .. .. . . .. . . .. .. .. . . . . .. .. .. . . . .. . .. .. . . . .. . ..390-398
Rheumatic fever .. . .. .. . . .. . . .. . . .. . .. .. . .. .. . .. . . . .. .. .. .. . .. .. . . . .. . . . .. . .. .. .. . .. .. . . . .. . . . .. . . . .. . . . .. . .. .. .. . ..4OO4O2
Diseases of arteries, connective tissue .. .. . .. .. .. . . . .. . .. .. .. . . .. .. .. .. . . .. . . .. .. .. . .. . .. .. .. . . . . .. .. . .. ..45O4%
Diseases of veins 460-466.. .. . . . . .. .. .. . . . . .. .. . . . .. . . .. . . . .. . .. . ... . .. .. . . . . .. . . .. . .. .. . .. . . .. . .. .. . . . .. . .. . .. .. .. . .. . . .. . . .
Other diseases of circulatory system .. .. . . .. . . .. . . . .. . . .. . .. .. .. . . . . .. .. . ... . .. . .. .. . .. .. . .. .. .. . . . . .. ....467468
Diseases of digestive Wstem ... .. .. . . .. . . .. .. . . .. . . .. .. .. .. . . . . .. .. .. .. . .. . .. .. .. . . .. .. .. .. . . .. .. .. .. .. . . .. .. ..53 O.567
Diseases of genito-urinary system .. .. .. .. . .. . . . .. .. .. . .. . .. .. .. .. . . . . .. .. .. .. . . .. .. .. .. .. . . .. .. .. . . . . .. .. ..6 OO+37
Infections of skin, subcutaneous tissue .. .. .. .. .. . .. .. . .. .. .. . . .. .. .. .. .. . . . . .. .. .. . . .. .. .. .. .. . . . . .. . . ..69O.698
Seborrheic dermatitis .. . .. .. .. . .. . . . .. .. .. . . . .. . .. .. . .. . . . .. .. .. ... . .. .. .. . ... . . .. .. .. . .. .. . .. .. . . .. . . .. .. .. .. . . .. .. .. ..7w
Eczema .. .. . . .. .. .. .. .. . . .. . . .. .. . .. . .. .. .. .. . . . .. . .. .. .. .. . . .. .. .. . . . .. . .. .. . .. . . . .. . . .. .. . . .. .. .. . .. . . . .. .. . .. . . . .. .. .. . . . . ...7Ol
Contact and other dermatitides .. . . . .. .. . .. .. .. .. . ... .. . . .. . . . .. . . . . ... . .. .. . .. . .. .. . .. .. .. . .. . .. . . .. . .. .. . .. . . . . ..7O3
Pemphigus and relatad conditions .. .. .. .. .. .. . . .. .. .. .. . . .. . . .. .. .. . . . . .. .. .. . . . .. . .. .. .. .. . . .. .. .. .. .. . . .. . . .. ..7M
Ewthemas .. .. . . . . .. .. .. .. . . .. .. .. .. . . . . .. .. .. .. .. . . .. .. .. . .. . .. .. .. . . .. . . . . .. . .. . . . .. .. .. . . . . .. .. .. .. .. . . .. .. .. .. . . .. .. .. . . ..7O5
Psoriasis ... . . ..d. .. .. . . . . .. .. .. .. .. . . .. .. .. . . .. . . .. .. ...c. . .. .. .. . . .. . . .. .. . . . .. . .. .. .. .. .. .. .. .. . . .. . . .. .. . . .. . . .. .. . . .. . . .. ...7W
Lichen planus and related conditions ... . . .. .. .. . . . . .. .. .. .. .. .. .. .. .. . ... .. .. .. . . .. . . .. .. .. . . . .. .. .. .. .. .. .. ..7o7
Pruritis and related conditions .. . .. . . . . .. .. .. .. .. . . .. .. .. . . . . .. .. .. . . . .. . .. .. . .. . . . .. .. .. . . . .. . .. .. . .. .. . .. .. .. . . . ..7O8
Corns, callosities .. .. .. . ..<. . .. .. ...! . . .. .. .. . . .. . . .. .. . .. . . . .. .. .. .. .. .. .. .. . . .. . . .. .. . .. . . . .. .. .. . . . . .. .. .. . . .. . . .. .. .. . ..7o9
Other hypertrophic and atrophic skin conditions ... .. . .. . .. .. .. . ... . . .. .. . . . .. . .. .. . .. . . . .. .. .. . . .. .. .. ..71 O
Diseases of nails . . . . .. . . .. . .. . .. .. .. .. . . .. .. .. .. .. . . ... . .. .. . . . .. . .. .. . . . .. . . . .. . .. .. .. . . . . .. .. . .. .. .. . ..<. . .. .. . . .. . . .. .. ..7l2
Diseases of hair, hair follicles . .. . . . .. .. .. .. . . .. .. .. .. . . . . .. .. .. . . . .. . .. .. . .. .. . .. .. . .. . . . .. . . .. . . . .. . . . .. . .. .. . .. .. ..7l3
Diseases of sweat, subcutaneous glands ... . . .. .. .. .. . . . .. . .. .. .. .. .. .. .. .. . . . . .. .. .. . . .. . . .. .. .. .. .. .. .. .. .. . ..7l4
Chronic ulcers of sKn .. .. .. . . .. . . .. .. .. . . . . .. .. .. .. .. .. .. .. .. . . .. .. .. .. . . . . .. .. .. . . . .. . .. .. .. . .. . .. .. .. . . . . .. .. .. .. . .. ..7l5
Other skin diseases ... . . .. . . .. .. .. . .. . .. .. . . .. . . . . .. .. .. .. .. ... . .. .. . . . . .. .. .. . . . .. . . . . .. . . .. . .. .. . .. . . .. . .. . .. . . . .. . . .. ..7l6
Diseases of bones, organs of movement .. . . . .. .. .. . .. . .. .. .. . .. . . . .. .. . .. . . . .. .. . .. . . . .. .. .. . .. . .. .. .. ..74O.744
Congenital malformations . .. . ... . . .. .. .. .. .. .. .. .. .. . . .. .. .. .. . . . . .. .. .. .. . . .. .. .. .. . .. . .. .. .. . . . . .. .. .. .. . . ..751 .759
Diseases of early infancy ... .. . .. . . . .. .. . . . .. . .. .. .. . .. . .. . . . . . . .. . .. .. .. . . . .. . .. . .. . . .. . .. .. . .. . . . .. .. . .. . . . ..766.7BO
Symptoms, senility, and illdefined conditions .. .. .. . . .. .. .. . . .. . . .. .. . . .. . . .. .. . .. . . .. . .. .. . . .. .. ..78l.795
Injuries, adverse effects of chemicals, and other external conditions such as sun-
burn .. .. .. . .. . . . .. .. .. .. . . . . .. .. .. .. .. .. .. .. .. .. . . .. .. .. .. .. . . .. .. .. . . . . .. .. .. . . . . .. .. .. . . .. . . .. .. .. . . . . .. .. . .. . . . .. . . ..850.988
lSce reference 8.


























































































































































































Significant skin I Nonsig-path.dogy nificant



















































































































































































‘Conditicm not-specifically identifiable On record,
3Hxcludes seborrheic keratosis (2 2X44X) which is listed with benign tumors in the NYU classification.
NOTE: NOS= not othwwise specified.
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Table 7. Prevalence of skin conditions of concern (complaints), significant skin pathology of concern and not of concern to the affected individual, and
nonsignificant skin pathology of concern to the individual among persons 1-74 yeara, by age and sex, showing rates, selected standard errOrs, and number ~f
persons affected: United States, 1971-1974
Age
Total, 1-74 years.. .. .. .
1-5 year. . . . . .. . . . . .. .. . . .. .. . . .. .. . . .. .. . . .
6-11 years . .. . . . . .. .. . . .. .. . . .. . . . . .. .. .. .. .
12-17 years . . .. . . . . .. . . . . .. . .. . .. .. . . .. .. . .
18-24 veals .. .. .. .. .. .. . . . . .. . . . . .. . . . . .. . .
25-34 years .. .. .. .. . . .. . . . . .. . . . . .. . . .. .. . .
35-44 years . .. .. . . .. .. . . .. .. .. .. .. . . .. .. .. .
45-54 years .. . . .. .. . . . . .. . . .. .. . . .. . .. . .. . .
56-84 years .. . .. . . .. . . . . .. .. . . .. .. . . . . .. . . .
65-74 years .. .. . . .. . . . . .. . . . . .. . . . . .. .. .. ..
Total, 1-74 years . . . . .. .




























































































Standard error of rate




























































Number of persons (in thousands) with one or more such conditions
22,929 18,841 41,760 4,088 12,072 10,168 21,820 1,904 10,857 8,673 19,940 2,184
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Table 8. Prevalence rates for skin conditions of ccmcern (complaints), all types and the most freauentlv reDorted tvPes, am.mg persons 1-74 years, by sex and Part of body
affected: United States, 1971-1974
Condition and NYU codel
Skin conditions of concern, total ... .. .. ... .. .. .. ... .. .. .. ... .. .... ..
Skin conditions of concern with site and type specified.,
Diseases of sebaceous glands .... .. .... ... .. ... .... ... .. .... .. ... .... ..7l4l.7l49
Acme vulgaris .... .. .. .. .. .. .. .. .. .. .. .. .. ..... ... .. ... . .. ..... ... .. .. .. .. .... .714150
Cystic acne ... ... .. .. ... ..... .. .. .. ... .... ... .. .. ..... ... . ... .... ... .. .. .. ... ..7l4l8O
Acne scars ..... .. .. .. .... .. .. .. .. .. .. .. ... ... .. .. .. .. .... .. .. .. .. ... .. .. ... .. ..7l4l9o
Xerosis .. .. .... .... .. .. .. .. .. .. .. .. .. .. ..... ... .. .. .. ..... ... .. .. .. .... . .. .. ... ..7l493O
Tumors2 .. .. .... .... .. .. ... .... ... .. .. ... ... .. .. .. .. .. .. ...... .. ...l9X.22X23X.23Y
Malignant .. .. ... ... .. .. .. .. ... .... ... .. .. .. .... .... .. .. .. .. .... .... .. .. .. . .... .... . 19X
Basal-xdl epithelioma ... .. .... ... ... ... ... ..... .. .... .. ... .... ... ... ...l9Xl
Benign2 .. .. .... .. .. .. .... .. .. .. .. .. .. .. .... .. .. .. .. ... ..... .. .. .. .. ... ..... .. .. .. .. ..22x
Lipoma .. .. ..... ... .. .. .... .... .. .. .. .. ..... ... .. .. .. .. ... .... ... .. .. .. ...22X959
Precancerous and not specified ..... .. .. .. .... .... .. .. .. .. ... ... ..23 X.23Y
Actinic keratosis .. ... .. ... .. .. .. .. ... ... ... ... .. .. ... .. .... ... .. .. ...23XO8l
Seborrheic dermatitis . ... .. .. .. .. .... .. .. .. ... ... .... .. .. .. .. .. ..... ... .. .. .. .. ... ...7OO
Sebmrheic dermatitis, type not indicated .. .. ... .. .. .. ... .. .. ..7 OOOlO
Atopic dermatitis, eczema ... .. .. .. .. .. ....701 ,708300,708310,708320
Atopicdermatitis . .. ... ..... .. .. .. .. .... .. .. .. .. .. ... ... .... .. .. .... .. .....7 0831 O
Lichen simplex chrOnicus ..... ... .. .. ... ... .. .... .. .. .. .. ... .... .. ... ..7O832O
Hand eczema ... ... .... ... .. .. .. .. .. .... .. .. .. .. .. . ..... .. .. .. .. .... .. ... ... ..701 OOO
Nummular eczema .... .. ... ..... .. .. .. ... .. . .... .. .. .. .... ... ... .. .. .. .. ...7ololo
Dyshidmtic eczema .. .... .... .. .. .. .. ..... ... .. .. .. .. .... .... .. .. .. .. ... ..7OlO3O
Contact dermatitis ... .. .. .. ..... ... .. .. .. .... ... ... .. .. .. ... .... .. ... .. .. .. ... .. .. ....7o3
Ichthyosis, keratosis .... .. .. .. .. .... .. .. .. .. .. ... .... ... .. .. .. ....71 O130.71 Ol5o
Seborrheic keratosis . ... .. .. .... .... .. .. .. .. .... . ... .. .. .. .. .... .... .. .. .. .. ..22X44X
Vitiligo . ... .. ... .. .... ... .. .. .... .. .. .. .. .. .... .. .. .. .. .. .. .. .. ... ... .. .. .. .... ... ....71621 O
Urticaria (hives, etc.) . .... .... .. .. .. .... .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .. ....242.243
Herpes simplex . . .. .. ... ... .. .. .. .. .. .... .. .. .. .. .. .. ... ..... .. .. .. .. .... .... .. .. ...O96
All other conditions .. .. .. .. .. ... ..... .. .. .. ... .. ..... .. .. .. ... ... .... .. .. .. ... . ..... . .... ..









































































































































Total Hand Foot Other




















































































































































































































































‘Excludes seborrheic kcrstmis (22 X44 X) which is listed with benign tumors inthe NYU classification.
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Table9, Prevalence rates far skin conditions of concern (complaints), all types and themmtfrequently repoited tvpes, among persons l-74 year$, byageandpart of body
affected: United States, 1971-1974

















































6-11 years I 12.17 years
Total
II
Hand Foot Other Total Hand Foot Other















































































































































Table9. Prevalence rates forskinc onditionsof concern (complaintsl, all types and themost frequently reported Wpes, among penon$l-74 years, byweatipa~ofbody
affected: United States, 1971-1974-Con.
Condition and NYU ~Odel
Skin conditions of concern, total . .. ..... .. .. ... .. .. ... .. .. .. .. ..... .
Skin conditions of concern with site and type specified.,
Diseases of ssbaceous glands ... .. .... .... .. .... .. ... .. .. .. ... .. .. ... ..7l4l .7I49
Acne vulgaris .. ... .... ... .. .. .. .. .. ... ... .. ... .. .. .. ... .. .... ... .. ... .. .. .....7l4l5a
CY$tic aCnC.. .. .... .. .. .. ... .. ... .. .. .. ... .. ... .. .. .. .. ... .. .. ... .. .. .. .. ... ...7l4l8O
Acne scars .... .. .. ... ..... .. .. .. .... .. .... ..! . .. .. .. ... .. ... .. .. .. ... .... .. ....7l4l9o
XerOsis . ..... ... .. .. ... ..... .. .. .. ... ... ... ... .. .. .... . .. .. .. ... .... .. ..... .. ....7l493o
Dermatophytoses ... .. ... .. .. ... ..... .. .. .. .. .... ... ... .. .. .. .. ... ... . ... .. .. ... . .... ..l3l
_finea pedis .. ... .... ... .. .. ... .. .. .. ..... .. ... .. .. ... .. .. ..... .. .. .. .. ... .... .. ... .1310
Tines un9uium .... . ... .. ... .. ..... .. .. .. .. ... ..... .. .. .. .. .. .... ... ... .. .. .. ....l3l2
Tineaversicolor .... ... .. .. .. .... .... .. .. .. .. ..... ... .. .. .. .. .... .. .... .. .. ..13191 O
TinBacruris . . .. ... ..... .. .. .. .. .... .... .. .. .. .. .... .... .. .. .. .. .. . .... .. ... .. .. 13131
Tumors2 .... .... ... .. .. ... .. .. .. ... .. .. ... .... ... .. .. .. .... .... . ...lgx.22x23x.23y
Malignant .. .. .. .. .. .. .. ... ... .. .. .. .. .. .... .. .. .. ... .... .. ... .. .. .. .. ..... ... .. .. ...lgx
Ba~al-cell epithBlioma .... .. .. .. ... .. ..... .. .. .. .. ... ..... .. .. .. .. ... ...l9xl
BenignZ ... .. .. .. .. .. .. .....!...... .. .. ..... ... .. .. .. .. .... .... .. .. .. .. .... . ..... .. .. . 22x
Lipoma ..... .... .. .. .. .. .... .. .. .. .. .. .. ... ..... .. .. .. .. ... ... .. .... .. .. ..22X959
precancerous and not specified .. . ... .. .. .. .. .. .. .. .. .. .. .. .. .. ... 23x,23y
Actinic keratosis . .... ... ... .... .. .. .. ... .... ... .. .. .. .. ... .. . .... .. ..23XOSl
Seborrheic dermatitis .... ..... .. ... .. .. ... .... .. ... .. .. ... .. ... . ... .. .. .. .. ... ... .. ..7oo
Seborrheic dermatitis, type not indicated .. ... ..... . ... .. .. ....700010
Atopic dermatitis, eczema .. ..... . .... .. ...701 ,70 B300,70B310,708320
Atopic dermatitis . .... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .... .. .. .. .. .. .. .. ...7O83l o
Lichen simplex chronicus ... ... .. .. ... .. .... ... .. .. .. .. .. ... .. ... .. .. ..7W32O
Hand eczema .... .... ... .. .. .. .....<.... .. .. .. ... ... .... .. .. .. .. ... ... .... .. ..7olooo
Nummular eczema .. .... .... .. .. .. ... ... .... .. .. .. .. .. ..... ... .. .. .. .. .. ...7ololo
Dyshidrotic eczema ... ..... . ... .. .. ... .. .. .. .. ... .... ... .. .... ... .. .. ..!..7olo3o
Contact dermatitis ... .. .. .. ... .. .. .. ... .. .. ... .. .... ... .. .. ... .. .. .. ... .. .... ... .. .. ..7o3
Ichthyosis, keratosis .. .. .. ... .. .. ... . ..... .. ... . ... .. ... .. .. .. ....7 10130,710150
Verruca vulgaris .. .. .... ... .. .... .. ... .. .. ... .. .... ... .. .. .. ... ... .... .. .. .. .. ....696o3o
Folliculitis .. .. .. ... .. .... ... .... ... .. .... ... .. .. ... . ... .. ... .. ... ... ... .. ..... .. ....713906
p$Oriasis.. .. ..... .. .... ... .. .... .. ..... .. ... .... .. .. ... .. .. ... .. .... ... .. .. .. .... . ....7O6WO
S&borrhoic keratOsis .. ... .. ... .. .. ... .. .. .. ... .. .. ... ... .. .. .. .. .. .. .. .. ... ...22Xwx
~tili90 .. ... .. .. .. ... .. ..... .. .. .. ... . ..... . .... .. .... ... .. ..... .. .. .. .. .... ... ... .. ..7l62lO
Urticaria (hives, etc.) .... .. .. .. .. ... ... ... ... .. .. .. .. ..... . .. .. .. .. .. .. .... ...242.243
Herpes simplex ... .. .. ... .... .. ... .. .. .. ... ... .... .. .... .. ... .... .. ... .. .. .. ..... .. ... ..W6
All other skin conditions .... .. .. .. ... .. .. ... .. .... ... .. .. .. .. ... .. .... ... .. .. .. .. ... .. ..
See footnotes at end of table.
18.24 years


























































I 2534 wars I 35-44 vears
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Table 9. Prevalence rwes for skin conditiomof concern (complaints), all types and themOst frequently reported types, amOngpepOns l.74years, byageandpart0fb0dy





























































55-64 years 65-74 years

























































































































































































































‘Excludes seborrheic dermatosis (22X44X) which is listed with benign tumorsin the NYU classification,
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Table 10. Prevalence rates forskin conditions of concern (complaints), all types and the most frequently repofled Wpes, among males l-74years, byageandpartof body
affected: United States, 1971-1974
Condition and NYU codel
Skin conditions of concern, total .. .. .. ... ... .. .. .. .. ... .. ..... .. .. ..
Skin conditions of concern with site and type specified..
Diseases of sebaceous glands ... .. .. ... ... .. .. ... ..... .. .. .. .. .... .....7l4l.7l49
Acne vulgaris ... .... ... .. .. .... .... . ... .. .. ... .. ... .. .. .. ... .. .. ... ..... .. ....7l4l5o
Cystic acne .. .. .. .. .. .. .. . ..... .. .. .. .. .. .. .. .. .. ... ... .. .. .. .. .. .... .... .. .. ..7l4l8O
Acne scars . .. .. .... .. .. ...... .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. ... ..... .. .. ..7l4l9O
Xerosis .. .. ... .. .. .... .... .. .. .. ... ... . ... .. .. ... .. .. ... .. .. .. ... .... ... .... ... ..714930
Dermatophytoses .... .. .. .. .... .... .. .. .. .. ... .. ... .. .. .. ... ..... .. .. .. ... .. ... .. .. .. ..l3l
Tineapedis ... .. .. .... .... .. .. .. .... .. .. .. .. .. .. .. .... .. .. .. .. ..... ... .. .. .. ... ....131 O
Tineaunguium .. . .. ... .. .. .. .... . ... .. .. .. .. ... ..... .. .. .. .. ..... .. ... .... ... ..1312
Tinea versicolor ... .. .. .. .... .... .. .. .. ... .... ... .. .. ... .... ... .. .. .. .... ....?3191 O
Tineacr.ris . .. .. .. .. .. .. .. .... .... .. .. .. .. .. .... .. .. .. .. .. .. .... .... .. .... .... ..l3l3l
Tumorsz ... .... .. .. ... ..... .. .. .. .... .. .. .. .. .. .... .. .... .. .. .. .. ..l9X.22X23X.23Y
Malignant .. .. .. ..... ... .. .. ..... ... .. .. .. .. .... .... .. .. .. .. .... .... .. .. .. .. ... ..... . 19X
8asal-cell eptthelioma ... .. .. .. .. ... .. .. ... .. .. .. ... .... ... .... .. ... ....l9Xl
Benign2 ... .. .. .. .. .... .. .. .. .... .... .. .. .. .. .... .... .. .. .. .. .. .. .... .. .. .. .. .... .....22x
Lipoma .. .. ...... .. .. .. .... .... .. .. .. .. .... .... .. .. .. .. ... ..... .. .. .. .. ...22X959
Precancerous and not specified ... .. .. .. .. .... .... .. .. .. ... .... ... 23x,23Y
Actinic keratosi$ .. .. .... .... .. .. .. ... ... .... .. .. .. .. .. ...... .. .. .. ...23XO8l
Seborrheic dematitis ...... .... ... .... ... .. .. .. .... ... ... .. .. .. .... ... ... .. .... .. ....7oo
Seborrheic dermatitis, type not indicated ...... ... .. .. .. ... ....7ooolo
Atopic dermatitis, eczema .. .... .. ... .. ....701 ,708300,708310,708320
Atopic dermatitis ... .. .. .... .... .. .. .. ... ..... .. .. .. .. .... .... .. .. .. .. .....7O83lO
Lichen simplex chronicus .. ... .. .. .. ... ..... .. .. .. ... .. ..... .. .. .. .. ...7o832o
Hand eczema .. .... ... ... ..... .. .. .. ... .. .. ... .... ... .. .. .. ... .... .. ..... ... ..7OlOOO
Nummulnr eczema ..... .... .. .. .. .... .... .. .. .. .. .... .... .. .. .. .. .... .. ....7OlOlO
Dyshidrotic eczema .. . ... .. ... .. .. .... ... ... .... ... .. ..... . ... .. ... .. .. ...701 O3O
Contcct dermatitis. . .. .. .. .. .. .. .. .. .. .... .. .... .. .. .. .. .... .... .. .. .. .. .. .. .... .. .. ..703
lchthyosis, keratosis ... .... ... .... ... .. .. .. ... .... ... .... .. .... ...7lol3o.7lol5o
Verruca vulgaris .. .. ..... ... .. .. .. .. .. .. .. .. .. .. .... .... .. .. .. ... .. ..... .. .. .. ....696o3o
Folliculitis . .. .. .... .... .. .. .. .. .... .. .. .. .. .... .... .. .. .. .. .... .... .. .. .. .. .. .. .... .713908
PsOriasls.... ... .. .. ... ..... .. .... .... ... ... .... .. ..... .. ... ..... .. .. .. ... .... ... .. .. ..706090
‘Seborrheic keratosis . ..... .. .. .. .... ... ... .. .. .. .... ... ... .. .. .. .... ... .. ... .. 22X44X
Vitiligo. .. .. .. .. .... .... .. .. .. .. .. .... .. .. .. ... .. ... .. .... .. ..... ... .. .. ... .... ... .. ..7l62lO
Urticarta [hives, etc.) .. .. ... ... . ... .. .. ... .. ... .. .. .. .. ... ... .. ... ... .... .. ...242.243
Herp% simplex .. .. .... .... .. .. .. .. .. .. .... .. .. ... .. .... ... .. .. .. .... .... .. .. .. .. .... ...o96
At” other skin conditions .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. ..




















1-5 years I 6-11 wars I 12-17 years

























Total Hand Foot Other Total Hand




















































































































Table 10. Prevalence rates for skin conditions of concern (complaints], all types and the most frequently reported types, among males l-74years, byageandpart of body
affected: United States, 1971.1974—Con.
Condition and NYU cede]
Skin conditions of concern, total..., .... .. .. .. ..... ... .. .. .... .... ..
5kin conditions of concern with site and type specified..
Diseases of sebaceous glands .... .. .. .. ..... .. ... ..... .. .. ... .... ... ...7l4l.7l49
Aone vulgaris .. ...... .. .. .. .... .... .. .. .... .. .. .. .. .. ..... ... .. ... .. ..... .. ...7l4l5O
Cystic 8cne ...... .. .. ... ... .... .. .. ... ... .. .. .. .. .. .. .. .. .. ... .. .. ... .. .. .. ....7l4lSO
Acne scars ... .. .... ... ... .... ... .... ... .. ... .... ... .. ..... .. ... .. .. ... .. .. .. ...7l4l9O
XerOsis . .. ..... ... .. .. .... ... ... .. .... .... .. ..... .. .... ..... .. ... .. ... .. ... .. ....7l493O
Dermatophvtoses ... .. .... .. .. ... ..... .. .. .. ..... ... .. .. ... ..... .. .. .. .. ... ... .. .. ... ..l3l
Tines pfidis . ... .. .. .. .... .... .. .. ... .... ... .. .. ..... .. ... ..... ..! . ... .... .. ... .. ...l3lo
Tines unguium ... .. .. .. .... .. .. .. .. .... .... .. .. .. ...... .. .. .. .... .... .. .. .. .....l3l2
Tineaversicolor .. ... .. .. .. ... .... ... .. .. ..... ... .. .. ... .... ... .. .. ... .... ...13191 O
Tines cruris ... .. .. .... .. .. .... .... .. .. .. ...... .. .. .. .... .... .. .. ... .... ... .. .. ..l3l3l
Tumors2 .. .. .. .... .. .. .. .... .. .. .. .. .. .... .. .. .. ... ... .... .. .. ... ..l9X.22X.23X.23Y
Malignant ... ... .. .. .. .... .... .. .. .. ...... .. .. .. ..... .. ... ...... .... .. .. .. ... .... ....91 X
Basal<ell epithelioma..,...,,., . .. ... .... ... .. ... .. ..... .. .. ... ..... ...l9Xl
13enignz .. .. .. ... ..... .. .. .. .... .. .. .. .... .... .. .. ... .. ..... .. .. ...... .. .. .. .. ..... ...22x
Lipoma ... .. .. .. .. .. .... .. .. .... . ... .. .. .. .... .... .. .. .. .... .... .. .. .... ..22X959
Precancerous and not specified.,..,., .... .. .. .. .... . ... .. .. .... .. 23 X,23Y
Actinic keratosis ..... .. ... .. ... .. ..... ... .. .. .. ... .... ..... ... .... ...23XOSl
Seborrheic dermatitis ... ..... .. .. .... .... .. .. ... .... ... .. .. .... .... .. .. ... ..... .. .. ..7OO
Seborrht?ic dermatitis, type not indicated ...... .. .. .. ... ..... ..7OOOlO
Atopic dermatitis, eczema ... .... .. .. .. ....701 ,708300,7083 10,70S320
Atopic dermatitis ..... .. .. .. .. .... .. .. .. .... .. .. .. .. .. .. .. .. .. .. .. ..... ....70831 O
Lichen simplex chronicu$ .. .. ...... .. .. .... .... .. .. ... .. ..... .. ... .. ...7O832O
Hand eczema.. . .. .. ... .. .. .. .... .. .. .. ... ..... .. .. .. .. ... ... .. .. ...... .. .. ...7olooo
Nummular eczema ..... .. .. ... ... .... .. ... .. ..... .. .. ..... ... .. .. .. .... ....701 OlO
Dyshidrotic eczema ...... .. .. .. .... .... .. .. ... ..... .. .... ...... .. .. ... ....701 O3O
Contact dematiris . .... .... .. .. .. ...... .. .. .. .... .... .. .. .. ..... ... .. .. .. .. .... .. .. ...7O3
Ichthyosis, keratosis .. .. .. .. .... .. .. .. .. .. ...... .. .. .. .. .. .. .. .. ..71 O130.71 Ol5O
Verruca vulgaris .. .. ... ..... .. .. .. ..... ... .. .. ... ..... .. .. ... ..... .. .. .. .... .... ..696O3O
Folllculitis .... .. .. ... .... ..... .. ..... ... .... ... ..... .. .. ... .... ... .. ... .. .. .. ... .. ..7l39O8
Psoriasis.... .. .. .. .... .. .. .. .... .... .. .. .. ... ..... .. .. ... ..... .. .. ... .. ..... .. .. ... ...7 O6O9O
Seborrheic keratosis . .. .. .. ...... .. .. .. ...... .. .. .. ... ..... .. .. .. .... .... .....22X44X
Vitiligo .. .. .. ... .... ... .. .. ... .. .. ... .. ... ... .... .. .. ..... .. ... .. .. .. . ... .. .. .. ... ....7l62lO
Urticaria (hives, etc. ) .... .. .. .. .. .. .. . ..... .. .. .. .... .... .. .. .... .. .. .. .. .. ...242.243
Hwpc+$ simplex .... .... .. .. ... ... .. .. .. .. ... ..... .. .. .. ..... ... .. .. ..... ... .. .. ... ......O96
All other skin conditions .. ..... .. ..... ... .... ..... .. ... .. ... .. ... .. .. ... .... ... .. .. ... ..














































25.34 years 35.44 years
Other Total Hand Foot Other Total Hand I Foot



























































































































































Table 10. Prevalence rates forskin conditions of concern (complaints), all Wpesand themost frequently repotied tvPes, among males l-74years, byageandpan of body
affected: United States, 1971-1974-Con.
Condition and NYU codel
Skin conditions of concern, total . .. ..... ... .. .. .. .. .... .. .... .. .. .. .
Skin conditions of concern with site and type specified..
Diseases of sebaceous glands ... .. ... .. .. ... .. .. ... .. .. .. ... .... ... ....7l4l.7l49
Acne vulgaris .. .... .... .. .. .. .... .. .. .. .. .. .. .... .... .. .. .. ... ... .. .. .. .. ...t.7l4l5O
Cystic acne ... .. ..... ... .. .. ... .. .... .. ... .. .. ..... .. ... .. .. ... .. .. .. ... .. .. ...714180
Acne scars ..... .. .. .. .... .. .. .. .. .. .. .... .. .... .. .. .. .... .... .. .. .. .. .... .. .. ..7l4l9O
Xerosis ... .. .... .... .... .. .. ... .. .... ... .. .. .. ... .... .. ... .. .. ... .... ... .. .. .. ...7l493O
Dermatophvtoses ... .... .. .. .. ... ..... .. .. .. .. ... .. ..... .. .. .. ... .... .. ... .. .. .. ... ....l3l
Tines pedis . .. .. ... .. ... .. .. ... .... .. ... .. .. .. ... .... ... .. .. .. ... .... ... .. .. .. .. ... 1310
Tinea unguium .. .. .. .... .... .. .. .. .. ... ..... .. .. .. ... .. ..... . ... .. ... .. ... ... ..1312
Tines versicolor . .. ... ..... .. .. .. .. ... ... .... .. .. .. .. ... ..... . ... .. .. ... .. ... 131910
Tines cruris ..... .. .. .. .... .. .. .. .. .. .. ... ..... .. .. .. .. .. .. .... .. .. .. .. ... .... .. .13131
Tumom2 ... .. .. .. ... ... .. .. .. ... ..... .. .. .. .. .... ... ... .. .. .. ... ...l9X.22X23X.23Y
Malignant ... .... ... .. .. ... .... ... .. .. .. ... .... .. ... .. .. ... .. .. .. ... .... .. ... .. .. ....l9x
Basal.cell epithelioma .... .... .. .. .. .. ... .. ... .. .. .. .. ... ..... . ... .. .. .. 19X1
Benignz .... .. ... .. .. .. .. ... .... ... .. .. ... .. .... ... .. .. .. ... .... .. ... .. .... ... .. .... .. 22x
Lipoma ... .. ... ... .... .. .. .. .. ...... .. .. .. .. .. ... .... ... .. .. ... .. .... .. ... 22X959
Precancerous and not specif ied .... .. .. .. .. .. .. .... .. .... .. .. .. .. . 23 X,23y
Actinic keratosis ... .... ... .. .. ... ... ... .. .. ... .. .. .... ... ... .. .. .. ... 23X081
Seborrheic dermatitis ..... .. .. .. ... .. ..... .. .. .. .. ... ... ... ... .. .. .. ... ... .... .. .. ...7OO
Seborrheic dermatitis, type not indiciated .. .. .. .. .. .. .... .....7OOOl O
Atopic dwrnatitis, aczema .. .... .. .... .. ...701 ,70B300,70831 0,708320
Atopic dermatitis . ... ..... .. .... ... .. .. ... .. .. .. .. .... ... .. ... .... ..... .. ..7 0831 O
Lichan simplex chronicus ... ... .. .... .. ... .. .. ... .. .. .. .... . .. ... .. .. ..7O832O
Hand eczema .. .. .. .. .... .... .. .... .. .... .... .. ..<.<. ... .... ... .. .. .. ... .. ....7olooo
Nummular eczema ... .. .. .. .... .... .. .. .. ... .... ... .. .. .. .. .. .. .. .... .. .. ..701 OlO
Dyshidrotic eczema ..... .. ... .. .. ... .... .. ... .. . .... .. .. .. ... .. .. .. ... ....7olo3o
Contact dermatitis ... .. .. .. .... .. .. .. .. .. ... .... .. ... .. .. ... ... .... .. .. .. .. .... .. .....7O3
Ichthyosis, keratosis .. .. .. .. ... ..... .. .. .. .. ... ..... .. .. .. .. .... ..71 Ol3o.7lol5o
Verruca vulgaris .. .. .. ... .... ... .. .. .. .. ... .. .. ... .. .. .. ... .. .. ... .. .. .. ... ... ....696O3O
Folliculitis .. .. ... .... ... .. .. ... .. .. .. ... .... ... .. .. .. ... .... ... .. .. .. ... .... ... .. .. .713908
Psoriasis .. ... .. .. .. .. ...... .. .. .. .. .. .... ... ... .. .. .. .. .... . ... .. .. .. .. ..... ... .. .. ...7WfflO
Seborrheic keratosis . ... .. .. ... .. .. ... .. .. .. ... .. .. ... .. .. .. ... ..... .. .. .... .. 22X44X
VitiligO ... .. .. .... .... .. .. .. .. ... ..... .. .. .. ... .. ..... . ... .. .. ... ..... . ... .. .. .. .... ..7l62lO
Urticaria [hives, etc.) .. .... .... .. .. .. ... . .. .. .. .. .. .. .. .. ... .... ... .. .. .. .....242.243
Herpes simplex ... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .... .. .. .. .. ... ..... .. .... .. ... ..... ..W6
All other skin conditions ... ... .. .. .. ... .... .. ... .. .. ... . ..... ... .. .... .. .... .... .. .. .. ..
45-54 years










































































55-64 years 65-74 years
Total Hand Foot Other Total Hand Foot



























































































































































2Excludes seborrheic keratosis (22 X44 X) which is listed with benign tumors inthe NYUcla.ssification.
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Table 11. Prevalence rates for skin conditions of concern (complaints), alltypes andthemost frequently reporfed wpes, among females l-74years, byageandpartofbody
affected: United States, 1971-1974
Female






















Fmx Other Total Hand Foot Other Total Hand Foot Other




























































































































Table 11, Prevalence rates forskin conditions ofconcern [comtiaintsl, all Wpesand themost frequently reported types, among females l.74years, by W?andpartofhdy
affected: United States, 1971-1974-Con.
Condition and NYU codel
Win conditions of concern, total ... .. .. ..... .. ... .... ... .... .. ... .. .
Skin conditions of concern with site and type specified..
Diseases of sebaceous glands ... .. .. .... .... .. .. .. ... ... ... ... .... ... ..7l4l.7l49
Acne vuIgaris .. .... .... .. .. .. .. .... .... .. .. ... .... . .... .. .. ... .... ... .. .... ...7l4l5O
Cystic acne .. .. .. .. .. .. .... .... .. .. .. .... .. .. .. .. .. .. .... .. .. .. .. .. .. .... .... ..7l4l8O
Acne scars . ...... .. .. .. .... .... .. .. .. .... .... .. .. .. .. ... ... .. .. .. .. .. .. .. .. ....7l4l9O
Xerosls .... .... .. .... .. .. .... .... .. .. .. .. .. .. .... .. .. .. ... ... .... .. .. .. ... .. . ....7l493O
Dermatophytoses ..... .... .. .... .. ..... ... .. .. .. .. .. ... ... .. .. ... .... .. ..... .. ... .. .. ..l3l
Tines pedis ... .. .... ... ... .. .. .. ..... ... .. .... .. .... .... .. .. .. ... .... ... .. .. .. ... ..1310
Tines unguium .. ... .... .. .. .. ..... ... .. .. .. ... .... ... .. .. .. ... .... ... .. .. .. ... ..l3l2
Tines v.wsicolor . .. .. ... ..... .. .. .. .... ... ... .. .. .. .... .... .. .. .. .. .... .... ..131910
Tines cruris ... .... .. .. .... .... .. .. .. .. .. .. .... .. .. .. .... .. .. .. .. .. .. .... .. .... ..l3l3l
Tumors2. .... .. .. .... .... .. .. .. .. ... ... .. .. .. ... .... ... .. .. ... .. ...l9XZ2X.23XZ3Y
Malignant .. .. .. .... .. .. .. ...... .. .. .. .... .. .... .. .. .. .. ... ..... .. .. .. .. .. . .... ... .. . 19X
Basal@ll epithelioma .... .. .. .. .. .. .. .... .. .. .. .. .. .. .... .. .. .. .. .. .. .. 19X1
BeniSn2 ..... ...<.n. ...<.... ..a. .. ..... ... .. .. .. .. ... ..... .. .. .. .. .... .... .. .... ... ...22x
Lipoma ..... ... .. .. .. .. .... .. .. .. ... .. ..... .. .... .. ... ..... .. .. .. ... ... ... 22X959
Precancerous and not specified ..... .. ... .. .. ... .. ... .. .. .. .. ... ..23 X.23Y
Actinic keratosis ... .. .. ... ... .. .. .. .. .. ... .... ... .. .. ... .... ... .. .. ..23XWl
Seborrhelc dermatitis ..... .. .. .. .... .... .. .. .. .. .... .. .. .. .. .. .. ... .... ... .... .. .....7OO
Seborrheic dermatitis, type not indicated .. .... .. .. .. .. .. ......70001 O
Atopic dermatitis, eczema .. .... .. .. .. .. ...701 ,70S300,708310,708320
Atopic dermatitis ..... .. .. .. .. .... .... .. .. .. .. ... ..... .... .. ... .... ... .. ...70S31 O
Lichen simplex chronicus ...... ... .. .. .. ... .... ... .. .. .. ..... .. ... .. ...7O832O
Hand eczema .. ... .. .. .. .... .. .. .. .. .. ... .... .. ... .. .. ... .... ... .. .. .. .. .... ..7olwo
Nummular eczema .. .. .. .. .. ... ..... .. .. .. .. ... .. ..... .. .. .. .... ... ... .. ...7 OlOlO
Dyshidrotic eczema ... ..... ... .. .. ... ..... .. .... .. .. ...... .. .. .. .. ... ... ..701030
Contect dermatitis .. .. .. .. .. .... .... .. .. .. ... .... ... .. .. .. ... .. .. .. ... .. ... ..<... ... ..7o3
Ichthyosis, keratosis ...... .. .. .. .. ... ... .. .. .. .. .. .... .... .. .. .. ..71 Ol3O.7lOl5O
Verruca vulgaris ... .. .. .. ...... .. .. .. ... .... .. ... .. ... .. ..... .. .... ... .... ... .. ...696O3O
Folllculitis .... .. .... .... .... .. .. .. .. ..... ... .. .. ... .. .... ... .. .. ... .. .. ... .. .... ....7l39OS
Pmriasis .. .. .... .... .. .. .. ...... .. .. .. ... ... .... .. .. .. ...... .. .. .. .. .... .... .. .. .. .. ..7O6O9O
Seborrheic keratosis . ... .. .. .. ...... .. .. .. .. .... .... .. .. .. .. .... . ... .. .. .. .. .. 22X44X
Vltiligo . .. .. ... ... .. .. .. .. .. .... .. .. .. .... .. .. .. .. .. .... .... .. .. .. ... ..... .. .. .. .. ....71621 O
Urticaria (hives, etc.] .. .. .. .... .... .. .. .. .. .... ... ... .. .. .. ... .... ... .. .. ....242.243
Herpes $Implox ... .. .... .... .. .. .. ..... ... .. .. .. .. ..... ... .. .. .. .. ... .. ... .. .. ... .... ...O96
All other skin conditions .. ... .. .. .. ..... ... .. .. .. ... .... ... .... .. .... .... .. .. .. ... .. ....
Sce footnotes at end of table
Female
18-24 years I 25-34 years I 35-44 years
Total Hand Foot Other Total Hand Foot
I
Other Total Hand Foot




















































































































































































































































Table 11. PrevalmIca rates forskln condltionsof concern (complaints), all Wpesand tll@most frequently reported types, among f#males l-74years, byageand part of, body
affected: United States, 1971 -1974 -Ccm.
Condition and NYu $~de~
Skin wnditicm$ of concern, total . .. .. .. .. .. .... .. .. .... .. .. .. .. .. .. .
Skin conditions of concern with site and typo specified,.
Dismses of sebaceous glands ... .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .....7l4l.7l49
Acne vulgaris .. ..... .... ... .. .. ... .. ... .. .. ... ..... .. .. .. ...... .. .. .. .... .....7l4l5O
CVstlcacne ... ... .. .. .. .. ...... .. .. .. .... .... .. .. ... .. .. ... .. .. .... .. .. .. .. ....7t41 SO
Acne scars. ... .. .. .. .. .. .. .. .. .. .... .. ..!.. !.. ... ... .. ....<. .. .. .. .. ... ..... ...7l4l9o
Xerosis .. .. .. .. .... .. .. .. .. .... .. .... ...... .. .. .. ... .. ... .. .. ... .... ... .. .. .. ... .714930
Dermptgphyto~ . ...... .. .. .... .... .. .. ... ..... .... ... .... ... .. .. .... .... .. .. .. .. ... ..l3l
Tines pedls. ... .. .. .. ...... .. ...#.. .. .... .. .. .. .... .. .. .. ...... .. .. .. .... .. .. .. .. ..l3lo
Tines ungulum .. ...... .. .. .. ...... .. .. .. .... .... .. .. .. ...... .. .. .. ...... .. .. .. ..l3l2
~n8averslc010r .. ..... .... .... .... .. .. ... ..... .. .. .... .... .. .. .. ..... .. ... ..l3l9lO
Tines cruris !. .. .. .. ...! .. .. .. .. .. .. ...... .. .. .. .... ....#. .. .... .. .. .. .. .. .. .. ...l3l3l
Tumors2 . .. ...... .. .. .. .. .... .. .. .... .... .. .. .... .. .. .. .. .. .. .... ..l9X.22X.23X23Y
Malignant ..... .. .. ... .... ... .... .... .... .. .. ... ..... .. .. .. ..... ... .. .. ..... ... .. .. .. 19X
6asal-call eplthelioma .. .... .. .. .... .... .. .. .. ......! . .. .. ...... .. .. ...!l9xl
6enlgn2 .. .. .. .. .. .... .... .. .. ... ..... .. .. .. ...... .. .. .. .... .... .. .. .. .. .... .. .. .. ....22X
Lkmma ,. .... .. .. ..... ... .. .. .... .... .. .. ... .... ... .. .. .. .... .. .. .. .... ...22X969
Precancerous and not $peclf lad .. .. ... ... .. .... .. .. .... .. .. .. ..... 23 X,23Y
,Actinlc knratosis . .. ... ... .. .. ... .. ... .. .. ... .... ... .. .. ..... ... .. .. ..23XO8l
Sebarrheic dermatitis . .. .... .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .... .. .. .. ...... .. ...7OO
.Seborrheic dermatitis, type nor indicated .... .. .. ... ..... .. .. ..70001 O
Atoplo dermatitis, eczema ...,..,. ,.......,701,708300,7083 10,70S320
Atopic dermatiti$ ,!,.,.. ,. .. .. ....!... ...1......,..,...,,., . .. .. ..... .. ... .70s310
Lichen simplex chmnicus ... .. .. .. ...... .. .. .. .... .. .. .. .. .. .... .. .. ...7O832O
Hand emema .. .... .... .. .. ... ..... .. .. .. ...... .... .. .... .... .. .. ...... . ... ...7OlWO
Nummular eczema .. ..... .. .. .... .... .. .. ... .... ..... .. ..... ... .. .. ... .. ...7OlOlO
Dyshidrotic aczema ... .. .. .. ...<.. .. .. ... .....<. .. ... . .... .. .. .. ... ..... ..7olo3o
Contsct dermatitis . .. .. .. .... .... .. .. ... .... ... ...... . ... .. ..,!, !...,.....,...,., . ... .703
Ichthyosis, keratosi$ ... .. .. .. .. .. .. .. .. ... .... ... .. .. .... .... .. ...710130.71 Ol5O
Verruua vulgaris . .. .. .. .. .... ...!.... .. .... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .696030
Folliculitls . .. .... .. .. .... .... .. .. ... ..... .. .. .. ...... .... .. ..... ... .. .. .... .. .. .. ...7l39O6
PsOriUls .. .. .... ... ... .. .. .. .... .... .. .. .... .... .. .. .. . .... ... .. .. .. .. .. .. .. .. ...... ..7WO9O
Seborrheic ker?to$is .. .. .. ..! . .. ..... ... .. .. .... .... .. .. .. .......i .. .. ..... ... 22X44X
VitlligO ... ... .. .. .... ... ... .. .... .... . ... .. ...... .. .. .. ..... ... .. .. .... .... .. .. ... .. ..71 S21 O
Urtlcaria (hives, etc.) .. .. .. .. .. .... .. .. ..... ... .. .. ... ..... .. .. .. .. .... .. .. ...242.243
Hwpesslmplex . .. .. .. ..... ... ..... .... ..... ... .. .. ... ..... .. .. .. ...... .. .. ... .. ... .. ..W6
All other skin conditions .. .. .. .. .... .. .. .. .. ..... ... .. .. .... .... .. .. .. ...... .. .. .. .... ..
Female
45-64 y’clars 55.64 years 6s.74 years





















































































































































































































2~xc,u~88 $eb~~~h~i~ ker~t~$is (22X44X) which is listed with benign tumors in the NYu classification.
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Table 12. Prevalence of skin conditions of concern (complaints] among persons l-74 years, by r~currence, duration, handicap, disfigurement and discomfort from





























































































































































































































































1-5 years . ... ... .... .. .. ... .. .... ... ..... .. .. .... ... .. ..... ..
6.11 years .. .. .. ..... ... .. .. .... .. ... ... .. .. .. .. .... .. .. .. ..
12-17 years .. ... .... .. ... .. .. ... .... .. ... .. .. .. ... .... .. ...
18-24 vears .. .. ..... ... .. .. .. .. ... . .. .. .. .. .. .. .. ... .. ... ..
25-34 years .. .. .... .... .. .. .... .. ... ... .. .. .. .. ... ..... .. ..
3544 years .. .. .. .... .... .... ... .... ... .. .. .. .. .. ... ..... ..
45-54 years .. .. .... ... ... .. ... .. .... ... .. .. ... .. .. .... .. ...
55.84 years ..... .. .. .. ... ..... .. .. ... .. ... .... .. ..c.. . ... ..
65-74 vears ..... .... .. .... .... .. .. .. .... .. .. .. .. .. .. .. .. ...




























1-5 years ..... .... .. .. .. ... ..... .. .. .. .... .. .... .. .. .. .. ... ..
6.11 years . .... ... .. .. .. .... .... .. .. .. .. ... ... .. .. .. .. .. ... .
12-17 years .. ... .... ... .. .. ... ... .. .. .. .. .. ... .. .... ... .. ..
18-24 years ... .. .. .. .. .. .. .... .. .. .. .. .... .... .. .. .. .. ... ..
25-34 years .. .. ..... ... .. .. .. .. ...... .. .. .. ... .. ..... .. .. ..
3544 yaars .. .. ... .. .. ... .. .. ... .... ... .. .. .. .... ... ... .. ..
45-54 yEas .. ... .. .. ... ..... .. .. .. .. ... ... .... .. .... .. ... ..
55.64 years ... .. .. .. ...... . ... .. .. ... .... ... .. .. .. .. .... . ..
65-74 years ... .. .. .. ..... .. ... .. .. ... .... ... .. .. .. .. .. ... ..




























l.5years . .. .. .. .. .. .. .. .. .... .. .. .. .. ...... .. .. .. .. .. .. ... . .
6-11 years .. .. ... ..... .. .. .. ... .. ..... .. .. .. ... ... ... ... .. ..
12-17 yeafi ... .. .. .. .. .... .... .. .. .. .... .. .. .. .. .. .. .... .. .
18-24 years ... .. .. .. .... .. .... .. .. ... ... .... .. .. .. .. ..... . .
25-34 years ... .. .. .. .... .... .. .. .. ... .... ... .. .. .. .. .... .. .
35-44 yearn .. ... .. .. .... ... ... .. .. .... ... ... .. .. .. .. .... ...
45-54 yaars .. ... ..... .. .. .. ... .. .. ... .. .. .. .... . .... .. ... ..
55-64 yean .. .. ... .... ... .. .. ... ..... .. .. .. .. .. .... ... ... ..











































































































Standard error of rate
8oth saxes, 1-74 years .. .. ... .. .. ... . 6.22 7.30 1.70 2.06 2.04 0.45 3.95 6.65 2.61 4.02 0.70 5.80
7.11 8.41 2.25 1.63 2.04 0.50 3.30 7.63 3.69 5.61 0.93 6.81
6.63 7.49 1.63 2.62 2.26 0.51 5.65 6.63 2.20 3.41 0.95 5.92
Numbar of persons in thousands
Male, 1-74 years ... .. .. .. ... .. .... ... .. .. ... ... .. .... .. .
Femda, 1-74 yaars ... .. .. .. .. ... ... .. .... .. ..... ... .. .
12,174 13,569 2,072 2,031 1,876 280 6,809 13.657 4,360 9,G65 1,086 11.475
6,551 7,153 962 919 936 124 3,071 7,033 2,435 5,174 573 6,217
5,623 6,416 1,110 1,112 1,040 166 3,736 6,624 1345 3,881 523 5,256
8oth :exec, l-74years ... .. ... ..... ..
Male, 1-74 yearn ... .. ... ... ... ... .... ... .. .. .. ... .. .. .. .
Female, 1-74 years .. .. .. .. ... .. .. .. ... .... ... .. .. .. .. .
45
Table 13. Type of care sought and adequacy of treatment for skin conditions of concern (complaints) among persons 1-74 Years, by age
and sex, showing rates, selected standard errors, and number of persons affected: United States, 1971.1974
All con.
Some
Care for skin complaint sought from





EzIIzlE. ‘~~ ‘:” ?r ‘:* ‘?? ‘:?
Age and sex
Rate per 1,000 population



































































































































1-5 years .. .. .. .. .. .. .. .. .. .. .. .. .. .. . ... .. .. .. .
6-11 years ... .. .. .... .. .. .. .. .. .. .. .. .. .... .. ..
12-17 years ... .. .. .. .. .. ...... .. .. .. .. .. .... ..
18-24 years .. .. .. .. .. .. .. .... .. .. .... .. .. .. ...
25-34 years ... .. .. .. .... .. .. .. .. .. .. .. .. . . ....
35-44 years .... .. .. .... .. .. .. .. .. .. .... .. .. ...
45-54 years .. .... .. .. .... .. .. ... . .. .. .... .. .. .
55-64 years ... .... .. .. .... .. .. .... .. .. .. .. .. ..
65-74 years .. .. .... .. .. .... .. .. .... . ... .... .. .



























































1-5years . .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. ....
6-11 years . ..... .. .. .... .. ...... .. .. .... .. . ....
12-17years .... .. .. .... .. .. .. .. .. .. .. .... . . ...
18-24 years .. .... .. .. .... .. .. .... ... . .... . ... .
25-34 years . .. .. .. .. .. .... .. .. .... .. .. .... .. ..
35-44 years .. .. .... . . .. .. .. .. .. .... .. .. .... .. .
45-54 years .. .. .... .. ... ... ... . .... .. .... .. ...
55-64 years ... .. .... .. .. ..... .. .. ... .. ... .... .
65-74 years .. .. .. .. .. .. .. ..... . .. .... .. . .. ....










1-5years ... .. .. .. .. .. .. .... .. .. .. .... ...... . ...
6-11 years .. .. .. .... .. ..... . .. .. ..... . . ..... .. .
12-17 years .. .. ...... .. . ... .. .. ...... .. .. .. ...
18-24 years . .. . . .... .. .. ...... .. .. .. .. .... ... .
25-34 years .... .. .. .... .. .. .... .. .. ... ... . ....
35-44 years ... .. .. .. .. .. .. .. .. .. .. .. .... .. .. ..
45-54 years .. .. .. .. .. .... .. .. .. .. .. .. .... .. .. .
55-64 years ... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. ..
































































Standard error of rate
8oth sexes, 1-74years.. 2.87 1.68 1.75
3.79 2.16 2.30
2.98 1.65 2.14
2.60 I 2.36 i 7.68 i 7.29 i 1.30 I 1.39
2.96 I 2.81 9.72 I 9,30 1,71 I 1,713.16 3.09 7.39 7,19 1.19 1.37Male, 1-74 years.., ... .. .. .... .. .. .. .. .. .. ..Female, 1-74 years ... .. .. .. .. .. .. .... .. .. .
Number of persons in thousands
4,179 I 15,914 1, 15.419 I 1,147 I 1,197
1
Both sexes, 1-74 years..
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The sampling plan for the first 65 stands of
the Health and Nutrition Examination Survey
(HANES) followed a stratified multistage proba-
bility design in which a sample of the civilian
noninstitutionalized population of the coter-
minous United States, 1-74 years of age, was
selected. Excluded from the selection were per-
sons residing in Alaska and Hawaii and those
within the coterminous United States confined
to institutions or residing on reservation lands of
American Indians. Successive elements dealt
with in the process of sampling were the primary
sampling unit (PSU), census enumeration district
(ED), segment (a cluster of households), house-
hold, eligible persons, and finally sample per-
sons.
The starting points in the first stage of this
design were the 1960 Decennial Census lists of
addresses and the nearly 100 PSU’S into which
the entire United States was divided. Each PSU
is either a standard metropolitan statistical area
(SMSA), a single county, or two or three contig-
uous counties. The PSU’S were grouped into 357
strata for use in the Health Interview Survey and
subsequently collapsed into 40 superstrata for
use in Cycles II and III of the Health Examina-
tion Survey and HANES.
Fifteen of the 40 superstrata contained a
single large metropolitan area of more than
2,000,000 population. These 15 large metropolit-
an areas were selected for the sample with cer-
tainty. The 25 noncertainty strata were classi-
fied into four broad geographic regions of
approximately equal population and cross-
classified into four broad population density
groups in each region. Then a modified Good-
man-Kish controlled selection technique was
used to select two PSU’S from each of the 25
noncertainty superstrata with the probability of
selection of a PSU proportionate to its 1960
population so that proportionate representation
of specified State groups and rate of population
change classes was maintained in the sample. In
this manner a total first-stage sample of 65
PSU’S was selected. These 65 sample PSU’S or
stands are the areas within which a sample of
persons would be selected for examination over
a 3-year survey period.
Although the 1970 Census data were used as
the frame for selecting the sample with PSU’S
when they became available, the calendar of
operations required that 1960 Census data be
used for the 44 of the 65 stands in the sample of
HANES. Census enumeration districts (ED’s) in
each PSU were divided into segments of an
expected six housing units each. In urban ED’s
the segments were clusters of six addresses from
the 1960 Census Listing Books. For ED’s not
having usable addresses, area sampling was
employed and, consequentIyj some variation in
the segment size occurred. To make the sample
representative of the current population of the
United States, the address or list segments were
supplemented by a sample of housing units that
had been constructed since 1960.
Within each PSU a systematic sample of seg-
ments was selected. The ED’s that fell into the
sample were coded into one of two economic
classes. The first class, identified as the “poverty
stratum, ” was composed of “current poverty
areas” that had been identified by the U.S.
Bureau of the Census in 1970 (pre-1970
Census), plus other ED’s in the PSU with a mean
income of less than $3,000 in 1959 (based on
1960 Census). The second economic class, the
48
“nonpovert y stratum, ” includes all ED’s not
designated as belonging to the poverty stratum.
All sample segments classified as being in the
poverty stratum were retained in the sample.
For those sample segments in nonpoverty stra-
tum ED ‘s, the selected segments were divided
into eight random subgroups and one of the sub-
groups was chosen to remain in the HANES
sample. This procedure permits a separate analy-
sis with adequate reliability of those classified as
being below the poverty level and those classi-
fied as being above the poverty level.
After identification of the sample segments,
a list of all current addresses within the segment
boundaries was made, and a person in each of
the households was interviewed to determine the
age and sex of each household member, as well
as other demographic and socioeconomic infor-
mation required for the survey.
To select the persons in sample segments to
be examined in HANES, all household members
age 1-74 in each segment were listed on a sample
selection worksheet with each household in the
segment listed serially. The number of house-
hold members in each of the six age-sex groups
shown below were listed on the worksheet under
the appropriate age-sex-group column. The
sample selection worksheets were then put in
segment number order and a systematic random
sample of persons in each age-sex group was





2044 years male 1A
2044 years female ?/?
45-64 years %
65-74 years 1
The persons selected in the 65-stand sample
of HANES make up a representative sample of
the target population and include 28,043 sample
persons 1-74 years of age of whom 20,749 or
74.0 percent were examined. When adjustments
are made for differential sampling for high risk
groups, the response rate becomes 75.2 percent.
All data presented in this report are based on
“weighted” observations. That is, data recorded
for each sample person are inflated to character-
ize the subuniverse from which that sample per-
son was drawn. The weight for each examined
person is a product of the reciprocal of the prob-
ability of selecting the person, an adjustment for
nonresponse cases (i.e., persons not examined)$
and a poststratified ratio adjustment that in-
creases precision by makiig the final sample esti-
mates of the population agree approximately
with independent controls prepared by the U.S.
Bureau of the Census for the noninstitutional-
ized population of the United States as of
November 1, 1972 (approximate midsurvey
point), by color, sex, and age shown in table I.
Population estimates are included in some of the
tables in greater detail than that used for weight-
ing. These population figures, while not precise
census estimates in this degree of age detail, are
included to give a rough idea of the number in
the population at risk.
A more detailed description of the survey
design and selection technique can be found in
the “Plan and operation of the Health and Nu-
trition Examination Survey, United States,
1971 -1973,” Vital and Health Statistics, Series
l-No. 10a.7
Nonresponse
In any heaIth examination survey, after the
sample is identified and the sample persons are
requested to participate in the examination, the
survey meets one of its more severe problems.
Usually a sizable number of sample persons will
not participate in the examination. Whether or
not an individual participates is determined by
many factors, some of them uncontrollable and,
therefore, may be reasonably treated as an out-
come of a random event with a particular proba-
bility of occurrence. If these probabilities of par-
ticipation were known and greater than zero for
all persons, then the examined persons would
constitute a probability sample from which
unbiased estimates of the target population
could be derived. In this situation, the effect of
nonparticipation would only be to reduce the
sample size, thereby increasing the sampling
NOTE: A list of references follows the text.
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Table 1, Unit6d States civilian nonin~titutional ized populdtioh, by age, $@x,and oolor, November 1, 1972
1. ~
Age in years
Sex and color Total
1-5 6-19 2044 45.64 65-74
Total ............................................ 193,976,447 17,282,843 55,434,127 66,307,351 42,344,237 12,607,889
Male ..............t ................ .............................. 94,151,059 8)8 18,156 28,014,291 31,757,861 20,090,701 5,469,960
White ........ ...... ........................................ 82,652,067 7,407,500 23,911,243 28,195,112 18,19C),f48 4,948,064
All other ................... ......................... ..... 11,498,992 1,410,656 4,103,048 3,562,749 1,900,643 521,896
Femak ........................... .............................. 99,825,388 8,464,687 27,419,836 34,549)490 22,253,446 7,137,929
White ...................................................... g6,932,196 7,070,629 23,261,515 30,102,612 20,011,119 6,4%6,421
All other ....................................... .......... 12,843,192 1,394,158 4,158,321 4,446,87g 2,242,327 651,508
Source: Unpublished estimates of September 27, 1974, from the U.S. Bureau of the Census.
errors of examination findings. In practice, how-
evert a potefitial for bias due to nonresponse
exists because the exact probabilities are never
known. A further potential for bias exists if: (1)
a sizable proportion of sample persons have a
zero probability of participation, that is, they
would nevet agree to participate in an examina-
tion survey of the same procedures and induce-
ments, and also (2) these persons differ from
other sample persons with respect to character-
istics under examination. It is for these reasons
that intensive efforts are made in HANES to
develop and implement procedures and induce-
ments that would reduce the number of non-
respondents and thereby reduce the potential of
bias due to nonresponse, These procedures and
inducements are discussed in the “Plan and oper-
ation of the Health and Nutrition Examination
Survey, United States, 1971 -1973,” Series l-No.
10a.7
Despite these intensive efforts, 24.8 percent
of the sample persons from the 65 stands were
not examined. Consequently, the potential for a
sizable bias does exist in the estimates in this
publication, From what we know about the non-
responderits and the nature of nonresponse, we
believe that the likelihood of sizable bias is
small, For instance, orIly a small proportion of
persons gave reasons for nonparticipation which
would lead to the belief that they would never
agree to participate in examination surveys and
that they may differ from examined persons
with respect to the characteristic under examina-
tion. Only 15 percent of the nonrespondents
gave as their reasons for nonparticipation per-
sonal illness, physically unable, pregnant, anti-
doctor, or fear of finding something wrong.
Typical among the reasons given by the other
nonre,spondents were: unable because of $vork,
school, or household duties; suspicious or slfepti-
cal of the program; just not interested in p~rtici-
pating; and private medical care sufficient o}rjust
visited doctor.
An analysis of medical history data obtained
for most nonexaminees as well as examinee$ also
supports the belief that the likelihood of sizable
bias due to nonresponse is small. No large differ-
ences were found between the examined group
and nonexamined group for the statistics com-
pared. For example, 11 percent of persons
examined reported having an illness or condition
that interferes with their eating as compared to
9 percent of persons not examined but who had
completed a medical history. The percent of per-
sons examined reporting ever being told ~by a
doctor that they had arthritis was 20 percent;
the percent for high blood pressure was 1? per-
cent and for diabetes, 4 percent. The corre-
sponding percents for nonexamined persons
were: arthritis, 17 percent; high blood pressurej
21 percent; and diabetes, 4 percent.
As was mentioned earlier, the data in this
report are based on weighted ob servation$, and
one of the components of the weight assigqed to
an examined person was an adjustment for non-
response. Because the probabilities of participa-
tion are not known for sample persons in
HANES, a procedure was adopted that rnulti-
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plies the reciprocal of the probability of selec-
tion of sample persons by a factor that brings
estimates based on examined persons only up to
a level that would have been achieved if all
sample persons had been examined. This nonre-
sponse adjustment factor is the ratio of the sum
of sampling weights for all sample persons
within a relatively homogeneous class defined by
age, sex, and five income groups (under $3,000;
$3,000-$6,999; $7,000-$9,999; $1o,ooo-
$14,999; and $15,000 and over) within each
stand, to the sum of sampling weights for all re-
sponding sample persons within the same homo-
geneous class for the same stand. To the degree
that homogeneous groups can be defined which
are also homogeneous with respect to the charac-
teristics under study, the procedure can be effec-
tive in reducing the potential bias from nonra-
table II. Percent distribution of non response adjustment fac-
tors: Health and Nutrition Examination Survey, stands
01-65, 1971-1974
Number Percent
Size of factor of distri -
cells bution
Total .. . .... . . ..... .. .. .... .. .... .. .. .... .. . .....
l. 00.1.24 .. .. .. .... .. .. ... ... .. .... .. . ... .. .. .... .. .. ....
l.25.1.49 .. .. .. .... . .. .... .. .. ... ... .. ... .. .. ... ... .. ... .
l.50.1.74 . . ... .... .. . ..... . ... ... ... . .... . .. .... . ... .....
l.75.1.99 . . .... .. ... . .... . .... ... ... . .... . .. .... .. .. .... .
2.00-2.49 ... .. ... .. .. ..... . .... .. .. . ..... .. . .... .. .. .... .
2.50-2.99 . .... . ... .. .. .... .. ... ... .. .. .... . ... .. ... . .... .

















sponse. For the 65-stand sample of HANES, the
percent distribution of the nonresponse adjust-
ment factors used for the 325 income group-
stand celk is shown in table H.
Missing Data
Examination surveys are subject to the loss
of information not only through the failure to
examine all sample persons, but ako from the
failure to obtain and record all items of informa-
tion for examined persons. The dermatology
examination was not obtained for 111 or 0.54
percent of the 20,749 examinees in this HANES
I program. The age-sex distribution of these non-
examined persons is shown in table III. In the
detailed tables and fiidings of this report, no
estimate has been made for what skin findings
they might have had. Rather it has been assumed
that they had normal skin.
Small Numbers
In some tables, magnitudes are shown for
cells for which the sample size is so small that
the sampling error may be several times as great
as the statistic itself. Obviously in such instances
the numbers, if shown, have been included to




In the present report, reference has been
made to efforts to minimize bias and variability
Table I I 1. Total number of exam inees and those not given the dermatological component, by age and sex: Health and Nutrition






I Total number examined
Ail ages, 1-74 years . . .. .... . ... .... .. . ...4. .. ... ... . ..... . . .... . ... ... .. .. .... .. .... .. ... ... .
1-5 years .. . ... .. .. .. .. .... . .. ... .... .... .. .. .... . . .... .. .. ..... . .. ... . .... .. .. .. .... . ... .. ... .. ... .. ... ... . . .... ..
6-11 years ... .. .... . .. .... .. .. .. .. .. ...... .. .... .. .. ... ... .. ... . .. .... .. .. .. ... . .... .. .. ... .. .. .... . .. .... .. .. .. ..
12-17 years . .... .. .. .... .. . .... . ... ... .. .. .... .. .. .. .... . ... .. .. .... .. .. ... .. .. .... . ... .. .. ... ... .. . .... .. .. ... ..
18-24 years . .... ... . .... . .. .... ... . .... .. .. ... . .. .... .. .. ..... . .. ... . ... ... .. .. .... . .. ... .. .. .... .. .. ... . .. .... ..
25-34 years . . .... .. . ..... .. .. ... ... .... .. .. .... . ... .. .. .. .... .. . ..... .. . ... .. .. .... . ... ... . .. ... ... . ..... . .. ... ..
3544 years .. .... .. ..... . .. .... .. .. .... .. .. ... . .. .... .... .... .. . .... .. .. .... .. . .... . .. ... ... .. .... . .. ... . .. .... ..
45-54 years .. . ... ... . .... .. .. ... ... ..... . .. .... . ... ... .. . ..... . . .. .. . ... ... .. .. .... . .. .... . .. ... ... .. ... .. . ... .. .
55-64 years .. ... .. .. .... .. .. .... .. .. ....<. .... .. .. .... .. . .....<. .... . ... .... .. . .... . .. .... .. . .... ... .....4.. ... . .























of measurement techniques. The potential of
residual bias due to the high nonresponse rate
has also been discussed.
The probability design of the survey makes
possible the calculation of sampling errors. Tra-
ditionally, the role of the sampling error has
been the determination of how imprecise the
survey results may be because they come from a
sample rather than from the measurement of all
elements in the universe.
The estimation of sampling errors for a
study of the type of the Health and Nutrition
Examination Survey is difficult for at least three
reasons: (1) measurement error and “pure” sam-
pling error are confounded in the data–it is not
easy to find a procedure that will either com-
pletely include both or treat one or the other
separately, (2) the survey design and estimation
procedure we complex and, accordingly, require
computationally involved techniques for the cal-
culation of variances, and (3) hundreds of sta-
tistics are presented in the tables in this report,
many for subclasses of the population for which
there are a small number of sample cases. Esti-
mates of sampling error are obtained from the
sample data and are themselves subject to sam-
pling error when the number of cases in a cell is
small or, even occasionally, when the number of
cases is substantial.
Estimates of the standard errors for selected
statistics used in this report are presented in
most of the tables in this report. These estimates
have been prepared by a replication technique
that yields overall variability through observa-
tion of variability among random subsamples of
the total sample.1 8)19 Again, readers are
reminded that these estimated sampling errors
do not reflect any residual bias that might still
be present after the attempted correction for
nonresponse. The standard error is primarily a
measure of sampling variability, that is, the vari-
ations that might occur by chance because only
a sample of the population is surveyed. As calcu-
lated for this report, the standard error also
reflects part of the variation that arises in the
measurement process. It does not include esti-
mates of any biases that might lie in the data.
The chances are about 68 out of 100 that an
estimate from the sample would differ from a
complete census by less than the standard error.
The chances are about 95 out of 100 that the
differences would be less than twice the stand-
ard error and about 99 out of 100 that it would
be less than 2% times as large.
Tests of Significance
The procedure used in this report for testing
the significance of the difference between the
two means consisted of dividing the difference
between the two means by the standard error of
the difference; that is, a z statistic was com-
puted. An approximation of the standard error
of a difference d = x - y of the two statistics x
and y is given by the formula
Sd = (s; + s; p
where SX and SY are the sampling errors, respec-
tively, of x and y. Of course, where the two
groups or measures are positively or negatively
correlated, this will give an overestimate or
underestimate, respectively, of the actual stand-
ard error.
Examiner Variability
The Data Collection Unit of the Committee
on Planning for the NationaI Academy of Der-
matology (NAD), under chairman Dr. Wu.-ie-
Louise T. Johnson, was responsible for planning
the content of the dermatology examination and
for recruiting and training the 101 dermatologist
examiners employed at the 65 examination loca-
tions in the Health and Nutrition Examination
Survey of 1971-1974.
Advance training in the dermatology examin-
ation protocol was given each dermatologist
before the survey examinations were started. In
addition, members of the NAD Data Collection
Unit periodically reviewed the methods used and
the recording of findings by the dermatologists
during the survey. After completion of the sur-
vey, Dr. Johnson thoroughly reviewed the
20,637 recorded examinations to ensure consist-
ency with the standard examination protocol,
including the selection of the significant diag-
noses, and resolved the diagnoses of skin cancer
and dermatophytoses on the basis of subsequent
findings from the biopsy and fungal laboratory
determinations, respectively.
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The number of examinees per dermatologist
ranged from 4 to 638, with 27 percent examin-
ing fewer than 100 persons, 28 percent 100-199
persons, 26 percent 200-299 persons, and 20
percent 300 persons or more.
Variation would be expected among the
examiners in the proportion of their examinees
found to have significant skin pathology and in
the proportion with skin complaints because of
differences in the age-sex distribution among
them in the groups examined, regional differ-
ences, and the extent or type of environmental
exposure that may affect the prevalence of vari-
ous types of skin pathology and other factors.
To assess the extent of examiner variability and
the effect that it may have had on the findings
from this dermatology examination, the effect
of age-sex differences in the groups examined by
each dermatologist have been controlled through
a direct adjustment method. In this the age-sex-
specific rates for each examiner have been
applied against the number of persons in that
age-sex group for the total population and the
age-sex-adjusted rate recomputed.
Among persons examined, the age-sex-
adjusted proportions found to have significant
skin pathoIogy range from O to 90.4 percent
per examiner, with one-fourth of the dermatolo-
gists finding 13.7 percent or less of their
examinees to have such pathology, one-half find-
ing between 13.7 and 46.1 percent, and the
remaining one-fourth finding 46.1 percent or
more with significant skin pathology (tables IV
and V). The range in such findings among
examiners is negligibly greater among females (O
to 90.0 percent) than among males (O to 88.2
percent).
Examiner variability in the proportion of
their examinees with skin complaints, when the
effect of age-sex differences among the groups
are removed by direct adjustment is somewhat
less than that for significant pathology because
of the lower rates in general for the complaints.
The range in the age-sex-adjusted rates of skin
Table IV. Range, mean, median, and quartiles in the distribu-
tion of dermatologist examiners, by the age-sex adjusted
proportion of examinees with significant skin pathology,
skin conditions of concern (complaints), and their ratio:
Health and Nutrition Examination Survey, 1971-1974
Measure and sex
Both sexes
Range .. . .. . ... .. . . .... . .. ... .. .. ..
Mean ... .. .. ... .. .. .... . . ..... .. .. .




Range . ... .. .. .... .. .. .. .. .. .... .. .
Mean . .... .. .. .... . .. ... ... .. ... .. .




Range . .... .. .. .... . ... .. .. .. ... .. .
Mean .. ... .. .. .. .. . ... . . .. .. .. .. .. .
Median .. ... . ..... . .. ... .. .. .... ..
’25 ““””””-”””””””””””””-””-”””-””””






























































lExclude~ examiner finding of no simsificant DatholoW but
with examinee having conditions of c;ncern (~4.2 pe;;ent).
complaints is from O to 70.8 percent per
examiner, with one-fourth of the examiners
recording 2.7 percent or less, one-half of the
examiners between 2.7 and 19.8 percent, and
the remainder 19.8 percent or more of their
examinees with skin complaints.
The ratio of skin compktints to significant
skin pathology per examiner ranges from O to
4.29, with one-fourth of the examiners showing
0.08 or less, one-half from 0.08 to 0.85, and the
remainder 0.85 or more.
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Table V. Number of examinees and age-sex adjusted proportion of examinees with skin pathology, skin conditions of concern
(complaints), and their ratio, by dermatologist examiner ancl sex of exam inee: Health and Nutrition Examination Survey, 1971-
1974
Examiner number






















































































































































































































Table V. Number of examinees and age-sex adjusted proportion of examinees with skin pathology, skin conditions of concern
(complaints), and their ratio, by dermatologist examiner and sex of examinee: Health and Nutrition Examination Survey, 1971-
1974–Con.
52 . .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .... .. .... .. .. .... .. .. .. .. .. .... .. .... .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. ... . .. .. .. .. ......
53 . .. .... .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .... .. .. .. .. .. .... .. .. .... .. .... .. .. .. .. .. .. ... . .... .. .... .. . ... .. .. .. .. .. .... . . ......
54 ... .... .. .. .... .. .. .... .. .. .. .. .. .... .. .. .. .. .. .. .. .. ... . .. .. .. .. .. .... .. .. .. . ... .. .. .. .... .. .... .. .. .. .. .. ... . .. ... .. . ......
56 .. .... .. .. .... .. .. .... .. .. ... . .. . ... .. .. ... . .. .... . . ... .. ... ... .. . .... . . .... . .. ... . .. .... .. .. ... . .. .... . . .... . .. .... . . .......
57 .. .... .. .. .... .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .... . . .. .. .. .. ... . .. .... .. .... . ... .. .. .. .... . . .... .. . .... . .. .... .. .... .. . ......
58 .. .. .. .. .. .... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .... .. .. .. .. .. .. .. .. . ... .. .. .. .. .. .... .. .... .. .......
59 .. .... .. .. .... .. .. .... .. .. ... ... .. .. .. .. .... . . .... .. .. .. .. .. .... . . ... .. . .... . .. .... . .. .. . .. .. ... . .. ... .. .. ... . .. ... . .. .......
60 .. .... .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .... .. .... .. .... .. .. .. .. .. .... .. .... . . .. .. .. . ... ... . ... .. . .... .. . ..... .. .... .. .......
61 ... .... . ..... ... ... ... . .... .. .. .... .. . .... . .. .... . . .... .. .. .. .. .. .... .. .. .. .. .. .. .. ... .. ... . ... .. .. .. .. .. .... .. .... .. ........
62 ...... .. .. .... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. ... . .. .... .. .. .. .. .. .... .. .... .. .... . . .. .. .. .. .. .. .. .... .. .... .. .. ... . .. .......
63 .... .. .. .. .. .. .. ... ... .. .. .. . . .... .. .. ... . .. .... .. .. .. .. .. ... ... . .... . .. ... . .. ... .. ... .. ... . ... . .. ... .. . .... .. . ... .. . ........
64 .. .. .. . . .. .. .. .. .... .. .. .... .. .... .. .. .... .. .... .. . .... . .. .... .. .. ... . .. .... .. .... .... .. .. .. .. .. .. .... . . .... .. .. .. .. .. .......
65 .. .. .. .. .... .. .. .... .. .. .. .. .. .... .. .. .. ... . .... .. .... .. .. ... .. .. ... .. .. .... . . .... . .. ... .. .. ... . .. .... . .. ... . ... .. .. .. .. ... . .
66 .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. . ... .. . ... .. .. .....4.... .. .. .. .. .. .... . . .... .. .. .. .. .. .......
67 ... .. .. .... .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .... .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. ... . .. .... .. .. .. .. .. .... .. .... .. .. .. .. .. ......
68 .. .. .. .. .. .. .. .. .. .. .. .... .. .... .. .. .. . . .. .. .. .. .. .... .. .... .. .. .. .... .... . . .. .... .. .... . ... .. .. .. .... . . .... . . .. .. . ... .......
69 .... .. .. .... .. .. .. .. ... ... .. . .... . .. .... .. .. .. ... . .... . . .... . ... .. .... . ... .. . .... .. . ... ... .. .. .. .. .... . .. .... . .. ... . . ........
70 .. .. .. .. .... .. .. .. .. .. .... .. .. .... .. .. .. .. . .... .. .. ... . .. ... . ... .. .... . ... . .. .... .. . .... . .. .. .... . .... . .. ... .. .. .. .. .. .......
71 .. .. .. .. .. .. .. .. .. .. .. .... .. . ... .. .. .... .. .. .. .. .. .... .. . ... . ... .. .. .. .... .. .... .. .. .. .. .. .... .. .. .. .. .. .... .. .. ... . .. .. .....
72 .... ... .. ... .. .. .... .. .... .. . . .... .. .. .. .. .. .... .. . ... .. . ... .. .. ... ... .. .. . .. .... . .. ... .. ... .. .. . ..... . .. .... . .. ... . .. .......
73 .... .. . .... . .. .. .. .. .. .... .. . ..... .. .. .. .. .. .. .. . . .... .. .. .. . ... ... ... .... .. . .... . .. ... . . .... ... . ..... .. .... . . .... .. .. ... .. . .
74 .. .. .. .. .. .. . ... .. .. .... .. .. .... .. .... .. .. .... .. .. .. .. .. .... .. .... .. .. .. .. .. .... . .. .... . . .... .. . .... .. .. ... .. . .... . .. ........
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76 .. ... . .. .... .. .. ... .. .. ... .. .. .... . ... .. .. .. ... .. . .... . .. .... . .. .. ... .. ... . .. .... . . .... .. .. ... .. . ... .. . .... . ... .... .. ........
77 .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .. .. .. .. .. .. . ... .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .......
78 .. .. .. .... .. .. .... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .... .. .. .... .... .. .. . ... .. .. .... .. .... .. .. .......
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81 ... .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .... .. .. .. ..o. .. .. .. .. .. .. .. ... . .. .. .. .. .. .... .. .. .. .. .. .. .. .. .... .. .... .. .. .. .. .. .. .. ....
82 ... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .... .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. ......
83 . .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. ......
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89 ... .. .. .... .. .. ... . .... .. .. .. ... .. . .... .. .. .. .. .. ... ... . ... .. .. .... .. .... .. .. .... .. .. .. . . .. .. .. . ... ... . .... .. .... . . .... ......
91 . .... .. .. ... . .... .. .. . ..... .. .... .. . ... . ... .. .... . ... .. . .... . .. .... .. . ... ... . ... .. . .... . ... ... .. . ... .. . ..... .. ... . .. .... . .. ..
92 ... .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .... .. .... .. .. .... ... ... .. .... .. .. .... . . .... .. .. .. .. .. .. .... .... . . .... .. . .........
93 . .. .. .. .. .. .. .. .... .... .. .. .. .... .. .... .. .. .. .... ... ... .... .. . .... . .. .. .. .. .. ... . .. .... . ... .. .. .. .. .. .. .... .. .. .. .. .... .. .. ..
94 ... .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .. ... .. .... . . .... . .. .... .. .. .. .. .. .... .. .. .. .. .. .... .. .... .. . ... .. .. ... . .. ..
95 ... .. .. ..... . .. .... .. .. ... . .. .... . .. ... .. ... .. .. .. ...` . . .... . .. ... .. .. .. ... . .... .. . .... . ... .. ... . ... .. .. ... . .. ... .. . .... .....
96 ..... .. .. .... .. .. .. .... .... .. . ... . ... .. .. .. .... .. . ... . .. .... . .. ... .. .. . .. .. . .... .. . ... .. ... .. .. .. .... .. . ... ... ..... .. ........
97 ... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .... .. .... .... .. .. .. .. .. .. .... .. .. .. .... .... .. .... .. .. .. .. .. .. ......
99 ..... .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .. .. .. . .... . .. .... ... ... .. .. .. .. .. ... ... .. .. . ... .. .. .. .... .. .. .. .. . ..... ... .......
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Table V. Number of examinees and age-sex adjusted proportion of examinees with skin pathology, skin conditions of’ concern
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Table V. Number of examinees and age-sex adjusted proportion of examinees with skin pathology, skin conditions of concern
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82 .............................................................................................................................
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Table V. Number of exam inees and age-sex adjusted proportion of exam inees with skin pathology, skin conditions of concern
(complaints), and their ratio, by dermatologist examiner and sex of examinee: Health and Nutrition Examination Survey, 1971-
1974–Con.
Examiner number

























































































































































































































Table V. Number of examinees and age-sex adjusted proportion of examinees with skin pathO109Y, skin conditions Of concern
(complaints), and their ratio, by dermatologist examiner and sex of examinee: Health and Nutrition Examination Survey, 1971-
1974–Con.
Examiner number
52 ....... ........................ ........ ................ ............ .......... .......................... .. ....................
53 ....................... .......... .......................................... ...... .. .......................... .. ..............
54 ....................... ................................................................................ ......................
55 ........................................ .............. ............ ........ .................... ........ ...... .................
56 ...................... .. ........ ........ ...... .................... ........ .................................... ...... .........
57 ............ .................................................................................. .. .................... .........
58 .... .........................................................................................................................
59 .............. ...... ................ .. ............................ ...........................................................
60 ................ ...... .. ...... ........ .. ...... .................................... ..........................C......... .......
61 .............. ............................... ................................................................................
62 ............ ................................ .................................................................................
63 .................................................... ........ .............. ...................................................
64 .............................................................................................................................









74 ......... ........ ........ .............................. .............. .. .... .. ...... ...... ........ ............................
75 .................................................................... .. .......................................................
76 ......................................... . ..................................................................................
77 ................................. ........W........................ .. .............. ........ ..................................
78 ....................... ..................A.................. .............. ...... ...................... ...... ................




83 .............. .................................... ................ ................................................ ......4....
84 ........................ .............. .......................................................................................
85 .............................................................................................................................
86 ............................ ........................................................... ......................................
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............. ...................................... ........ ............ ........ ........ ...... ................................
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97 ... ., !.......................................................... .............................................................
99 ............................................................................ .................................................
100 ......................................................................................... ..................................






































































































































































































































THE DERMATOLOGY EXAMINATION FORM
r > . .
HE AL THAN DNu TRIT I ON EXAMINATIONS URVEY
DE RMATO LO GY EXAM IN AT ION
151Deck No.
(USE RED PENCIL TO FILL FORM)
NAME (Last, First, Middle) “SAMPZENUMBER EXAMINER NO.
I
STATE OR FOREIGN COUNTRY OF LONGEST
RESIDENCE
——. —— __ m
OCCUPATIONAL EXPOSURE la Yes
m——=
2R No EX=URE TO LIGHT
IF YES: (CHECK ALL THAT APPLY) ~ (by history)
~ In Chemicalq f.me$or vapors ~ lU Immersion (hands or feet)





SIGNIFICANTDESMATOLOGICAL DIAGNOSIS FROM THIS EXAMINATION
Clinical Impression Code Biopsy
1.
~ Cm 1 Done l~Refusesl
—.-— ——— Not done+ 2
mn
2.
~ ;U Done ~ 10 Ref.sed
2U Not done+ 2mOther reason
3.
ma 10 Done mla Refused
—-—— —— 2m Not done+ 2n Other reason
FINDINGS RELATING TO NUTRITION
.,, ,
SIGNIFICANT DERMATOLOGICAL DIAGNOSIS MADE PKEVIOUSL~ PHOTOGRAPHY OF SKIN: Frame No.




1. a ~=.—.—. — !lQL ~ 1 J 2 3n
:.~d----
GENERAL APPEARANCE (1 - 3)
~Age at first
graying years--1. Jipircolor (Natural)
(CHECK 1 BOX)












Medium to ii~h~ ~r~;__ _ _ _
Chestnut or auburn
Red (titian, carro~,-e;c~)- --
Dark blonde
---- .




Black ---- --- ---- __ 04m







---- ----- ----- _____ ____ ___ - -- -.
CHECK “YES OR ‘NO“ FOR EACH





2. Eye Color -(CHECK 1 BOX)
la Dark brown SD Dark blue
20 Light brown 6D Light blue
3D Gray,green, 7U Mismatch
hazel 8a Other(SPECIF$
40 Speckled
---- ____ ____ ____ ____ ____ _
Nevus of Iris - (CHECK 1 Box)
m ;~ M;:t
3n Both
m 2 “-12’(?age 1)
7-W
.Iumllii-l I 2rl I 3U,
3. Skin Texture
Surface 10 NO FINDINGS
~ ~U Coarse 2U Fine
~ ~D-5ii~------ZB-E;:5 miE;EG5”-E;EG--”~ ~u-i;:sE--..------...--. ---------------
---------------------------------,--------.
m Dry 1n Senile 20 Winter
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4. PIGMENT ABERRATIONS








la Melanin ~eneral-hypo------.------- -------- ---------------------
In Melanin general-cosmetically disfiguring















20 Tatoo - traumatic - cosmetically disfig.
In Addison’s disease-------------------------------------------.-
In Albinism - Total
2n Albinism - Partial--------------------------------.----.-------
:D Pella~oid pigmentation------ ------- --------------------------
In Vitiligo - Total
~U Vitili&o - Partial------: ---------------------------------
~u Peat Inflammatory------,.--------- ~F$Fzij----------------
Iu Chronically ill
iU-W&:-W%c~FYj-------------------------
Significant Trau- Surgi- *oth Herbie
Scars matic cal Zoster
Hypertrophic lU 2U 3U 4U
Atrophic lU 2U 3U 4U
Keloids ll_J 21.._l 31-I 4U
Senile Lentigenes ~ 10 Many (10+)------------ -------------------------- ---------- -.----
EphiIidee ~ ~ 10 Many (10+)
6. Vascular
—
VASCULAR CHANGSS OTHRR TNAN NBVI (7 - 10)
ITEMs 7-10-+@ I&l NO FINDINGS @-Tc)~T&KL~ ~--g-..----.---..-.-------.---..------....--.....--.L---
---‘-‘~~~~1 ~-~~fiM%Oti- -------
7. . VASCUL4R CHANGES OTNSR THAN NSVI
Source (CHSCK ONE) Location (CHECK ONE)
~ 10 Observed UIQ 11=1 Hands
~ 10 Furpura-senile ~ :U Coldness---------
Other purpura(CHECK ONE) ~ ~B Qanosis
2D BY history 20 Feet ~ In Traumatic
-. ------
~ In Sdema




3D Dis. related ~ lU Persistent
—— years f+m Idiopathic 20 Recurrent
SD Etiology obscure ~ lD-~;;~;-----
mermorsta









Overall impression 123 In 2 3
Fine telangiectasia 124 In 2 3r-
Senile Elaetoais 125 lU ~ 3q-1
Actinic keratoses .126 lU 2 3
10. OTHER TELANGIECTASIA
Location



















~ la Mother 20 Father 30 Both
~ 10 Paternal 2m Paternal 3D Both
male female
~ In Maternal 2U Maternal 3m Both
male female
12. NEOPLASTIC CWANGE
~ lm NO FINDINGS (GO TO ITEM 13)
‘- mSuperficial BCE--------
Squamous Ce11 Carcinoma- - 6
l!=%
Bowen’s disease__ _ _ - - 67 II
Lymphoma, leukemia_ _ _ _ . 70 1U1
Metastatic__ _ _ _ _ . 73 1[
L MISCELLANEOUS LESIONS OF COLOR AND TEXTO’RE
~ 10 NO FINDINGS(GO TO Few Many
ITEM 12) d5 5+
Clams (feet) ---------------- ~ In in
Seborrheic keratoses
Face and scalp 141 In 2n---------------
Back and cheat---.----------- 142 la zn
Nasolabial or other
body folda 143 10-------------------
Papuloaa nigra---------------- 144 10 g
Epithelial tags--------------- 145 lU
Neurofibromata --------------- 146 IU [1
Dermatofibromata 147 1u-------------- +
Epidermal Levi----------------K lrl _
Warts-hands ------------------.% m 2
Warts-feet--------------------150 lrl 2[
Warts-genital---------------m-351 In !2
Warta-other(SPECIFY) 152 1[-J 2n
Tophi------------------------- 153 lU
Xanthomta -------------------- 154 lu _ –+
Acanthosis nigracanS---------- 155 lU



























13. Ectodermal glands ~ ~ lU NO FINDINGS (GO TO ITEM 14)
Eccrine
Locati“,x





Dishydrotic. I /\ U, r-l W,rl I--- 1/ -4 .L , I *A4J
1[_l Anhydrotid
Apocrine (Poat pubertal)
Mammary gland developmen~ Fox Fordyce disease
la Absent !3D Marked ~1~ Axillary m la
2a Deficient ~ 10 Para-areolar
Sebaceous glands:
Sebum production ~ 1 n Increaaed
i;:iG:i:;-:;;EG-7i::~ -i-U-Z-L--------? -D-:5 -?---
Genital
La;gest ~ cm. (9 or > code to 9)
Location of cysts :~ ~ lU Chest ~ 10 Face
mm In Back lD Other(SPECIFY)+





14. NAILS - ~ ~ 1D NO FINDINGS (GO TO ITEM 15)
Fingernails (TOTAL NIJMBSR) ~ _ _
Abnormsliti.es(RECORD NUMBER OF NAILS INVOLVED. IF LESS THAN ~ PRECEDE
Color m— — whit’; ~ ye;::: m91_
Quality — — soft;
Contour
——
~~ Raised; ~ ~~dd
Surface — — Ridged; .—
Other ~] Thickened; ~ Clubbed
Complete absence of nails, not traumatic ~ 10
B●nds White,cross;~~ pigmented 10ng—.
NUMBER WITH ())
_ Green, brown or black
Clinical impression of abnormalities noted above:
~ 1U Fungus ~ In Trauma @ lU Alopecia areata
~ la Lichen plan.a ~ la Nevus ~~ 1U Psoriasis




~ In Thickened ~ la Discolored ~ la Pigmented bands
Clinical impression of abnormalities noted above:
~ lU Fungus ~ 10 Psoriasis ~ 1[~ Nevw7
~ 1U Trauma ~ la Other (SPECIFY)
15. HAIR —> ~ la NO FINDINGS
~: Alopecia Min. Mod . Severe
Male
Pattern--- m lrl 2n 30
>
Localized m lrl 2n 30
Diffuse-- m lrl 21-I 3n
Impression
of etiology
~ 1n Areata ~ 10 Infection
H la Anti meta- ~ 10 Trauma
bolites
~ 10 POstcli- ~ la Familial
macteric
Texture:
~ lC]Fj.ne 2CI COarse
UZZl lUDry staring Za Easily plucked 30 Both
,Eyebrows:
~ lnSparse 2U Absent
Evelashes:
~ laSParse 20 Absent
Facial Hair (post pubertal)
Males
~ luSparse 2U Absent
Females >
~ l~cessive 1
~ 10 Alopecia @ In Genetically
Areata determined
~ In Post infec- ~ la Post trauma
tion
~ la Endocrine ~ 1n Other(SPECI-
FY)
Axillar~
~ lnsparae 2H Absent
Pubic
~ l[~Sparse 2~ Absent (not shaved)
Body Weir
m 10 Inappropriate -xutch-n
Location ‘None Minimal Marked Excessive
Anterior Thorax
Posterior Thora~~ 262 1
Arms
..........
H;M7$?5-12 (Page 4) Form Approved




m la NO FINDINGS (GO TO ITEM 17)
‘% Scalin$. .ZQ-.EEY!L%E---?-Q--!?!!. 7 --------- --
-Impressions:—
l.@ la Seborrheic dermatitis
~ In Trauma





~ 10 Acquired 2a Congenital
@ la Chondodermatitia helicis nod.laris
Nose
Deform~
~ la Acquired Zu Congenital (saddle, etc.)
Mouth Bucca









L?!2.8w (-t’,. ) General ma-wzlossia
Mal developed generally
~ In Forked ~ la Partial atrophy 20 Fu11 atrophy
Papillae
~ 10 AtrOphic ~ 10 Geographic 30 Pyramidal
Zn Black hairy 4n Scrotal
Palate





= lU Beefy red Za Magenta
Other findings:
~81 In Serrations 2U Swelling(marginal 3[Z Bc,th
(marginal bilateral) bilateral)
18. THIGHS AND BUTTOCKS
~1 la NO FINDINGS (Go To ITEM 19)
[~ ~D Veno.a stars
~ l~-F1i;il~;i-Zj; i;:d’li~i:-------
20 Pilonidal cysts-drainage
3D Pilonidal cysts-no drainage
AU Pilonidal cysts-repaired
~ l~-~~~~~i-~~~~; i;---------------








I 3ii Both4U Uncertain
2(?. EXTREMITIES
~] la NO FINDINGS(W TO ITEM 21)
NO FINDINGS (GO TO ITEM 20)
Chancre
I
Redness and scaling due to:
Other VD ~ l~Posriasis













Varicoaities bin. jMod. ISever
Right 13581 1C112CI 30
Left-~z4 13591I lrllzcl I 3LI
----------------------------------- -------- --------
N3 color Peri-’foll.
Follicular hyperkeratosis change redness
Upper-outer arm 36~ 1n 2CI---------
Rest of upper extrem. m m 2D---
Entire arm m In 2rl-------.------
Upper-outer legs m 1c1 2Kl--------
Rest of lower extrem---- m ~ 20
Entire leg m 1n 20--------------
Upper back ---- ------ =~ la 2L
Abdotnen_ -- _ ..- -,--- .m . la 2U
Buttocks----- - ._.- _ -- .= 13.CI 2m-:,
,
17, THORAX AND ABDOMEN —m la NO FINDINGS(GO% ITEM 18)
Supernumerary areolaeL.= number with glandular tissue







Striae:- --.------------~ lEI purple ~ 1n White
~ In Draining fistulae or other lesions
= lD Pigmented
m Congenital malformations
HSM 425-12 (Page 5) Form Approved
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DISEASE ORIENTE D EXAMINATION
[3691 1[ 1 NO DISEASE [(ITE?JB21-31) SKIP TO EVALUATION ON NEXT PAGE-]
21. ACNE VULGARIS 26. cent.’d Cause of Urticaria (CIDICKALL TK4T APPLY)
~ lU Inactive
b~’
Min. I Mod. ISever =~~U-F~od ~n Inhalant
20 Active
.:.--:---









!27. CONTACT DERMATITIS (CHSCK ALL THAT APPLY)
~ la Plant ~ In Rubber
~ 10 Medication ~ la Leather
~ la Chemical ~ In Cosmetics
~ 10 Metal ~ 10 Obscure
in Fabrics
.-














SEBORRHEIC DERMATITIS (CHBCK ALL THAT APPLY)














~ 10 Scalp only ~~ 10 Trunk
2U Extremities only 2r2 SebOrrheic 11— .–Viral Vesi
/12’.‘lM:lNFE::~@xcE~wARTs)
: Diagnostic Impression
3a Both areas only W 11-J H. Simplex 3U M. Contagiosum




~ la Parent 20 Sibs 30Parents and sibs Min. Ii-l In
~ i~-~~~~-;;l;~~;; ;--------------------------- Mod . 20 2n
------------------------------------------------------- Severe >1 J 5( II SI J15
Did joint problem precede psoriasis? Folliculitis M mlwy




Severe r “- ‘ --
Severity Impetigo
~ la Minimal 2Q Moderate 3U Severe Min. 1r] In
Distribution
Mod. 20 20
H la Flex.ral areas only TBC
2U Flexural areas and other(SPECIFY) Min.
3U Generalized
Mod . 2
Severe 31 1 I-1,
Family History Hansen’s rh-1[ml
EEH El
Ato~ Disease Min. lrl 11--I.-=.----
‘~;~icarla and?~~-~;~~;------------ Mod . 2m 2m,-4-------------------- ---------------Severe 3 31--I 31_J JI
Personal History Swim. Pool
~ la Urticaria and/or asthma Gran. Min.
1
Mod . 2
26. URTICARIA (CHRCK ALL THAT APPLY)
Joint Involved
~ ~D Fi.~ers 2U Toes
~ in Positive 2D Negative 3n Not done
30 Both~ ~n.~;in:---------------------------- on BACTERIAL INFECTIONS
m Ln-6iR6i-I:IiE7EFEEiH j-------------
--------------------- --------------------------
~ ~U Cholin&gic ~ lnAn@o-ne”roticede !=
@19~nczi;;--- ‘--- IIEEmiCl&.lZ---------------mt3E3lnb;~ifi;;~-;;;icaria----------------- --------------------------------------
I
lD Yes
ARTKROPOD AND PROTOZOAN INFECTIONS
~ l~%rimmer ‘a itch
~ lCIMites
~ la Leiahmaniaais
] la Pedic.losis capitis ~
] 10 Pediculosis pubis ~
Q la Pediculosis corporis ~. _
IJ= 1~ _ __.._.——–Creeping eruption I
















— ———-— —- —-- - .——. -
Recurrent? 4L9Ql ruul 1
1 D Yes 1 D Yes 1 mYe
2DN0 2 m No 2 No
IF YES-Months
active in past 12
months
.— ._ ~s X
m TOTAL
SKIN








Part-severe Zn 2[7----- / 2rl !21-J







34. Handicap to Social
Relations
UIJ u M
Severe Ir] 1rl---------- in In
Minimal Zr--l Zn--------- 2[~ z~





























lr-1 21--J 3r-J 41-1
lr) Zrl 3n 4CI





















9. OBSTACLE TO IMPROVEMENT OF CONDITION (CHECK ALL
TH4T APPLY)
= lo NO medical advice sowht




- - ‘iiiEiGGi-??ii-iiZZEii-GGi;”--------- ~------- ----.------- ~~ Availablllty of transportation
~u-FIi:&;----------------------
lrY-6E&---------- ”-----”--”-----
Emp. or W In in !------ 1[1 I
Part. Emp. or I-W Zn Zn 1 2n
No change 3r-1 i 3n 3n I
I
-------







AND GLOSSARY OF SELECTED TERMS
Classification
Inclusions in the groupings of conditions
from the Code of Skin Diseases of the Depart-
ment of Dermatology, New York University
School of Medicine (February 1968 edition)8






















Diseases due to Viruses-SmalI-
pox, Rubeola, Rubella, Chicken
Pox, VariceIla, Herpes Zoster,
Trachoma, Herpes Simplex, Foot
and Mouth Disease, etc.
Herpes Simplex, Foot and Mouth
Disease, etc.
Rickettsial Diseases – Typhus,
Rocky Mountain Spotted Fever,
Q Fever, etc.
Leishmaniasis and other Parasitic
Diseases–including Trypanoso-
miasis, Toxoplasinosis, Trichino-
sis, Pin Worm, etc.
Dermatophytoses–including Ath-
lete’s Foot, Tinea Pedis, Tinea
Manuum, Tinea Capitis, Tlnea
Barbae, Tinea Unguium, Onycho-












mycosis, Paronychia, Tinea Cru-
ris, Tinea Corporis, Favus, Tri-
chophytids, Tines Versicolor,
Tinea Nigra Palmaria, etc. (ex-
chding Monilial)
Dermatophytoses of Foot, Ath-
lete’s Foot, Tinea Pedis (ex-
cluding Nails)
Dermatophytoses of Nails, Tinea
Unguium, Onychia due to Der-
matophytes, Onychomycosis, Par-
onychia (excluding Bacterial and
Monilial)
Dermatophytoses-Crura.I, Tinea
Cruris (excluding Monilial and
Erythrasma)








Zoonoses – including Scabies,
Mites, Pedictdosis, Chiggers, Tick
Bites, etc.




ease, Erythroplasia, Paget’s Dis-


























Malignant Tumors – Base-Squa-
mous Epithelioma, Base-Squa-
mous Carcinoma, Intermediary
Metatypical Epitheliorna or Car-
cinoma, Mixed Metatypical Epi-
thelioma or Carcinoma, Prickle-















Hemangioma, Cafe au Lait Spot,,
etc. (excludes 22X44X–Sebor
rheic Keratosis )
Seborrheic Keratosis, NOS or NEC
Benign Tumors–Lipoma
Precancels–including Actinic Ker-





Edema, Nettle Rash, Lichen
Urticatus, Telangiectasia Macu-
Iaris Eruptiva Perstans, Masto-
cystosis, Hives
Allergic Eczema or Dermatitis due
to extermd agent–Eczema, Aller-

































Avitaminosis and Nutritional De-
ficiency States–including Beri-
beri, Pellagra, Scurvy, Rickets,
Alopecia, Vitamin Deficiencies,
etc.






Polycythemia, Hemophilia, Pur- ,
pura, etc.
Psychophysiologic, Mental Psycho-
Neurotic, and Personality Dis-
orders
Diseases of Nerve-including Bell’s
Palsy, Erythredema Polyneurot-
ica, Meralgia Paresthetic,
Diseases of Eye–including Con-
junctivitis (nonallergic), Blephari-,
tis, Sty(e), Chalazion, E@ropion,
Entropion, Ptosis, etc.
Disease of Ear–includir~g Otitis
Externa, Chondrodermatitis Nod-
ularis Chronica Helicus
Rheumatic Fever–with or’ without
Heart Involvement





Diseases of Veins–includihg Statis
Ulcer or Dermatitis, Varicose
Veins, Hemorrhoids, Phlebitis,
etc.
Other Diseases of Circula~ory Sys-
tem–including Osler-Weber’s Dis-
ease, Telangiectasis (h&editary
























Diseases of the Digestive System–
Buccal Cavity, Salivary GIands,
Lips, Anus, Pancreas
Diseases of the Breast and Genito-
Urinary System
Infections of the Skin and Subcu-
taneous Tissue–including Boils,
Carbuncles, Cellulitis, Impetigo,





Seborrheic Dermatitis, NOS or
NEC
Eczema
Hand Eczema or Dermatitis
Nummular Eczema
Dyshidrotic Eczema
Other Dermatitides – including
Contact Dermatitis due to Plants,
Oils and Grease, Solvents, Drugs,
other Chemicals, Radiation, Cos-
metic, other Agents (such as
Dyes, Furs, C1othes, Dress, WOOI,
Clothing Finishes, Shoes, Leather,






thema, Erythema Simplex, Acne
Rosacea, Rhinophyma, etc.
Psoriasis including Parapsoriasis
and other and unspecified types
of Pityriasis
Psoriasis (all types, NOS or NEC)
Lichen Planus and some other
Lichenoid Dermatoses
Pruritus and related conditions
Infantile Atopic Dermatitis
Neurodermatitis Disseminate and
Atopic Dermatitis, NOS or NEC
Lichen Simplex Chronicus, Cir-
cumscribed Neurodermatitis
Corns and Callosities
Other Hypertrophic and Atrophic

























Diseases of Nails-including In-
growing Nail, Hangnails, Discolor-
ations, etc.












Acne: S&rs or NOS or NEC
Xerosis
Chronic Ulcers of Skin
Diseases of Skin, NEC–including
Acne Scaring, Chickenpox Scar-
ring, Smallpox Scarring, Cicatrix,
Tattoo, Freckle, etc.
Vitiligo, Albinism, Piebaldism





Certain Diseases of Early Infancy–
including Ritter’s Disease, Sclero-
derma Neonatorum, Impetigo
Neonatorum, etc.
Symptoms, Senility and Ill-Defined
Conditions
hjuries and Adverse Effects of
Chemical and Other External
Causes
For those who are not familiar with the der-
matological terminology in the tables and ex-
amination form a glossary is included to identify
and explain certain clinical observations. For
fi.u-therclarification and discussion, the reader is
referred to a standard text of dermatology;
three are cited:
MoscheIla, S. L., Pillsbury, D. M., and Hurley,
H. J., Jr.: Dermatology, Vol. 2. Philadelphia.
W. B. Saunders, Nov. 1975.
69
Fitzpatrick, T. B., et al.: Dermatology in Gerz-
eral Medicine, New York. McGraw-Hill, 1971.
Rook, A., Wilkinson, D. S., and Ebling, F. J. G.:
Textbook of Dermatology, 2d ed. Oxford and
Edinburgh. BlackweU Scientific Publications,
1968.
A canthosis niqicans. —A warty velvety
change in the skin of the axillae, groin, and
about the neck that can be associated with
obesity, endocrine disturbances, and in adults
with visceral malignancy.
A ctinic keratosis. –Adherent yellow to brown
scale on a red-tinged base associated with solar
da*age) a Pre*~iwancY of the epiderfis.
Addison’s disease. *Primary adrenal cortical
insufficiency. It can have secondary hyper-
pigmentation in the skin from an outpouring of
pituitary hormones responding to the adrenal
cortical failure,
Albinism. –The result of an inherited failure
of the melanocyte to produce normal amounts
of pigment in the skin, or eye, or both. Partial
albinism (piebaldism), an autosomal dominant
trait, involves only the skin and hair. All forms
of albinism are present from birth.
Apocrine glands. –Developmentally associ-
ated with hair and sebaceous glands, they
atrophy during fetal Iife but persist in the axillae
and genital area to secrete at puberty an oily,
colorless, odorless substance that undergoes
bacterial decomposition to produce body odor.
A topic dermatitis. –An inflammatory con-
dition of the skin characterized by itching, red-
ness, and occasionally vesiculation and weeping,
that is found in individuals with the inherited
diathesis called atopy. The patient may present
one or several manifestations of the atopic state
such as hay fever, allergic rhinitis, asthma, and
urticaria or hives.
Basal-cell epithelioma. –An epithelial car-
cinoma arising in the basal cells of the surface
epidermis. It may be further characterized as
superficial eryth,ematous or nodular, and may be
pigmented or not.
Bowen’s disease. -A precancerous dermatosis
presenting as a defined brownish-red plaque
without eIevated border single or multiple,
which may have an historical association with
arsenic ingestion.
Callus. –Hyperkeratosis of the epidermis ad-
jacent to thinner skin and the apparent rdspcmse
to constant rubbing or pressure. A corn is similar
but has a sharply demarcated translucetit core.
Neither lesion is vascularized.
Candida. –A yeast genus of which the species
Albicans is the most common pathogen for man.
It infects the mucous membranes of mouth and
vagina most commonly but also body foIds and
can be widespread in the immune deficient
patient.
Dermatofibromata. –Firm circumscribed .
papules of a half centimeter or so, in the skin,
usually on legs and often hyperpigmented. They
may represent a cellular reaction to injury.
Dermatophytosis. –Infection of the skin
with fungus.
Eccrine glands. –Sweat glands that produce
and transport to the skin surface a hypotonic,
clear, odor-free solution (eccrine sweat) in re-
sponse to heat or psychological factors.
Eczema.–See eczematous dermatitis, ~
Eczematotis dermatitis. -Not a condition but
an inflammatory resptmse of the skin to a num-
ber of stimuli from within and without, ~Poison
ivy can produce a characteristic weeping derma-
titis that is eczematous, so too can surdight in
certain sensitive individuals, Ingested dtiugs, as
well as the patient’s own host response to a
superficial infection as with fungus, can evoke
a similar eruption. Because atopic dermatitis
in children is often eczematous, it has been com-
monly called “eczema” with consequent cow
fusion of the reaction pattern with the disease.
“Atopic dermatitis. “ “ is the term to be preferred
and shouId designate the active atopic condition
whether in adults or children.
Ephelides. –Freckles, those circumscribed
tan-brown macules scattered over Iight-qxposed
skin.
Epithelial tags, –Hyperplasia of the skin re-
sulting in soft polypoid lesions less than a cen-
timeter in diameter that are skin colored and
multiple around neck, upper chest, and inner
surface of the arms.
Herpes simplex. –A virus that inddces an
infection characterized by small vesicles on a red
base (fever blisters or “cold sores”) anld recur-
rence. It can occur on head or neck, in the gen-
ital area, over the buttocks, and more rarely on
the extremities.
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Ich.thyosis. –Accumulation of polygomd scale
that gives a fishlike appearance to the skin. It
may be congenital or acquired and in its sudden
appearance can be associated with occult malig-
nancy.
Lichen planus. –A papuIosquamous eruption
of violaceous polygonal lesions and character-
istic histology that is often pruritic, can last 1 to
2 years, and is of obscure etiology.
Lichen striatus. –A self-limiting Iinear derma-
titis of unknown etiology that appears inflam-
matory and occurs more often in children.
Moniliasis. –Infection with Candida.
Mycosis fungoides. –A chronic fatal disease,
a T-cell Iymphoma of the reticuloendothelial
system, initially invoIving the skin, with a name
descriptive of the large fungating lesions that can
occur and should not impIy fungal infection.
The disease can be limited to the skin, but may
also involve lymph nodes and viscera.
Neurofibromata. –An overgrowth of
Schwann cells and endoneuria that resuIts in a
smooth soft to firm skin-colored papule that can
be inva~nated. In size they can range from a few
millimeters to several centimeters in diameter.
These lesions are found in large numbers in
neurofibromatosis (Von Recklinghausen’s dis-
ease).
Nevus. –The Latin for birthmark, is used
most commonly for the clinical evidence of
aggregates of normal melanocytes or pigment
cells in the skin. In color they range from tan,
brown to black, in size from millimeters to an
entire trunk (giant hairy nevus). By histological
level of mektnocytes, they are divided into (1) a
junctional nevus that histologically has aII the
melanocytes above the basement membrane,
(2) a dermal nevus with all melanocytes in the
dermis, and (3) a compound nevus with melano-
cytes in the dermis and epidermis.
Onychomycosis. –A fungous infection of the
nails.
Papulosa nigra. –The hyperpigmented sebor-
rheic keratoses of the more pigmented races
occurring usually on the face.
Pityriasis versicolor. –See tinea versicolor.
Psort”asis.–An inherited disease of the skin
characterized by circumscribed red scaling
patches with silvery scale that may be few in
number or may extend to involve the skin
totalI y. It can be associated with arthritis.
Seborrheic dermatitis. –A persistent erythe-
matous, scaling dermatitis, more greasy than
dry, that involves the scaJp, eyebrows, anterior
chest, and the areas about the nose and behind
the ears. It can be extremeIy bard as in miId
dandruff or proceed to generalized redness and
scaIing.
Seborrheic keratoses. –Raised, greasy, warty
lesions that appear tacked on, vary in pigment
content from pale yellow to black, and in size
from a millimeter to centimeters in diameter.
They are found mostIy on the trunk or face but
may appear on the extremities.
Senile keratosis. –See actinic keratosis.
Squamous-cell carcinoma. –A tumor of the
epidermis which in its invasive form has all the
characteristics of malignancy including the
ability to metastasize, but which usually has a
more beni~ course when arising on sun-exposed
skin.
Sweat glands. –hlay be eccrine or apocrine
(see both).
Telangz”ectasia. –Dilated superficial vessels
that appear as coarse or fine vascular threads
on the skin. They can be a response to solar
damage and are characteristic of the lesions of
certain dermatological diagnoses.
Tinea. –A superficial infection with fungus.
The term is usually further modified by ana-
tomical site: T. capitis, of the scalp; T. corporis,
of the body; T. pedis, of the foot; T. manuum,
of the hand; T. umguium, of the nail; T. cruris,
of the groin.
Tines nigra palmart”a. -A superficial fungous
infection of the palms leaving residual pig-
mented macules seen largely in tropical climates.
Tinea versicolor. –A superficial fungous in-
fection of the skin with Malassezia furfur.
Tophi. –Subcutaneous, firm to hard nodules
of a salmon-pink color that occur most com-
monly on the helix of the ear, over the bursae
of the elbow, and about the digits of the hands
and feet. They consist of urate deposits from
elevated uric acid levels of the blood and are
seen in gout.
Trichoph ytids. –A generalized or Iocalized
skin reaction in individuals allergic to the fun-
gus, Trz”chophyton.
Tumors. –Cellular aggregates that are clin-
ically apparent in the skin.
Urticarib. -Hives or wheals.
Verruca. –Warts are epidermal responses to
the human papilloma virus that appear on the
skin as circumscribe ed elevated, rough-surfaced
papules (verruca vulgaris or common warts);
as threadlike polypoid growths (verruca fili.-
formis, the filiform or digitate wart); as ia
smooth flat or slightly elevated skin-colored
or gray-yellow papule (verruca plana, the plane
wart); on the sole of the foot as a horny papule,
(verruca plantaris or plantar wart); in the genitaI
area as the venereally transmitted pink, elong-
ated, occasionally filiform or peduncuIated
warts (cond ylomata acuminata or acuminate
warts).
Vitiligo. –A spontaneous loss of pigment
with disappearance of the melanin-producing
cells of the hair bulbs, skin, and mucous mem-
branes but not other parts of the me~anocyte
system such as those in the eyes and brain.
It is probably an inherited defect and is more
commonly found in those with diseasq associ-
ated with autoimmune mechanisms, pernicious
anemia, hyperth yroidism, Addison’s disease, and
idiopathic hypoparathyroidism.
Xanthomata. –Erythematous papules with a
yellow cast that appear singly or diffusely and
are associated with abnormal concentrations or
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